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� Tea is the fragrant brew prepared from the leaves of tea plant called Camellia 
sinensis which is an evergreen tree belonging to the family of Theaceae. Second to water, 
tea is one ofthe most popular and widely consumed beverages worldwide. According to 
the manufacturing process, tea can be divided into three main types including green tea, 
oolong tea and black tea. Green tea generally refers to the non-fermented tea and oolong 
tea is partially fermented while black tea is the completely fermented one. The chemical 
composition of green tea is very similar to that of the fresh tea leaves. Over 30% ofthe 
dry weight ofgreen tea are polyphenolic compounds, most of them are known as flavan-
3-ol or tea catechins. The green tea catechins (GTCs) consist of four major structurally-
related epicatechin isomers known as (-)-epigallocatechin gallate (EGCG),(-)-
epigallocatechin (EGC), (-)-epicatechin gallate (ECG) and (-)-epicatechin (EC). Green 
tea is widely consumed among the Chinese population and it is believed to have various 
health-promoting properties. Over the past decade, GTCs were found to have diverse 
physiological and pharmacological properties including hypolipidemic, 
hypocholesterolemic, anti-inflammatory, anti-microbial, anti-oxidative, anti-mutagenic, 
anti-carcinogenic and anti-tumor activities. Although evidence has been accumulated 
showing that GTCs can inhibit the growth of various types of tumor cells both in vitro 
and in vivo, the precise mechanisms by which GTCs can exert their effects on tumor 
cells and the relationship between their chemical structures and anti-tumor activity 
remain poorly understood. 
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Abstract 
In the present study, the direct anti-tumor effects of different tea extracts 
including green tea, oolong tea and black tea on various leukemic cell lines were first 
studied in vitro. Results showed that all the tea extracts exhibited differential anti-� 
proliferative and cytotoxic activity to various leukemia cells in a dose-dependent manner. 
They could also induce apoptosis in the human promyelocytic leukemia, HL-60 cells. 
The potency oftheir anti-tumor effects was in the decreasing order ofgreen tea « oolong 
tea > black tea. 
To have a better understanding of how GTCs can exert their effects on tumor 
cells, the growth-inhibitory, cytotoxic and apoptosis-inducing effects ofindividual green 
tea epicatechin isomers were studied. Their in vitro anti-tumor activities were compared 
using a panel of human and murine leukemic cell lines. Among the four green tea 
epicatechin isomers being studied, EGCG and EGC but not ECG and EC were found to 
be the most potent isomers which displayed differential anti-proliferative and cytotoxic 
effects on various leukemic cell lines in a dose-dependent manner. The results showed 
that the myeloid leukemia HL-60 and JCS cells, and the murine lymphocytic leukemia 
L1210 cells were very sensitive to the growth-inhibitory effect of EGCG and EGC 
whereas the murine macrophage-like tumors were relatively resistant. 
Exposure of the myeloid leukemia HL-60 and JCS cells to various green tea 
epicatechin isomers failed to trigger differentiation, as judged by the morphological 
criteria. Besides, EGC and EGCG could induce apoptosis in HL-60 and JCS cells in a 
dose-dependent while the other two epicatechin isomers EC and ECG were found to be 
inactive. Results in this study also showed that the in vivo tumorigenicity of the 
• • 
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leukemia JCS cells and L1210 cells was markedly reduced by treating the cells with 
EGCG in vitro. 
� 
It was found that the anti-proliferative activity of EGCG on leukemia cells was 
significantly enhanced by the presence of vitamin analogs (ATRA and Vit D3), 
cytokines (IL-1, IFN-y and TNF-a), or other plant phytochemicals (Taxol, 18p_ 
Glycyrrhetinic acid). Among them, cytokines such as IFN-y and TNF-a exhibited a 
synergistic effect with EGCG in inhibiting the growth of the murine myeloid leukemia 
jCS cells. These findings suggested that green tea or green tea epicatechin isomers 
might be a potential candidate to be used in combinations with other cancer-preventive 
or therapeutic agents for the prevention and treatment ofcancer. 
Furthermore, the molecular mechanisms by which EGCG could induce apoptosis 
of the HL-60 cells were examined. The expression of growth-related and apoptosis-
regulatory genes and proteins were studied by the techniques of RT-PCR and Westem 
blot -analysis respectively. Our preliminary mechanistic studies demonstrated that Bcl-2 
expression was suppressed while there was an enhancement of Bak expression in 
EGCG-treated HL-60 cells. On the other hand, the expressions of other growth-related 
and apoptosis-regulatory proteins including PKC-5, c-Myc, Fas, Fas-ligand (FasL) and 
NFKB were found to be significantly upregulated in apoptotic HL-60 cells after 
treatment with EGCG. 
Apart from the leukemia cells, the effects of EGCG on mouse splenocytes and 
normal hematopoietic progenitor cells were also studied. It was found that EGCG did 
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not exhibit cytotoxicity on both cell types. Interestingly, the growth and differentiation 
of mouse bone marrow cells were significantly enhanced by the presence of EGCG in 
yitro. Our results suggest that EGCG might have beneficial effects on the hematopoietic -* 
stem cells especially for the recovery of hematopoiesis after radiotherapy. Quite 
unexpectedly, EGCG was also found to inhibit the growth factor-induced proliferation 
and differentiation ofbone marrow cells. 
It is hoped that the above findings can provide better insights into the beneficial 
health-promoting effects of green tea and leads to better understanding of the molecular 
basis and action mechanisms of the epicatechin isomers on various leukemia cells. This 
ultimately can lead to the development of better and more efficacious strategies for the 











或可稱為綠茶兒茶素a^reen Tea Catechins, 011：3)的物質°綠茶 
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Chapter 1 General Introduction 
1.1 Hematopoiesis 
1.1.1 Introduction to Hematopoiesis 
� Hematopoiesis is the process of formation and development of blood cells 
including red blood cells, white blood cells and platelets from pluripotential 
hematopoietic stem cells. The pluripotential stem cell which has an extraordinary self-
renewal power to expand and differentiate into stem cells that are committed to three, 
two or one hematopoietic differentiation pathways. Several stages are involved in the 
derivation of the functional, recognizable cells from their primitive, less differentiated 
and unrecognizable precursors. None of these stem cells are morphologically 
distinguishable (Morrison et aL, 1995). Hematopoiesis first takes place in the yolk sac 
during the first few weeks of gestation in humans. The process then shifts to liver and 
spleen in fetuses and in the bone marrow in adults. In normal adults it occurs in the bone 
marrow and lymphatic tissues (Hoffband & Pettit, 1993). 
All the cells that circulate in the peripheral blood are derived from the 
pluripotential hematopoietic stem cells. Hematopoiesis is strictly regulated to maintain a 
balanced number of blood cells and blood cell types in our body. In the marrow of a 
healthy person, there are about one hematopoietic stem cell per 10^  marrow cells 
(Metcalf, 1995) and most of them are neither dividing nor differentiating. These cells 
can be called into division during times of hematopoietic stress and then differentiate to 
immature progenitor cells of various blood cell lineages (Metcalf, 1995). The process of 
hematopoiesis is depicted in Figure 1.1. 
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The very first step in hematopoietic differentiation involves a commitment of the 
stem cell to either one of the two large pathways, myeloid or lymphoid. Subsequently, 
cells committed to each of these two pathways may become obligated to specific •� 
sublines of development. The cells are referred to as committed progenitor cells after 
becoming committed to a specific pathway, or lineage. There are three major branches 
of myeloid pathway: erythroid, megakaryocytic, and phagocytic. The erythroid and 
megakaryocytic lines do not branch further and give rise to red blood cells and blood 
platelets respectively. However, the phagocytic pathway can be further subdivided into 
monocytic and granulocytic pathways. The monocytic pathway gives rise to monocytes 
and macrophages while the granulocytic pathway can be further divided into 
neutrophilic, eosinophilic and basophilic pathways. For the lymphoid pathway, it can be 
subdivided into B and T cell pathways which are responsible for the generation ofB and 
T lymphocytes respectively (Goldstein, 1995). 
2 
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Figure 1.1 Normal hematopoiesis 
BFU: burst-forming unit; CFU: colony-forming unit; GM; granulocyte-macrophage. PMN: 
polymorphonuclear leucocyte 0V4odified from Goldstein, 1995) 3 
Chapter 1 General Introduction 
1.1.2 Cytokines in Hematopoiesis 
The growth and differentiation ofhematopoietic stem cells to specific committed 
lineage and to form the mature blood cells in our body is strictly regulated by a wide � 
variety of cytokines, commonly known as hematopoietic cytokines, in association with a 
complex stromal microenvironment. These cytokines are all glycoproteins with 
molecular mass of 20-50kDa. They can act on more than one lineages in the process of 
hematopoiesis. For example, interleukin-4 (IL-4) plays important roles in inducing the 
proliferation and differentiation of precursors of basophils, mast cells and eosinophils 
into mature cells (Favre et al., 1990). 
On the other hand, other cytokines are relatively lineage-specific and only exert 
their activities late in hematopoiesis on a single pathway. Erythropoietin (EPO) and 
Thrombopoietin (TPO) are two examples. EPO can stimulate the proliferation and 
differentiation oferythroid precursor cells (CFU-E, BFU-E) to more mature erythrocytes 
(Sieff, 1987). TPO is initially identified as a specific factor for megakaryocytopoiesis 
and thrombopoiesis. The primary target cell population for TPO in bone marrow 
comprises of megakaryocyte progenitors at the late stage of differentiation (Kato et al, 
1998). It also plays role as a differentiation factor for the development of erythroid and 
myeloid progenitors (Tanimukai et al., 1997). In addition, two cytokines including 
granulocyte colony stimulating factor (G-CSF) and macrophage colony stimulating 
factor (M-CSF) are also relatively lineage-specific. G-CSF can stimulate the growth and 
development of neutrophils while M-CSF plays an important role in the proliferation, 
differentiation and activation of cells of the monocyte-macrophage lineage (Crosier & 
Clark, 1992). 
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The granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 
(IL-3) and stem cell factor (SCF), on the other hand, act at a very early stage of 
hematopoiesis on stem cells or committed progenitor cells for the development ofblood � 
cells. GM-CSF and IL-3 were found to have effects in stimulating the survival, function, 
proliferation, and differentiation of different target cells. GM-CSF and IL-3 are multi-
lineage hematopoietic growth factors that act on early myeloid progenitor cells and 
support their proliferation and terminal differentiation into the granulocytic, monocytic, 
megakaryotic, and erythroid lineages, in both the murine and human systems (Ikebuchi 
et al, 1987; Metcalf et al., 1986). All lineages ofhematopoiesis are stimulated by SCF. 
The major stimulatory effect of SCF is in combination with other growth factors. It 
stimulates the formation ofBFU-E-derived colonies and megkaryocyte colony formation 
when in combination with EPO and TPO respectively (Hunt et al., 1994). SCF can also 
stimulate myeloid progenitors when in combination with GM-CSF, G-CSF and IL-3 
(McNiece etal., 1991). 
There are cytokines including IL-1 and IL-6 that do not induce the formation of 
colonies but can induce myeloid precursor cells to differentiate. It was found that all four 
CSFs and IL-3 can induce the production of IL-6 (Sachs, 1995). In a colony with 
differentiated cells, induction of a colony by CSFs is followed by the production ofIL-6, 
which can then induce differentiation of different cell lineages (Lotem et al., 1991). This 
induction ofadifferentiation factor by a growth factor serves as an effective mechanism 
to couple growth and differentiation. Moreover, IL-6 and GM-CSF also induce 
expression of genes for the transcription factors, including c-jun and c-fos (Shabo et al, 
1990), which can participate in the activation of other genes including genes for cellular 
functions and other cytokines. These cytokines include the M-CSF, GM-CSF, IL-6, IL-1 
5 
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and TNF (Lotem et aL, 1991). As a result, a cytokine network can amplify the signals 
and target specific cellular functions with the induction of other cytokines in different 
cell types. � 
In maintaining homeostasis, there are inhibitory cytokines that can selectively 
inhibit the activity ofcertain CSFs and ILs. Tumor necrosis factor a (TNF-a), interferon 
a and y (IFN-a& IFN-y), macrophage inflammatory protein la(MIP-la), and 
transforming growth factor P (TGF-P) are some of the examples. These cytokines act in 
a network to inhibit the proliferation of various precursor and progenitor cells (Lotem & 
Sachs, 1990; Clemens, 1991; Lotem etal., 1991). 
1.2 Leukemia 
1.2.1 Leukemia: Abnormalities in Blood Cell Formation 
Leukemia is an abnormal and uncontrolled process of hematopoiesis in which 
hematopoietic cells undergone neoplastic proliferation without differentiating into their 
mature functioning cells in specific lineages (Figure 1.2). Leukemia cells result from 
clonal proliferation by successive divisions from a single abnormal stem or progenitor 
cell. They circulate in the peripheral blood, accumulate and therefore replace the normal 
hematopoietic precursor cells of the bone marrow causing bone marrow failure 
(Hoffbrand & Pettit, 1993). The leukemia cells may spread to other organs including 
central nervous system, testicles, ovaries, kidney, gum, skin etc. and produce specific 
symptoms corresponding to the types of leukemia and organs involved. Patients usually 
have some generalized symptoms such as fatigue, lack of appetite and fever. Gout and 
6 ： 
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renal impairment may result because of hyperuricaemia caused by excessive purine 
breakdown (Hoffbrand & Pettit，1993). 
� By the end of year 2000, there will be about 30,800 new cases of all types of 
leukemia in the United States. About 28,200 of these will be adults and 2,600 will be 
children. There will be about 9,700 new cases of acute myelogenous leukemia (AML) 
and about 1,400 adults will develop acute lymphocytic leukemia (ALL). Unfortunately, 
about 21,700 adults and children in the United States will die of leukemia during this 
year. The average age of a patient with AML is 65 years of age. AML is slightly more 
common among men than among women while ALL is more common among children 
under 10 years of age than adults. ALL is less common in middle-aged adults but 
become more common again after 70 years old (The American Cancer Society, 2000) 
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Figure 1.2 Uncontrolled hematopoiesis leads to leukemia 
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1.2.2 Classification of Leukemia 
Leukemia can be broadly divided into acute or chronic leukemia according to the 
onset and duration of the disease. It can further be subdivided into myelocytic or � 
lymphocytic leukemia according to the morphology and cytochemistry of the leukemia 
cells (Goasguen et al., 1996). Therefore, there are four main types of leukemia: acute 
myeloid leukemia (AML), acute lymphocytic leukemia, chronic myeloid leukemia 
(CML) and chronic lymphocytic leukemia (CLL). Based on the French-American-
British (FAB) classification scheme, AML can be subdivided into eight variants ofFAB 
MO to M7 based on immunophenotyping, chromosome and gene rearrangement and 
morphological features (Table 1.1). ALL is classified into three types including L1, L2 
and L3 based on the morphology of each case. The CML and CLL are also subdivided 
into six and seven categories respectively (Hoffbrand & Pettit, 1993). 
1.2.3 The Causes and Molecular Basis ofLeukemia 
The exact cause of most cases of leukemia is still unknown. However, it is 
generally believed that changing in specific gene family when exposed to irradiation, 
chemical carcinogens including benzene, chloramphenicol, phenylbutazone and cigarette 
smoking for a long time may play a role in the development of leukemia. Besides, 
leukemia caused by infection with infectious leukemia virus, such as adult T-
leukemia/lymphoma virus and inheritance of the oncogenes for leukemogenesis are also 
documented (Greaves, 1991). These events cause changes in DNA and result in gene 
mutations, fusion, rearrangement, deletions or chromosomal translocations or inherited 
disorders that contribute to the activation of oncogenes and loss of tumor suppressor 
genes and products (Hoffbrand & Pettit, 1993; Campbell, 1995). As a result, 
hematopoietic cells transform and continue to proliferate but fail to differentiate. 
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The differentiation defectiveness in certain leukemia may be due to change in 
homeobox genes such as rearrangement of the Hox-2.4 homeobox gene. The abnormal 
expressions of homeobox gene cause inhibition of specific pathways of myeloid cell � 
differentiation (Sachs, 1996). Chromosomal translocations are frequent in 
leukemogenesis. It commonly rearranges genes encoding transcriptional factors that play 
important roles in blood cell development. The aberrant protein products generated by 
these translocations may interfere with the functions of wild-type proteins especially 
those associated with cell growth and differentiation. For example, the cause of acute 
promyelocytic leukemia (APL or AML-M3 according to the FAB nomenclature) which 
is a common form of AML accounting 10% of all AML cases in adults is due to 
chromosomal translocation t(15;17). It fused the retinoic acid receptor (RAR) a gene to 
the promyelocytic leukemia (PML) gene. This PML-RAR a fusion gene plays an 
important role in leukemogenesis through antagonizing retinoic acid signalling and the 
regulatory pathways mediated by PML (Chen et aL, 1997b; Lin et al, 1999). 
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Table 1.1: Classification of leukemia 
~ T y p e Subclass Variant 
Acute Acute Myeloid MO: minimal differentiation 
Leukemia (AML) M1: myeloblastic (>90% myeloblasts) 
� M2: myeloblastic with granulocytic maturation (>10% 
promyelocytes or later granulocytes) 
M3: promyelocytic (coarsely granular or micro granular 
promyelocytes) 




M6: erythroblastic (>50% erythroblasts) 
M7: megakaryoblastic (>50% megakaryoblasts) 
Acute Lymphocytic^ L1: homogeneous small blasts with little cytoplasm 
Leukemia (ALL) L2: heterogeneous larger blasts with variable amounts of 
cytoplasm 
L3: homogeneous large blasts with vacuolated basophilic 
cytoplasm 
Chronic^ Chronic Myeloid Philadelphia-positive chronic myeloid leukemia 
Leukemia (CML) Philadelphia-negative chronic myeloid leukemia 
Juvenile chronic myeloid leukemia 
Chronic neutrophilic leukemia 
Eosinophilic leukemia 
Chronic myelomonocytic leukemia 
Chronic Lymphocytic B-chronic lymphocytic leukemia 
Leukemia B-prolymphocytic leukemia 
Hairy cell leukemia 
Plasma cell leukemia 
T-chronic lymphocytic leukemia 
T-prolymphocytic leukemia 
Adult T-cell leukemia / lymphoma 
Adapted from Greaves, 1991 and Hoffbrand & Pettit，1993 
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1.2.4 Therapy of Leukemia 
The conventional chemotherapy and radiotherapy are the most commonly used 
therapeutic strategies for most cancers including leukemia. In chemotherapy or � 
combination chemotherapy, leukemia patients are usually treated with combinations of 
at least three drugs initially to increase the cytotoxic effects, improve remission rates and 
reduce the frequency of drug resistance. These drugs include anti-metabolites (e.g. 
methotrexate), alkylating agents (e.g. cyclophosphamide), and DNA binding agents (e.g. 
adriamycin). All of these drugs used in leukemia therapy non-specifically target actively 
dividing cells and aim at damaging their reproductive capacity. Therefore, apart from the 
problem of multi-drug resistance, the side effects of damaging fast-growing normal cells, 
such as blood cells and hair follicles, is another problem. A number of clinical 
symptoms like weight loss, vomiting, diarrhea, fatigue and hair loss, etc. often appear 
after receiving chemotherapy (Hoffbrand & Pettit, 1993). 
Radiotherapy and bone marrow transplantation are alternative therapeutic 
methods for leukemia patients. The use ofX-rays and y-rays in radiotherapy can kill the 
leukemia cells as well as normal cells in the patients and results in a number of side 
effects. In bone marrow transplantation, it has the limitation of searching for MHC 
compatible donors for the patients. Regarding the above problems and limitations, it is 
required to search for and establish new effective therapeutic strategies for leukemia 
(Hoffbrand & Pettit, 1993). 
In recent years, a number of cytokines, physiological compounds and 
phytochemicals including steroid hormones, vitamins and plant flavonoids have been 
identified to have the ability to induce the differentiation and/or apoptosis in leukemia 
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cells with lower toxicity in normal cells. A new concept of differentiation therapy has 
been proposed with the use of cytokines or other inducers to trigger the differentiation 
and maturation of the myeloid leukemia cells. One successful example is the use of � 
retinoic acid clinically in the treatment of promyelocytic leukemia (Sachs, 1996). It is 
believed that, not only for leukemia, other therapeutic strategies can be defined with the 
increasing understanding ofhow cells grow, differentiate, and undergo apoptosis. 
1.2.5 Control of Leukemia by Hematopoietic Growth Factors and Other 
Compounds 
Similar to normal hematopoietic cells, the growth of human leukemia cells can 
be enhanced by a variety of cytokines including IL-3, SCF, CSFs, EPO, TPO and TNF, 
etc. (Touw & Dong, 1996). However, there are reports suggesting that some cytokines 
that induce differentiation of normal hematopoietic cells can also induce leukemia cells 
to differentiate into mature nondividing cells or undergo apoptosis. These cytokines can 
induce the growth inhibition and differentiation of differentiation-competent clones 
(called D+ clones) of leukemia via alternative pathways bypassing the genetic changes 
that inhibit the response to normal differentiation inducers (Sachs, 1993). For examples, 
D+ clones of mouse leukemia cells can be induced to differentiate by cytokines such as 
IL-6 to become mature nondividing cells (Sachs, 1978). In addition, D+ leukemia cells 
that respond to IL-6 can also be induced to differentiate by IL-la and IL-ip, and this is 
mediated by the endogenous IL-6 production (Sachs, 1990). Other cytokines such as IL-
3, IL-4, GM-CSF, G-CSF, TNF-a and IFN-y are also found to regulate the 
differentiation of a number of myeloid leukemia cells either by acting alone or in 
combination with other cytokines (Sachs, 1990). For example, IL-4 and TNF-a were 
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found to act synergistically in inducing the monocytic differentiation of the murine 
myeloid leukemia WEHI-3B JCS cells (Leung et al； 1994). 
� 
A variety of compounds can also induce differentiation or apoptosis in clones of 
leukemia that are not induced to differentiate by cytokines. These include steroid 
hormones, chemotherapeutic compounds, vitamins and radiation. These compounds can 
act alone or in combinations to induce differentiation of leukemia cells. In addition, 
other compounds such as insulin, bacterial lipopolysaccharide, certain plant lectins, 
retinoic acid, tumor promoting phorbol esters can also induce differentiation in myeloid 
leukemia cells. Some of these compounds such as glucocorticoid hormones and retinoic 
acid are now being used clinically in the differentiation therapy and induction of 
apoptosis in leukemia (Sachs, 1996). 
1.2.6 Molecular Control of Apoptosis and Cell Cycle in Leukemia 
The number of cells in any tissue is dependent on the balance between cell gain 
by proliferation and cell loss by differentiation and/or cell death. This balance is clearly 
demonstrated in the hematopoietic system in which billion of cells are produced every 
day to replace cell loss. The control of apoptosis (programmed cell death) as well as cell 
cycle is very important in maintaining homeostasis. Imbalance of this control will 
contribute to a number of cancers such as leukemia in which apoptosis is suppressed 
while cell cycling is increased. 
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1.2.6.1 Regulation of Cell Cycle and Apoptosis by Genes and Regulatory Proteins 
1.2.6.1.1 Cell Cycle 
The growth and division of cells are well regulated by the control of so called 
、 
‘‘cell cycle clock". The cell cycle clock or cell cycle consists of four well characterized 
stages or phases known as G1, S，G2 and M phases. In G1 phase, a cell increases in size 
and prepares to duplicate their DNA. During the S phase, the cellular DNA is duplicated 
and a complete copy of the chromosome complement is made. After that the cell enters 
the G2 phase and prepares itself for division. In the M phase, each cell divides by 
mitosis. There is another phase, GO, which is the resting stage of a cell. 
The cell cycle machinery is controlled by a variety of genes and gene products. 
Some of these products are cyclins and cyclin-dependent kinases (cdks) which only 
became activated in the presence of cyclins. Within the cell cycle, there is a decision 
point or called restriction point (R point), located at the end of G1, which decides 
whether a cell should enter the rest of the cell cycle for division or not. The 
retinoblastoma protein (pRB) is the molecular control of the R point. When 
unphosphorylated or hypophosphorylated, pRB blocks the R point transition. There is a 
D-type cyclin (cyclin D) which can be induced to express by the growth signals. Cyclin 
D acts as a mediator in combination with cdks. When the cell receives mitotic signals, 
cyclin D becomes activated. It acts in association with CDK 4 or CDK 6 and initiates the 
phosphorylation of pRB. The partially phosphorylated pRB subsequently undergoes 
further phosphorylation by a number of cyclins/cdks and permits the cell from entering 
and progressing in the cell cycle (Meikrantz & Schlegel, 1995; Lundberg & Weinberg, 
1999). 
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A tumor suppressor gene, p53, can act as a cell cycle inhibitor. The gene product 
is a transcription factor that causes the expression of a cdk inhibitor, p21, which acts 
widely on a variety of cyclin/cdk complexes. The p53 protein is also believed to activate 
*x 
apoptosis. One possible mechanism is due to its ability to induce the pro-apoptotic Bax 
protein. Therefore, the down-regulation or lacking of p53 function may cause the cells 
continuously to grow and replicate (Lundberg & Weinberg, 1999). 
1.2.6.1.2 Apoptosis 
Apoptosis is the major physiological mechanism of cell death. Its regulation is 
highly conserved with similar or the same gene control processes present in a wide 
variety of species. It is a general biological phenomenon necessary for development and 
homeostasis. Apoptosis is characterized by a series of typical morphological and 
biochemical features, such as shrinkage of cell, chromatin aggregation, nuclear and 
cytoplasmic condensation, intemucleosomal fragmentation of genomic DNA, 
fragmentation into membrane-bound apoptotic bodies and rapid phagocytosis by 
neighbouring cells (Saraste & Pulkki, 2000). 
A number of stimuli can induce a cell to commit apoptosis. These stimuli include 
genotoxic damage (e.g. radiation, chemotherapy) and deprivation of growth factors (e.g. 
EPO). During apoptosis, there is a group of enzymes called caspases, which are cysteine 
proteases mediating the terminal steps of apoptosis. Caspases are classified as either 
initiators (caspase 2，8, 9, 10) or effectors (caspase 3, 6, 7). The initiators activate the 
effectors which result in cleavage of cytoskeletal proteins, disruption of nuclear 
membrane and cell-cell contact, and activation of DNA nuclease to allow DNA 
fragmentation. These irreversible proteolytic events are responsible for the 
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morphological characteristics of apoptosis. There is a family of caspase inhibitors, IAPs 
(Inhibitors of apoptosis), which are overexpressed in many malignant cells. These 
inhibitors can selectively inhibit the effector caspases and therefore, blocks the apoptotic � 
process (Thomberry & Lazebnik, 1998). 
A variety of genes have been identified to have apoptosis-enhancing or 
apoptosis-suppressing effects. The p53 protein is a transcription factor that binds to 
DNA and recognizes DNA damage. It can induce cell cycle arrest in G1 and G2/N 
checkpoints by activating p21 inhibitory proteins or promotes apoptosis (Lundberg & 
Weinberg, 1999). 
There is a bcl-2/bax gene family regulating the downstream apoptotic death 
signals of a cell. Sixteen members of this family have been recognized. Others such as 
Bcl-2 and Bcl-Xt are apoptosis-inhibitory proteins while some of them such as Bax, Bad, 
Bak and Bid are promoters of apoptosis. They can form homo- or heterodimers. p53 
may function to control the ratios of these two forms of dimers in order to regulate cell 
survival. A high expression of Bax group promotes apoptosis whereas a high expression 
of Bcl-2 inhibits apoptosis. The function of Bcl-2/Bax family proteins requires the 
presence of mitochondria. In response to apoptotic signals, the Bax proteins induce the 
release of cytochrome c and apoptosis-inducing factor (AIF) that cause the chromatin 
condensation. The released cytochrome c binds to and activates apoptotic protease 
activating factor-1 and subsequently activates caspase-9. Caspase-9 then activates 
downstream caspases, including caspase-3, that are responsible for the apoptosis 
(Antonsson & Martinou, 2000; Reed, 1998). 
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In addition, other growth regulatory proteins such as c-myc also promote 
apoptosis. The proto-oncogene c-myc has been shown to play important roles in growth 
control, differentiation, and apoptosis (Hoffman & Liebermann，1998). Evan et al. (1992) � 
showed that deregulated c-myc expression can induce apoptosis in fibroblasts. However, 
Askew et al (1991) demonstrated that activation of a c-myc gene by IL-3, induced 
apoptosis in myeloid cell line. These results suggested that c-myc protein could trigger 
both proliferation and apoptosis. This protein has a variety of other downstream targets 
that affect cell cycle progression but the identities of these targets remain unclear. 
1.2.6.2 Role ofApoptosis and Cell Cycle in the Development of Leukemia 
The major cause of leukemia is due to the suppression of apoptosis in 
hematopoietic progenitor cells that leads to the disruption of the balance between cell 
loss and cell gain. Several mechanisms including up-regulation of survival genes, 
increased levels of survival factors or down-modulationy'loss of death-inducing genes 
will contribute to the suppression of apoptosis. This suppression make cells have 
survival advantage and alive for a long time with higher risk to acquire further mutations 
for malignancy. 
In leukemogenesis, mutation or change of genes ultimately results in 
enhancement of cell survival. The expression of Bcl-2 protein is increased in both AML 
and B-lineage ALL cells. This change makes the leukemia cells have the ability to grow 
outside the bone marrow microenvironment and grow in vitro. The increased Bcl-2 
protein expression can also enhance the clonogenicity of leukemia cells and the 
resistance of them to certain chemotherapeutic drugs, p53 mutation is commonly found 
in human cancer and the mutated gene can also be found in B-cell ALL, B-cell CLL and 
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AML. Mutated p53 protein products cannot function normally and fail to prevent G1 or 
G2/M cell cycle arrest and/or apoptotic response to DNA damage. Cells with DNA 
damaged, therefore, cannot be eliminated via apoptosis. They continue to mutate and � 
progress to become more malignant (Lunderg & Weinberg, 1999). Besides, the Rb 
tumor suppressor gene is also associated with the pathogenesis of leukemia. pRB is able 
to execute a potent brake on cell proliferation. It is also involved in the process of 
differentiation. Hypophosphorylation of pRB results in cellular differentiation. 
Inactivation of the Rb tumor suppressor gene is important in leukemogenesis. The 
absence of or altered pRB expression suppresses the differentiation of myeloid leukemia 
cells and results in uncontrolled cell cycle (Karp, 1997). As mentioned above, the c-myc 
protein has dual roles on cell proliferation and apoptosis. Activation or overexpression 
of this oncogene may lead to apoptosis but it also plays a secondary role in 
leukemogenesis if apoptosis has already been suppressed by other factors such as bcl-2 
or mutated p53 (Chapman et al., 1996). 
Apart from genetic control, cytokines acting as growth factors in normal 
hematopoiesis also serve to enhance the survival of leukemia cells. For example, GM-
CSF, G-CSF and IL-6 suppress apoptosis induced by several anti-cancer drugs in 
myeloid leukemia cells and IL-3 can protect cells from X-irradiation (Lotem & Sachs, 
1990). In leukemogenesis, cells can be altered to have different responses to growth 
factors. The tumor cells may have increased expression of growth factor receptors or 
amplified signaling pathways which activate cell cycling and therefore become fast 
growing. Besides, cytokines can be over-expressed in some leukemias as well (Chapman 
etal., 1996). 
1 ^ 
Chapter 1 General Introduction 
1.3 Green Tea 
1.3.1 Origin and Cultivation of Tea Plants 
� Tea is the fragrant brew prepared from the leaves of plants called Camellia 
sinensis which is an evergreen shrub or tree belonging to the family of Theacea (Fig. 
1.3). The tea plant grows widely from tropical to temperate regions in Asia. The plant 
was originally discovered and grown in China and Southeast Asia thousands of years 
ago. Tea consumption can be traced back by the Chinese to 2737 BC at the time of 
Emperor Shen Nung. It was spread to Japan in the 6th century (Weisburger, 1997). Since 
then, tea drinking rapidly spread worldwide and the tea plant is currently cultivated in 
approximately 30 countries. At present, tea consumption is the second only to water, 
with a per capita human consumption of approximately 1200 ml/day (Katiyar and 
Mukhtar, 1996; Ahmad et al, 1998). 
The tea plant is a vegetatively propagated plant and the propagation is usually 
done by the cloning method. It is heavily branched with dark-green, hairy, oblong-ovate 
leaves and can grow to a height of 30 feet, but is usually clipped to a height of 2-5 feet 
(Figure 1.4). The tea plants can be roughly classified into two varieties, Camellia 
assamica and Camellia sinensis (Chu, 1997). The assamica variety generally has large 
leaves and tall trunk which is cultivated ranging from Yun-nan province of China to the 
Northern region of Myanmer and Assam region of India. The sinensis variety is grown 
in the Eastern and Southeastern districts of China. It has small leaves and its trunk is of 
bushtype (Chu, 1997). 
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Fig 1.3 Chinese green tea plant (Long Jing) 
(Adapted from World Consortium of Companies, 1998) 
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Fig 1.4 Clipped tea plants heavily branched with dark-green leaves. 
(Adapted from World Consortium of Companies, 1998) 
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1.3.2 Classification and Manufacturing of Tea 
Tea was classified based on distinct manufacturing processes. There are roughly 
three main types of teas: green tea, oolong tea, and black tea. Of the total amount of tea � 
produced and consumed in the world, about 78% is black tea, 20% is green tea and less 
than 2% is oolong tea. Black tea is the major type of tea consumed predominantly in 
Western countries and in some Asian countries. Green tea is consumed primarily in 
China, Japan, India, a few countries in North Africa and the Middle East, the production 
and consumption of oolong tea are confined to Southeastern China and Taiwan (Katiyar 
& Mukhtar, 1996; Ahmad etal, 1998). 
Freshly harvested young tea leaves or shoots undergone different manufacturing 
processes to produce green, black, and oolong teas. To produce green tea, the process of 
fermentation is not required. Tea leaves are chopped and rolled. They are then rapidly 
steamed or pan-fired and dried to inactivate the polyphenol oxidase enzyme so as to 
prevent the oxidation of tea polyphenol present in the tea leaves. In black tea production, 
the chopped and rolled tea leaves are allowed to wither for several hours. During this 
period, the polyphenols are enzymatically oxidized. Normal oolong tea is not fully 
fermented when compared with the black tea. It is an intermediate stage in the enzymatic 
oxidation ofblack tea (Tomlins & Mashingaidze, 1997; Mukhtar & Ahmad, 2000). 
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1.3.3 The Chemistry of Tea 
1.3.3.1 Chemical Composition of Tea 
The composition of tea leaves varies with climate, season, horticultural practices, 
、 
and the type and age of the tea plant (Mukhtar & Ahmad, 2000). A representative 
composition oftea leaf is shown in Table 1.2. The distinctive color, flavor, and aroma of 
tea result from chemical changes that occur during leaf processing. The chemical 
composition of green tea is similar to that of fresh tea leaves and shoots. It contains 
many polyphenolic compounds, which account for 30-40 % of the extractable solids of 
dried green tea leaves. These polyphenolic compounds include fIavanols, flavandiols, 
flavonoids, and phenolic acids. Most of the polyphenols in green tea are flavanols, 
commonly known as catechins (Ahmad et al, 1998; Katiyar & Mukhtar, 1996). The 
major catechins in green tea are (-)-epicatechin (EC), (-)-epicatechin-3-gallate (ECG), 
(-)-epigallocatechin (EGC), and (-)-epigallocatechin-3-gallate (EGCG). EGCG is the 
most abundant among the four epicatechin isomers, accounting for 50 % of the 
polyphenol fraction (Ho et al, 1993). The chemical structures of these compounds are 
shown in Figure 1.5. In addition, there are caffeine, theobromine, theophylline, phenolic 
acids such as gallic acids and characteristic amino acids such as theanine. The principal 
components present in typical green and black tea beverages, with considerable 
variations, are shown in Table 1.3. In black teas, flavanols are oxidized by phenol 
oxidase and undergone oxidative condensation via either C-0 or C-C bond formation in 
oxidative polymerization reactions. They are being polymerized to bisflavanols, 
theaflavins, thearubigins, and other oligomers in the process of fermentation. The 
effective components in black tea are not clearly understood. About l%-2% ofthe total 
dry matter of black tea are theaflavins which include theaflavin, theaflavin-3-O-gallate, 
theaflavin-3‘-0-gallate, and theaflavin-3,3'-0-gallate. These compounds possess 
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benzotropolone rings with dihydroxy or trihydroxy substitution systems which give the 
characteristic color and taste ofblack tea. About 10%-20% of the dry weight ofblack tea 
are thearubigins, which are more extensively oxidized and polymerized, have a wide � 
range of molecular weights, and are not well characterized (Yang & Wang，1993). The 
structures of major components of black tea are shown in Figure 1.6. Oolong tea 
contains monomeric catechins, theaflavins, and thearubigins. In addition, 
epigallocatechin ester, theasinensins, dimeric catechins, and dimeric proanthocyanidins 
also occur as characteristic components in oolong tea (Yang & Wang, 1993). 
Table 1.2 Composition ofthe tea leaf 
Components Percentage of dry weight 
Flavanols 25.0 
Flavonols and flavonol glycosides 3.0 
Phenolic acids and depsides 5.0 
Other polyphenols 3.0 
Caffeine 3.0 
Theobromine 0.2 
Amino acids 4.0 







Chlorophyll and other pigments 0.5 
Ash 5.0 
Volatiles 0.1 





































Figure 1.5 Major polyphenols in green tea (Adapted from Mukhtar & Ahmad, 2000) 
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Figure 1.6 Major polyphenols in black tea (Adapted from Mukhtar & Ahmad, 2000) 
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Table 1.3 Principal components of green and black tea beverages (measured in 
% weight of extract solids) 
�Components Green Tea Black Tea 
Catechins 30-42 3-10 
Flavanols 5-10 6-8 
Other flavonoids 2-4 -
Theogallin 2-3 -
Ascorbic acid 1-2 -
Gallic acid 0.5 -
Quinic acid 2.0 -
Other organic acids 4-5 -
Theanine 4-6 -
Other amino acids 4-6 13-15 
Methylxanthines 7-9 8-11 
Carbohydrates 10-15 15 
Minerals 6-8 10 
Volatiles 0.02 <0.1 
Theaflavins - 3-6 
Thearubigins - 12-18 
Adapted from Katiyar & Mukhtar, 1996. 
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1.3.3.2 Separation and Purification of Green Tea Polyphenols 
To extract green tea polyphenols, green tea leaves are first extracted by hot water 
for several times and then allowed to cool down. Caffeine and pigments were removed 
� b y chloroform extraction. Finally, the aqueous portion was further extracted by ethyl 
acetate in which GTCs were collected. Ethyl acetate was evaporated under vacuum and 
the crude GTCs extracts were redissolved and lyophilized. Individual epicatechin 
isomers in GTC extracts were further separated and purified by HPLC. The composition 
of GTCs extracted from the Chinese green tea Ji Pin Long Jing was shown in Figure 1.7 
(Chen & Chan, 1996). 
Others BC 
9% 3% BCG 
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Figure 1.7 Composition of GTCs extracted from the Chinese green tea Ji Pin Long 
Jing (Chen et al., 1996) 
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1.3.3.3 The Chemical Properties of Green Tea Polyphenols 
Tea polyphenols, particularly green tea epicatechins such as EGCG, EGC, ECG 
and EC, are strong anti-oxidizing agents which can be easily oxidized to the � 
corresponding 0-quinones. These flavanols and quinones can function as either 
hydrogen acceptors or hydrogen donors. In addition, they can prevent the formation of 
reactive oxygen species (ROS) and free radicals by chelating transition metal ions. They 
can also scavenge ROS and free radicals by stabilizing free electrons through several 
proposed mechanisms including delocalization of electrons, formation of intramolecular 
hydrogen bonds and rearrangement of their molecular structures (Katiyar & Mukhtar, 
1997). 
Although green tea epicatechins are strong antioxidants, their free-radical 
scavenging capacity is affected by different pH fNanjo et al, 1999). In order to account 
for this observation, Zhu et al. (1997) found that the stability and availability of green 
tea epicatechins could be easily affected by the pH values. The reason of this is still 
unknown. Total green tea catechins in alkaline solution (pB. > 8) are extremely unstable 
and degraded almost completely within a few minutes, whereas in acidic solution (pH < 
4) they are very stable. For individual epicatechin isomers, EGCG and EGC are 
extremely unstable in alkaline solution while EC and ECG are relatively more stable in 
both acidic and alkaline solutions (Zhu et al., 1997). 
1.3.4 Bioavailability and Pharmacokinetic of Green Tea Epicatechins 
There are differences in the amount of tea consumption within species as well as 
species differences in bioavailabilities and actions of the active polyphenolic 
components such as EGCG, EGC, ECG and EC. Therefore, to study the association of 
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tea consumption and cancer, a good understanding of the quantitative data on the 
bioavailability of tea components are required. Moreover, an understanding of the 
pharmacokinetics of tea regarding the absorption, distribution, metabolism, and � 
elimination of the effective components is important for the mechanistic studies of tea 
polyphenols in inhibiting a variety of tumors. These studies may be useful in designing 
future strategies for the development of green tea as a practical chemopreventive agent. 
1.3.4.1 Human Studies 
In recent years, pharmacokinetic experiments of tea polyphenols have been 
conducted in human subjects. Accumulating evidences illustrated that green tea 
polyphenols are at least partly absorbable and ingested tea polyphenols and their 
metabolites could provide a localized tissue action. In addition to indirect 
gastrointestinal effects, their localized tissue action could be demonstrated by the 
presence of them in blood, urine, saliva, and feces following oral ingestion of green tea 
infusion. It was found that green tea consumption resulted in greatest fecal and urinary 
excretions, and with the highest retention and highest whole blood concentrations of 
polyphenols compared with black tea, decaffeinated black tea, and no tea treatment 
(Unno et al, 1996; Yang et al, 1998a; Mukhtar & Ahmad, 1999). 
Yang et al. (1998a) further demonstrated a saturation phenomenon in the 
bioavailability of green tea catechins in human blood. It was found that the 
concentration of EGCG in human plasma could reach the highest point without 
significant change with increasing EGCG consumption. Evidences also suggested that 
EGCG has a longer half-life than that ofEGC and EC. After green tea ingestion, EGCG 
could be metabolized in the liver. It was predominantly metabolized to the sulfate form 
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(58 to 72%). The free form (12 to 28%) and the glucuronide form (8 to 19%) were also 
present in human plasma after 1 hour of green tea ingestion (ILSI North America 
Technical Committee on Food Components for Health Promotion, 1999). Green tea � 
catechins could also be degraded or metabolized by microorganisms in the intestine. A 
recent study has identified two metabolites, in human urine and blood, produced by 
intestinal microorganisms with EGC and EC as precursors (Li et al, 2000). Urinary 
excretion of EGC was observed in human consuming green tea but intact EGCG and 
ECG were not detected in urine samples suggesting that EGCG might be excreted 
through bile or being metabolized and circulating in blood plasma (Pietta et al, 1998; 
Brown, 1999). 
1.3.4.2 Animal Studies 
Ingested green tea polyphenols such as EGCG and their metabolites also provide 
a localized tissue action in rats and mice as well as having a wide tissue distribution and 
localization. Yang et al. (2000) reported that the distribution of green tea polyphenols 
was varied by different routes of administration. Higher amounts of EGC and EC could 
be observed in blood, urine, esophagus, large intestine, kidney, bladder, lung, and 
prostate while lower amounts of them were found in liver, spleen, heart and thyroid after 
oral administration of green tea. 
Although EGCG was detected in rat plasma after oral administration (Unno & 
Takeo, 1995), large amount of EGCG was found only in the esophagus, large intestine 
and feces, showing a poor systemic absorption of EGCG by rat and a biliary excretion of 
glucuronides of polyphenols in intestine. Another distribution study suggested that 
EGCG was mainly excreted through bile or converted to EGC while EGC and EC were 
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excreted through both the bile and urine (Yang et al, 1997; Yang et al, 2000). It was 
found that in rats, only EGC and EC but not EGCG and ECG were present in blood after 
oral ingestion of green tea, suggesting that EGC and EC are the mostly active � 
components (Zhang et al., 1997). It had been reported that after intravenous 
administration of decaffeinated green tea (DGT) in rats, the highest amount of EGCG 
was found in intestine. The highest levels of EGC and EC were observed in kidney and 
the levels declined rapidly. The liver and lung levels of EGCG, EGC, and EC were 
generally lower than that in the intestine and the kidney (Chen et al, 1997a; Hollman et 
al., 1997). 
The bioavailability ofEGCG in mice was much higher than that in rats. Recently, 
Suganuma et al. (1998) studied the distribution of radiolabeled [^HJEGCG in mouse 
organs following oral administration. The target organs of EGCG and green tea extracts, 
such as the digestive tract, lung, liver, pancreas and skin showed significant radioactivity. 
In addition, similar radioactivity was also found in other organs, such as kidney, brain, 
uterus, ovary and testes. The results showed a wide range distribution of EGCG in mice 
suggesting a similar wide range of target organs for cancer prevention in humans 
(Suganuma et al., 1998). 
1.3.5 Physiological and Pharmacological Activities of Green Tea Catechins 
Tea is a pleasant, socially accepted and one of the most popular beverages 
consumed worldwide for a very long time. It is considered to be safe and generally non-
toxic. Epidemiologic observations and laboratory studies have indicated that tea also 
provides a dietary source of biologically active compounds especially green tea 
M 
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catechins that help to prevent a wide variety of diseases, e.g. cancer, cardiovascular 
diseases, the formation of kidney stone, bacterial infections and dental cavities. In recent 
years, many researches have been conducted to study the physiological and � 
pharmacological properties of green tea catechins including anti-oxidative, anti-
mutagenic, anti-carcinogenesis, anti-microbial activities etc. which contribute to human 
health benefits. 
1.3.5.1 Anti-oxidative Activity 
Similar to ascorbic acid and P-carotene, green tea polyphenols are naturally-
occurring strong antioxidants that can protect humans from a variety of diseases (Cozzi 
et al, 1997). Their anti-oxidative activities are believed to be one of the possible 
mechanisms for cancer prevention. Recently, green tea catechins are extensively studied 
for their capacity to protect organisms and cells from damages by reactive oxygen 
species (ROS), including superoxide radical, singlet oxygen, hydroxyl radical and 
peroxyl radical which could damage DNA, other cellular molecules and initiate lipid 
peroxidation. The anti-oxidative activity of green tea catechins was suggested to be 
contributed by the presence of ortho-dihydroxy (3',4'-OH) group in the B ring and a 
galloyl moiety at the 3 position of catechins which make them as effective radical 
scavengers and strong metal ions chelators (Guo et al., 1999; Nanjo et al., 1999). 
Green tea epicatechin isomers EGCG, EGC, ECG and EC have been shown to 
inhibit Fe^7ADP-induced and photo-enhanced lipid peroxidation in mouse epidermal 
microsomes (Katiyar et aL, 1994). They could also protect red blood cell membrane 
from hemolysis induced by 2,2'-azo-bis(2-amidinopropane) dihydrochloride (AAPH), 
an azo free radical initiator, both in vivo and in vitro (Zhang et al, 1997). Besides, green 
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tea exhibited inhibitory effects on LDL oxidation both in vivo and in vitro (Wiseman et 
al., 1997) It could also suppress lipoxygenase activity (Salah et al., 1995). A recent 
report also showed that green tea extracts could inhibit endothelial cell-induced LDL � 
oxidation and decrease its relative electrophoretic mobility when compared to oxidized 
LDL (Yang & Koo, 2000). In addition, repeated oral administration of green tea was 
also shown to inhibit the serum glutamic oxaloacetic transaminase (GOT) activity, 
hepatic lipid peroxidation, oxidative DNA damage and cell proliferation in liver of rats 
repeatedly treated with 2-nitropropane (2-NP) (Sai et al, 1998). 
1.3.5.2 Hypocholesterolemic and Hypolipidemic Activity 
Apart from the anti-oxidative activities of green tea catechins to inhibit LDL 
oxidation, cardiovascular diseases such as atherosclerosis and coronary heart disease 
may also be prevented by the ability of green tea to lower the blood lipid or cholesterol 
levels. Several epidemiological studies on human subjects indicated an inverse 
association of tea consumption with plasma total cholesterol levels (Tijburg et al, 1997). 
A Japanese study found that green tea consumption in human subjects was associated 
with decreased cholesterol and triglyceride and an increased proportion of HDL (Kono 
et al., 1992). In animal models, consumption of mixed catechins (Muramatsu et al., 
1986), catechin (Valsa et al., 1995) decreased serum cholesterol levels in rats and mice 
fed with an atherogenic diet. A study on hamsters showed that green tea was 
significantly more effective than black tea in reducing the triglyceride and cholesterol 
and enhancing HDL levels in plasma (Vinson & Dabbagh, 1998). A more recent study 
demonstrated that long-term oral administration of Chinese green tea lowered plasma 
cholesterol level by increasing fecal bile acids and cholesterol excretion. Moreover, the 
activities of three major lipid metabolizing enzymes, 3-hydroxy-3-methylglutaryl-
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coenzyme A (HMG-Co A) reductase, cholesterol 7a-hydroxylase and fatty acid 
synthase (FAS) were not affected (Yang & Koo, 2000). In addition, Chan et al. (1999) 
also demonstrated that the hypolipidemic effect of jasmine green tea epicatechins in � 
hamster did not affect the liver fatty acid synthase but increased the fecal excretions of 
total fatty acids, neutral sterols and acidic sterols. These results suggested that 
hypolipidemic activity of green tea epicatechins was not due to inhibition of synthesis of 
cholesterol or fatty acids but is likely mediated by their influence on lipid absorption. 
Collectively, these results on animal studies give some insights in humans and further 
investigations are required to elucidate the exact mechanisms for the 
hypocholesterolemic and hypolipidemic actions of green tea. 
1.3.5.3 Anti-inflammatory Activity 
Most of the anti-inflammatory effects of green tea were studied on animal 
models. Lipoxygenase plays a key role in inflammatory responses. Katiyar et al. (1992) 
reported that green tea polyphenols (GTP) could protect against 12-0-
tetradecanolyphorbol- 13-acetate (TPA)-caused effects on cyclooxygenase and 
lipoxygenase activities in SENCAR mice after prior skin application. Besides, GTP 
could inhibit TPA-induced epidermal edema and hyperplasia (Katiyar et al., 1992). In 
another experiment on mice, GTP showed a protective effect against UVB radiation-
caused cutaneous edema and depletion of antioxidant defense system in epidermis 
(Mukhtar et al., 1996). The oral feeding of GTP also confers protection against UVB 
radiation-caused induction of epidermal ornithine decarboxylase and cyclooxygenase 
activities in a time-dependent manner (Mukhtar et al., 1996). 
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1.3.5.4 Anti-microbial Activity 
Green tea and its catechins, especially the major constitutuent EGCG, were 
found to have anti-microbial activities both in vitro and in vivo. It has been reported that � 
tea catechins have anti-bacterial activity against various foodbome pathogenic bacteria, 
such as Staphylococcus aureus and Bacillus cereus (Hara & Ishigami, 1989). Recently, 
Mabe et al (1999) studied the anti-bacterial activity of tea catechins against 
Helicobacter pylori both in vitro and in vivo. EGCG was found to have bacteriocidal 
effect against Helicobacter pylori with a higher activity at pH 7. Previous study had 
suggested that the bacteriocidal activity might be attributed to the damage of lipid 
bilayer by catechins (Ikigai et al, 1993). A recent study in Japan also showed the 
protective effect of EGCG on gnotobiotic mice infected with the enterohemorrhagic 
Escherichia coli 0157:H7 strain (Isogai et al, 1998). EGCG and ECG were also shown 
to inhibit the extracellular release of Vero toxin from E. coli 0157:H7 suggesting a 
possible role of these catechins for the protection against infection (Sugita-Konishi et al, 
1999). Apart from the anti-bacterial activity, green tea catechins also have anti-viral 
activity. EGCG markedly inhibited the infectivity of influenza A virus and B virus in 
vitro through viral agglutination and reduced viral absorption to the target cells 
OS[akayama et al., 1993). On the other hand, EGCG and ECG were reported to have the 
ability to inhibit HIV replication by inhibiting the human immunodeficiency virus 
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1.3.5.5 Anti-mutagenic Activity 
It is generally believed that the gene mutations induced by various chemicals are 
important as an initial event in carcinogenesis. In the past decade, numerous experiments � 
demonstrated the anti-mutagenic activity of tea extracts and their catechins. Green tea 
infusion or its polyphenolic compounds could inhibit the mutations induced by aflatoxin 
Bi (AFBi), 2-aminofluorene, benzo[a]pyrene (BP), and methanol extracts of coal tar 
pitch in bacterial or mammalian cell test system (Wang et al., 1989). A recent report 
compared the inhibitory effect on a number of mutagens with various tea extracts and 
EGCG (Hour et al., 1999). Various tea extracts and EGCG were found to have 
differential inhibitory activities on eleven mutagens including A -^methyl-A/^  -nitro-A -^
nitrosoguanidine (MNNG), folpet, monocrotophos，2-acetylaminofluorene (AAF), 
benzo[a]pyrene (BP), 9-aminoacridine (9AA), aflatoxin Bj (AFBj), A -^nitroso-iV-
methyllurea (MNU), 4-nitroquinoline-A^-oxide, captan and fungicides. Among the tea 
polyphenols, in vitro studies showed that EGCG was the most effective anti-mutagen 
(Wang et al., 1989). It was found to ftinction as a nucleophile to scavenge the 
electrophilic mutagens (Hour et al., 1999). 
In a recent in vivo study, when EGCG was administered orally for the first 3 
weeks and benzo[a]pyrene (B[a]P) was injected intraperitoneally on day 7, there was an 
approximate 60% reduction in the B[a]P-induced mutations in the lung of rpsL 
transgenic mice (Muto et al., 1999). The results suggested that drinking green tea might 
reduce the tumor-initiating potency ofB[a]P in the lung. 
^ 
i 
Chapter 1 General Introduction 
1.3.5.6 Anti-carcinogenesis 
In the past two decades, the relationship between tea consumption and cancers 
has been extensively investigated in both human and animal models. The epidemiologic 
*x 
studies conducted in 1991 by the Working Group of the International Agency for 
Research on Cancer (IARC) on tea consumption and various cancers did not yield 
consistent and conclusive results. The study concluded that there is inadequate evidence 
for the carcinogenicity of tea in humans and experimental animals O^CI, DCPC, 
Chemoprevention Branch and Agent Development Committee, 1996). The 
inconsistencies of the results might be due to some factors including diet habit, use of 
alcohol and tobacco, geographical location, the concentration of the tea and consumption 
of too hot tea which were not being ruled out in some studies O^CI, DCPC, 
Chemoprevention Branch and Agent Development Committee, 1996). Since then, many 
experimental and epidemiological studies defining an association between tea 
consumption and cancer risk and prevention have been published (Yang & Wang, 1993; 
Katiyar & Mukhtar, 1996; Yang et al., 1997). 
With regard to the cancer preventive effects of tea, numerous in vivo experiments 
showed a conclusive and positive result in animal models. Tea extracts, green tea 
polyphenols (GTP) and EGCG were reported to inhibit carcinogenesis in rodents at 
different organ sites induced by a variety of carcinogens. A wide range of target organs 
including esophagus, forestomach, duodenum, large intestine, colon, mammary glands, 
prostate gland and skin were tested using initation, promotion, and progression protocols 
(Yang & Wang, 1993; Katiyar & Mukhtar, 1996; Brown, 1999; Yang et al., 1997). The 
in vivo studies on the anti-carcinogenic effects of tea in rodents are summarized in Table 
1.4. The biological mechanisms for the anti-carcinogenic activities of green tea and 
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green tea polyphenols on animal models were also studied in various processes of 
carcinogenesis as follows: (Stoner & Mukhtar, 1995; Katiyar & Mukhtar，1996) 
• prevention against mutagenicity and genotoxicity of carcinogens 
、 
• reduction in biochemical marker of tumor initiation and promotion 
• regulation of detoxification enzymes 
• trapping of activated metabolites of carcinogens 
• regulation of antioxidant and free-radical scavenging activity 
• effects on metastasis 
Table 1.5 summarized the possible mechanisms for the anti-carcinogenic effects of 
green tea and green tea catechins. 
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Table 1.4 Examples of studies demonstrating chemopreventive effect of tea or its 
components against tumorigenesis in different animal models 
Target Organ Species Carcinogen°^° Treatment * Mode of Application 
Colon Fisher rat AOM GTP Drinking water 
F344 rat MNU GTP Drinking water 
Duodenum C57BL/6 mice ENNG EGCG Drinking water 
Esophagus Sprague-Dawley rat NMBzA Decaffeinated green Drinking water 
and black tea extract 
Mice NMBzA Green tea infusion Drinking water 
Forestomach A/J mice B(a)P, DEN Green tea infusion Drinking water 
Liver Rat Aflatoxin B, Green tea leaf Diet 
Rat DEN Green tea leaf Diet 
Swiss mice Tobacco Decaffeinated black Gavage 
tea extract 
Lung A/J mice B(a)P, DEN Green tea infusion Drinking water 
Af] mice NNK Decaffeinated green Drinking water 
and black tea extract 
Mammary glands* Sprague-Dawley rat DMBA GTP Diet 
C3HmeN mice Spontaneous GTP & Al(OH)3 Diet 




Small intestine F344rat DEN + MNU + GTP Diet 
DMH + BBN + DHPN 
Skin BALB/c mice 3-MC GTP Topical 
CD-1 mice DMBA&TPA GTP Topical 
CD-lmice DMBA&teleocidin EGCG Topical 
CD-1 mice DMBA&okadaicacid EGCG Topical 
Senear mice DMBA & TPA GTP/EGCG Topical 
Senear mice BPDE & TPyV GTP Topical 
SKH-1 UV-B/ TPA Green tea infusion Drinking 
SKH-1 DMBA & TPAAJV-B Green tea infusion Drinking 
* Only found in tumor size reduction. 
# GTP: green tea polyphenol; EGCG: epigallocatechin-3-gallate. 
o,�AOM: azymethane; B(a)P: benzo(a)pyrene ； BBN: N-butyl-N-(hydroxybutyl)nitrosamine; 
BPDE: benzo(a)pyrene diolepoxide; DEN: diethylnitrosamine; DHPN: 2,2'-dihydroxy-di-n-
propylnitrosamine; DMBA: 7,12-dimethylbenz(a)anthracene; DMH: dimethylhydrazine; ENNG: 
N-ethyl-N'-nitro-N-nitrosoguanidine; 3-MC: 3-methylcholanthrene; MNU: N-methyl-N-
nitrosourea; NMBzA: N-nitroso-methylbenzylamine; NNK: 4-(methylnitrosamino)-1 -(3-
pyridyl)-1 -butanone; NOA: N-nitroso-bis(2-oxopropyl)amine; TPA: 12-tetradecanoylphorbol-
13-acetate. 
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Table 1.5 Mechanisms for chemoprevention by tea and green tea catechins with 
possible molecular targets 
Mechanisms Possible molecular targets Representative agents 
Reduce mutagenesis & Genotoxicity 
Reduce mutagenicity of carcinogens Nitrosation reaction (inhibit) Green tea extract, EGCG 
Reduce carcinogen formation Reduce heterocyclic amines Green & black tea extract 
Theaflavine gallate, EGCG 
Inhibit Biochemical Marker 
ofTumor Initiation 
Reduce carcinogen activation Cytochromes P450 (inhibit) Green tea extract, EGCG 
aryl hydrocarbon hydroxylase, 
mono-oxygenase (inhibit) 
Reduce carcinogen-DNA binding Enzyme mediated binding of Green tea extract, EGCG 
carcinogen to DNA (inhibit) 
Inhibit Biochemical Marker 
ofTumor Progression 
Reduce polyamines, Ornithine decarboxylase (ODC) GTP 
epidermal hyperplasia, Cyclo-oxygenase (inhibit) 
inflammation 
Reduced lipid peroxidation Lipoxygenase (inhibit) GTP 
Enhancement of gapjunction _ EGCG, ECG 
intercellular communication 
Enhance Detoxification 
Increase carcinogen detoxification UDP-glucuronyltransferase Green & black tea extract 
(increased) 
Free Radical Scavenging and 
antioxidant enhancement 
Reduced reactive oxygen species Peroxide, superoxide, anion (O2.), GTP, EGCG, EGC, ECG 
in exposure to carcinogens hydrogen peroxide (H2O2) (reduced) 
Enhancement of antioxidant Glutathione peroxidase, catalase, GTP 
NADPH-quinone oxidoreductase, 
and glutathione-S-transferase 
Inhibition of Metastasis 
Decreased tumor progression Binding to laminin to decrease (+)-catechin, EC 
by reducing invasive activity cell adhesion 
Inhibit proteolytic enzymes Collagenase (inhibit) EGCG, EGC 
GTP: green tea polyphenol; EGCG: (-)-epigallocatechin-3-gallate; EGC; (-)-epigallocatechin; ECG:(-)-
epicatechin-3-gallate; EC: (-)-epicatechin (Adapted from Ahmad et al., 1998; Kelloffe^ al., 2000) 
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1.3.5.7 Direct Anti-tumor Activity 
In addition to the prevention of cancer development and formation, tea or green 
tea polyphenols can directly kill cancer cells or inhibit their growth through a variety of � 
mechanisms. Different researches have been carried out recently to study the in vitro 
growth inhibitory effects of green tea and its catechins on a wide variety of both human 
and animal cancer cell lines. Some of the results are summarized in Table 1.6. EGCG is 
generally the best inhibitor in most cases. 
One of the growth inhibitory mechanisms of green tea and green tea polyphenols 
is the inhibition of growth and induction of apoptosis (Table 1.6). EGCG may act as a 
prooxidant through H2O2 production to induce apoptosis (Yang et al., 1998c). It can also 
induce a synergistic apoptotic effect in combining with other drugs like sulindac and 
tamoxifen (Suganuma et al., 1999). Other common mechanisms for the growth 
inhibition of cancer cells may be through the induction of cell cycle arrest and by 
interference of the signal transduction pathways of cancer cells. 
There is a limited number of in vivo studies on the anti-tumor effects of green tea. 
Intraperitoneal (i.p.) injection of EGCG was found to inhibit the growth of human 
prostate and breast tumor cells in athymic nude mice (Liao et al., 1995). Wang et al. 
(1992) demonstrated that GTP or EGCG given i.p. inhibited the growth and caused 
partial regression of established skin papilloma in CD-1 mice. Previous studies in our 
laboratory also showed that i.p. injection of green tea catechins could inhibit the growth 
oftransplantable tumors, WEHI-3B JCS and EAT, in BALB/c mice (Tung, 1999). The 
in vivo anti-tumor mechanism was found to be mediated, at least in part, by the 
activation of the host's cell-mediated immune response. 
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Table 1.6 Examples of growth inhibition and apoptosis caused by EGCG in human 
and animal cancer cell lines 
Type ofcancer Origin Cell line Biological activity ECgp of EGCG QiM) 
Oral Human 1483 HNSCC Growth inhibition 18 
Human MSK-LEUK1 Growth inhibition 8 
Human MSK-LEUKlS Growth inhibition 11.5 
Human 1483 Growth inhibition 18 
Breast Human MCF-7 Growth inhibition 120 
Human Hs578T Growth inhibition 10 
Fibroblasts Human WI38VA Growth inhibition 10 
Apoptosis 200 
Liver Rat HTC Growth inhibition -
Lung Human PC-9 Growth inhibition 140 
Apoptosis 100 
Human A-427 Growth inhibition 94 
Human H441 Growth inhibition 60 
Human H661 Growth inhibition 22 
� Apoptosis 100 
Human H1299 Growth inhibition 22 
Lymph Mouse LY-R Apoptosis -
Mouse L5178Y Apoptosis 80 
Stomach Human KATOIII Apoptosis 200 
Colon Human Caco-2 Growth inhibition 40 
Human HT-29 Growth inhibition 86 
Prostate Human DU145 Growth inhibition 25 
Prostate Apoptosis 175 
Human PC-3 Growth inhibition 1 
Human LNCaP Growth inhibition <1 
Apoptosis 200 
Skin Human A431 Apoptosis 87 
Human HaCat Apoptosis 175 
Human UACC-375 Growth inhibition 130 
Blood Human Molt-43 Growth inhibition 100 
Apoptosis 100 
Human THP-1 Growth inhibition 18 
Apoptosis 50 
Human U937 Growth inhibition 15 
Mouse NFS60 Growth inhibition 3 
Apoptosis 20 
Mouse DS19 Growth inhibition -
(Adapted and modified from Chen et al., 1998; Khafife/ al., 1998; Paschka et al, 1998; Otsuka 
et al., 1998; Yang et al” 2000) 
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1.3.5.8 Modulating Activity in Endocrine System 
Two recent reports demonstrated that EGCG could exhibit modulating effects in 
the endocrine system of rats. EGCG was found to inhibit type I 5a-reductase activity at 
a modulate concentration. It also inhibited accessory sex gland growth in rat, suggesting 
a possible role of EGCG in regulating androgen action in target organs (Liao & 
Hiipakka, 1995). In addition to lowering of plasma cholesterol and triglyceride levels, 
EGCG also significantly reduced food intake, body weight, blood levels of testosterone, 
estradiol, leptin, insulin-like growth factor I, insulin, LH, glucose and the growth of 
prostate, uterus and ovary after i.p. injection into rats. Similar effects were observed in 
lean and obese male Zucker rats, suggesting that the effect of EGCG was independent of 
an intact leptin receptor (Kao et al., 2000). 
1.3.5.9 Other Biological Activities 
Apart from the above discussed physiological and pharmacological activities of 
GTCs as described in previous sections, many other biological effects of tea and its 
components have been reported. Tea consumption has been recently reported to have 
beneficial effects to kidneys in which 2-3 cups per day can help to prevent the formation 
of kidney stone (Curhan et al., 1998). Studies showed that black tea consumption or 
some purified tea catechins could alleviate the risk of cardiovascular diseases and stroke 
by reducing the blood pressure (Stensvold et al., 1992; Chung et al., 1998). Besides, 
green tea or its components has been shown to reduce blood pressure in rats (Abe et al., 
1995; Juneja et al., 1999). In addition, EGC was found to have significant inhibitory 
effects on ADP-induced human platelet aggregation comparable to the potency observed 
with aspirin. EGC inhibited platelet thromboxane formation from exogenous and 
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endogenous arachidonic acid in a dose-dependent manner (Chang & Hsu, 1991). Other 
biological effects of tea included the stimulation of gastric secretion, diuretic activities 
and antipyretic effects (Trevisanato & Kim, 2000). More investigations have to be done 
*v 
to further clarify these health benefits of tea. 
1.3.6 Possible Anti-cancer Mechanisms of Green Tea Epicatechins 
Tea consumption has been shown to have protective effects against many types 
of cancer, therefore, defining the mechanisms of action of tea on cancer cells is 
important. The followings are some of the possible anti-cancer mechanisms of green tea 
catechins which have been studied, though the molecular bases of these mechanisms are 
still poorly understood. 
1.3.6.1 Modulation of Anti-tumor Immunity 
Previous study in our laboratory indicated that GTCs could modulate the immune 
I 
functions of BALB/c mice both in vitro and in vivo (Tung, 1999). Green tea catechins 
were found to have mitogenic and co-mitogenic activities on mouse splenocytes in vitro. 
They were also capable of stimulating macrophages in vitro by increasing their 
phagocytic and cytostatic activities. In addition, the in vitro cytolytic activity of natural 
killer (NK) cells was greatly enhanced by in vivo treatment of mice with GTCs. The 
lymphokine activated killer (LAK)-like cell activity was also induced by in vitro 
treatment of splenocytes with GTCs (Tung, 1999). There is only one report on the 
immunomodulatory activity of purified green tea epicatechins. Zenda (1997) showed 




Chapter 1 General Introduction 
1.3.6.2 Direct Growth Inhibition by Controlling the Signal Transduction 
Pathways 
� Cell growth and proliferation are controlled by different complex signaling 
pathways involving numerous signaling molecules, enzyme cascades and regulation of 
transcription factors. More recently, green tea polyphenols were found to interfere with 
the cellular signaling pathways to exert their chemopreventive and anti-tumor activities 
on cancer cells. In a recent study, EGCG was found to inhibit the protein expression of 
the inducible nitric oxide synthase (iNOS) as well as the generation of NO in LPS-
activated peritoneal macrophages via a down regulation in the transcription factor 
nuclear factor-KB ^s[F-KB) (Lin & Lin, 1997). This result was supported by Chan et al. 
j 
(1997) who demonstrated that EGCG inhibited the LPS- and IFN-y-activated iNOS 
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EGCG and theaflavins can inhibit cell growth during tumor promotion. They j 
， 
inhibit tumor promoter-induced activator protein 1 (AP-1) activation and DNA-binding 
activity in JB6 mouse epidermal cell line treated with EGF and TPA. The inhibition of 
AP-1 activation occurred via the inhibition of c-Jun N-terminal kinase-dependent 
pathway (Dong et aL, 1997). Green tea polyphenols also exert anti-proliferative effect 
on normal vascular smooth muscle cells. EGC was found to inhibit the proliferation of 
smooth muscle cells by the inhibition of protein tyrosine kinase activity, c-Jun mRNA 
expression and JNK1 activation (Lu et al., 1998). EGCG could also block the binding of 
epidermal growth factor (EGF) to its receptors and prevented the phosphorylation of 
epidermal growth factor receptor (EGF-R) (Liang et al., 1997). These results suggested 
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that EGCG can inhibit cell growth and proliferation by interfering with the signal 
transduction pathways. 
� 
1.3.6.3 Induction ofApoptosis and Cell Cycle Arrest 
Recent studies have demonstrated that green tea polyphenols or EGCG can 
inhibit cell growth via cell cycle arrest and induce apoptosis in a wide variety of cancer 
cell lines in vitro (Table 1.6). However, the actual molecular mechanisms for the 
cytostatic and apoptosis-inducing effects of tea polyphenols are far from being 
understood. Until recently, Liang et al. (1999) demonstrated that EGCG can induce cell 
cycle arrest at G1 phase in human breast carcinoma cells via the inhibition of cyclin- ； 
^ 
dependent kinases 2 and 4 activities. EGCG was also found to induce the expression of | 
•I 
Cdk inhibitors, the p21 and p27 proteins. This study suggested that green tea � 
( 
polyphenols could regulate the expression of cell cycle regulatory proteins so as to ； 
( 
inhibit or suppress tumor growth. In addition, another study showed that EGCG could ！ 
I 
inhibit cell cycle progression in epidermal growth factor (EGF)-stimulated MCFlOA -
breast epithelial cells. In this study, EGCG was found to synergize with the growth 
factor-dependent signals to induce p21^"'^ and impaired cell cycle progression through 
the inhibition of cyclin Dl-associated pRB kinase activity and pRB phosphorylation 
(Liberto & Cobrinik，2000). 
Tea polyphonels can induce apoptosis in certain cancer cells. A recent report 
suggested that the flavonoid-induced apoptosis was stimulated by the release of 
cytochrome c to the cytosol, by procaspase-9 processing and through a caspase-3-
dependent mechanism (Wang et al., 1999). It was suggested that tea polyphenols had to 
possess a pyrogallol-type structure to induce apoptosis and the presence of 3-0-gallate 
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group in cis-relationship to B-ring can enhance this activity (Saeki et al., 2000). 
However, the molecular events leading to the control ofapoptosis by tea polyphenols are 
still poorly understood. Many growth-related and apoptotic genes or regulatory proteins � 
such as PKC, c-Myc, c-Fos, c-Jun, Bcl-2, Bak, Bad, p53 and caspases are being the 
molecular targets for further studies. 
1.3.6.4 Inhibition of Tumor Metastasis 
Human cancers need proteolytic enzymes to invade cells and form metastases. It 
i 
1 
was reported that EGCG exhibited inhibitory effects on lung metastasis of the highly 1 
1 
invasive B16-F10 cells in male C57BL/6 mice. Statistically significant inhibition of lung 
metastasis caused by intravenous injection of Lewis lung carcinoma cells was also | 
I 
observed after intraperitoneal administration of EGCG (Tanighchi et al., 1992). Green � 
I 
tea catechins were suggested to inhibit metastasis by reducing the activities of ； 
• 
collagenase in human gingival cervicular fluid (Makimura et al, 1993). Another ; 
example of these enzymes is urokinase (uPA) which is one of the most frequently . 
expressed enzymes in human cancers and is crucial for cancer growth. With the use of 
molecular modeling, Jankun et al. (1997) demonstrated that EGCG inhibited urokinase 
by blocking the His 57 and Ser 195 of the catalytic triad and extending toward Arg 35 
from a positively charged loop. However, the result was challenged by Yang (1997). 
4 7 
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1.4 Aims and Scopes of This Investigation 
Tea is produced from a tea plant called Camellia sinenesis and is a very popular 
beverage consumed worldwide. It has been used as a social beverage and is widely 
accepted by the general public in different communities. Green tea is widely consumed 
among the Chinese population and is believed to have various health-promoting 
properties. Over the past two decades, numerous epidemiological and experimental 
studies showed that green tea catechins (GTCs), the major polyphenols in tea, possess a 
number of beneficial physiological and pharmacological properties including anti-
oxidative and anti-carcinogenic activities. These activities of green tea have been | 
extensively studied and accumulating evidences also supported the applicability of green 
1 
tea or GTCs as a useful chemopreventive agent against certain types of disease including \ 
\ 
cancer. However, the therapeutic effects of green tea on cancer and its action I 
I t 
mechanisms have not been fully understood. Therefore, the major objectives of this ‘ 
_ 
thesis project are to investigate the direct anti-tumor activities of green tea and to define | 
4< 
the possible molecular mechanisms by which the green tea epicatechin isomers can exert 
their anti-tumor effect in vitro and possibly in vivo. 
In the present study, the anti-proliferative activity and cytotoxicity of green tea, 
oolong tea, and black tea will be first studied and compared using a number of human 
and murine leukemic cell lines. The induction of apoptosis by the three tea extracts will 
also be examined. Moreover, the anti-tumor activity of purified green tea epicatechin 
isomers including EGCG, EGC, ECG and EC will be investigated. The in vitro growth-
inhibitory, cytotoxicity and apoptosis-inducing effects of different epicatechin isomers 
will be examined using a panel ofhuman and murine leukemic cell lines including T cell 
^ 
i 
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lymphomas (MBL-2, YAC-1, L1210), macrophage-like tumors (PU5-1.8, P388D1) and 
myeloid leukemia cells (HL-60, K562, KG-1，Ml, WEHI-3B JCS and EoL-l). The 
cytotoxicity and anti-proliferative effects will be measured by the trypan blue exclusion � 
test and the standard ^H-TdR incorporation assay respectively. The differentiation-
inducing activity of EGCG and other epicatechin isomers on the leukemia HL-60 cells 
will be assessed by morphological analysis of the treated cells after cytocentrifugation. 
Besides, the ability of epicatechin isomers to induce apoptosis in leukemia cells will be j 
measured by DNA fragmentation analysis, Annexin V assay using flow cytometry and 
) 
) 
morphological examination. Moreover, the effect ofEGCG on the in vivo tumorigenicity 1 
i 
oftwo leukemia cell lines L1210 and WEHI-3B JCS will also be studied. 
Furthermore, the ability of EGCG to synergize with other physiological inducers � 
and pharmacological compounds such as vitamin analogs, cytokines and plant ； 
( 
phytochemicals in modulating the growth of leukemia cells will be investigated. j 
I 
Attempts will be made to elucidate the molecular mechanisms by which EGCG could � 
exert its effects on the myeloid leukemia cells. The expression of growth-related and 
apoptosis-regulatory genes and their protein products in EGCG-treated leukemia cells 
will be measured using the RT-PCR method and the Western blot analysis respectively. 
Finally, apart from the studies on leukemia cells, the effects of EGCG on the 
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2.1 Materials 
2.1.1 Animals 
Inbred female BALB/c (H-2^) mice aged 6-8 weeks old were used in the 
experiments indicated. They were bred under a specific pathogen-free condition, fed 
with animal diet (Chow 5001, Rodent Laboratory) and tap water ad libitum by the 
University Laboratory Animal Services Center of the Chinese University ofHong Kong. 
) 
2.1.2 Cell Lines I 
1 
1) Myeloid Tumors: I 
a) HL-60 is a human promyelocytic leukemia cell line derived from the peripheral �, 
blood leukocytes of a 36 years old Caucasian female with acute promyelocytic j 
leukemia (Collins et al, 1978). It was purchased from the American Type | 
Culture Collection (ATCC), U.S.A. j 
1» 
！ 
b) K562 is a human chronic myelogenous leukemia cell line purchased from ATCC. 
It was established from the pleural effusion of a 35 years old female with chronic 
myelogenous leukemia in terminal blast crises (Lozzio & Lozzio，1975). 
c) KG-1 is a human acute myelogenous leukemia cell line purchased from ATCC. 
It was obtained from the bone marrow of a 59 years old Caucasian male with 
acute myelogenous leukemia (Koeffler & Golde, 1978). 
5 0 
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d) Ml is a murine myeloblastic leukemia cell line originally established from a 
spontaneous myeloid leukemia of SL strain mice in vitro (Ichikawa, 1969). It 
was purchased from ATCC. 
� 
e) WEHI-3B D' is a mineral oil-induced murine myelomonocytic leukemia cell line 
derived from BALB/c mice and was originally obtained from Dr. D. Metcalf 
(Walter and Eliza Hall Institute for Medical Research, Melbourne, Australia). It • 
was subsequently subcloned at the John Curtin School of Medical Research, 
i, 
Canberra, Australia and one of the subclones was designated as WEHI-3B JCS | 
(Leung et al, 1994). . 
I: 
2) Lymphoid Tumors: � 
a) L1210 is a murine lymphocytic leukemia cell line purchased from ATCC. It was : 
» 
developed in an 8-months-old female #234 of subline 212 of the DBA strain | 
ji 
following skin paintings with 0.2 % methylcholanthrene in ethyl ether (Wilkoff , 
etal” 1967). 
b) MBL-2 is a Moloney leukemia virus-induced T cell lymphoma derived from 
C57BL/6J mice Q^g et al, 1978). It was obtained from the Department of 
Pathology, University of Cambridge, U.K. 
c) YAC-1 is a Moloney leukemia virus-induced T cell lymphoma derived from 
A/Sn mice (Asjo et al, 1977). It was purchased from ATCC. 
M 
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3) Macrophage-like Tumors: 
a) P388D1 is a murine macrophage-like tumor cell line purchased from ATCC. It 
was derived from the macrophages and monocytes of DBA/2 mice induced by 
� 
methylcholanthrene (Koren et al, 1975). 
b) PU5-1.8 is a murine macrophage-like tumor cell line derived spontaneously from 
BALB/c mice (Ralph et al, 1977). It was originally obtained from the ‘ 





4) Other Tumor: , 
EoL-1 is a human eosinophilic leukemia cell line established from the peripheral | 
blood of a patient with Philadelphia chromosome-negative eosinophilic leukemia S 
(EL) (Saito et al. 1985). This cell line was kindly provided by Dr. C. K. Wong, ； 
I 
Department of Chemical Pathology, The Chinese University ofHong Kong. j 
I 
2.1.3 Sheep Red Blood Cells (SRBC) 
Sheep red blood cells in Alsever's solution were purchased from Serotec Ltd. 
The cells were kept at 4°C and washed with phosphate buffered saline (PBS) three times 
before use. 
2.1.4 Cell Culture Medium, Buffers and Other Reagents 
1) RPMI1640 Medium 
The sterilized liquid form of RPMI 1640 Medium, supplemented with 25 mM N-
2-hydroxy-ethyl-piperazine-N'-2-ethane-sulfonic acid (HEPES) and 2 mM L-
glutamine at pH 7.2，was purchased from GIBCO BRL Life Technologies Inc. It was 
5 2 
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used for the preparation of stock solution of cytokines and other chemicals for cell 
cultures. The powder form ofRPMI 1640 medium (GIBCO BRL Life Technologies 
Inc.), supplemented with 25 mM HEPES and 2 mM L-glutamine was used for the 
� 
preparation of culture medium which was used for sub-culturing and washing of 
cells. One-liter culture medium was prepared by dissolving 16.2 g of powder in 
double distilled water and buffered with 2 g sodium bicarbonate ^NJaHCO;) (Sigma 




(Sigma Chemicals Co.). It was then sterilized by filtration through a 0.22 jiun | 
i « 





2) Serum Supplements ^ 
I 
Fetal Calf Serum (FCS) was purchased from GIBCO BRL Life Technologies Inc. � 
I 
It was stored as 20 ml and 10 ml aliquots. Heat-Inactivated Fetal Calf Serum (HI- ； 
FCS) was prepared as 20 ml and 10 ml aliquots in sterile universal bottles by heating \ 
at 56°C for 30 minutes. Both kinds of serum aliquots were stored at -20°C. ‘ 
3) Antibiotic Solutions 
The Antibiotic-Antimycotic [10,000 units/ml penicillin G (sodium salt), 10,000 
|Lig/ml streptomycin sulfate and 25 ^g/ml amphotericin B as Fungizone in 0.85% 
saline PSF] and Antibiotic [5,000 ^g/ml penicillin G sodium, 5,000 p,g/ml 
streptomycin sulfate and 10,000 ^ig/ml neomycin sulfate in 0.85% saline PSN] 100x 
stock solutions were purchased from GIBCO BRL Life Technologies Inc. and were 
stored as 5 ml aliquots at -20°C. 
5 3 
i 
Chapter 2 Materials <fe Methods 
4) Complete RPMI Medium 
RPMI medium supplemented with only 1% antibiotics, which was designated as 
� 
“ Plain Medium" which was usually used for washing cells. Complete RPMI 
Medium (CM) was prepared by supplementing plain medium with 10% or 20% HI-
FCS or FCS. Usually CM supplemented with 10% FCS was used for sub-culturing 
most of the human and murine cell lines while 20% supplemented CM was used for _ 




5) Normal Saline (NS) j 
4 
Normal saline was prepared by dissolving 9 g sodium chloride (Sigma Chemicals | 
Co.) in one liter double distilled water and sterilized by autoclaving at 12TC for 15 � 
minutes. ； 
I I 
6) Dulbecco's Phosphate-Buffered Saline (PBS) ! 
PBS (Sigma Chemicals Co.) containing 0.2 g monobasic potassium phosphate, 
0.2 g potassium chloride, 8 g sodium chloride and 1.15 g dibasic sodium phosphate, 
was prepared by dissolving in one liter double distilled water. The pH was then 
adjusted to 7.4 by 1 M HCL and 1 M NaOH and then sterilized by autoclaving at 
12rC for 15 minutes. 
7) Ficoll-Paque Solution 
Ficoll-Paque containing 5.7 g Ficoll, 9 g sodium diatrizoate and calcium EDTA 
in 100 ml water (density = 1.077 g/ml) was purchased from Pharmacia Biotech., 
Asia Pacific Ltd., Hong Kong. It was used for the isolation of lymphocytes in vitro. 
5 4 
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8) Mitogens 
a) Concanavalin A (Con A) 
� 
Con A (from Canavalia ensiformis, Sigma Chemical Co.) was dissolved 
in RPMI medium at 500 ^g/ml and stored as 50 ^1 aliquots at -20�C until use. 
b) Lipopolysaccharide (LPS) 
LPS (from E. coli, Sigma Chemical Co.) was dissolved in RPMI medium ‘ 
. 
at 500 ^ig/ml and stored as 200 ^1 aliquots at -20°C until use. 
9) 2-Mercaptoethanol (2-ME) Solution | 
0.1 M stock solution of 2-ME (Sigma Chemical Co.) was prepared in sterilized | 
double distilled water and stored as 200 i^l aliquots in dark at -20°C until use. ： 
f , \ 
10) Dye solutions � 
i 
a) Trypan Blue Solution 
Trypan blue solution was purchased from Sigma Chemical Co. It contains 
0.4% (w/v) trypan blue dissolved in 0.817% sodium chloride and 0.06% dibasic 
potassium phosphate. 
b) Hemacolor Staining Solutions 
Hemacolor staining solutions were purchased from Diagnostica Merck. 
They were used to stain cells after cytocentrifugation and consisted of three 
separated solutions. Hemacolor Solution 1 was methanol for fixing cells, 
Solution 2 was a buffered color reagent red and Solution 3 was a buffered color 
5 5 
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reagent blue. The buffer solutions were prepared by dissolving 1 buffer tablet in 
1 liter of freshly distilled water and they were stable for at least 4 weeks when 
stored in a tightly closed glass bottle. All staining solutions were light-protected 
� 
and stored at room temperature. 
2.1.5 Tea Extracts and Green Tea Epicatechins 
1) Tea Total Extracts : 
Green Tea Extract (GTE) and Oolong Tea Extract (OTE) purified from Chinese 
green tea and oolong tea respectively were kindly provided by Prof. Z.Y. Chen, 
Department of Biochemistry, The Chinese University of Hong Kong. These tea 
extracts were isolated from the corresponding tea leaves obtained from local markets 
using the method as described by Chen & Chan (1996). The GTE and OTE had been 
separated and quantitated by HPLC as described previously (Chen & Chan, 1996). 
Black Tea Extract (BTE) purified from black tea (contained minimum 80% 
theaflavins) was purchased from Sigma Chem. Co. (U.S.A.). They were dissolved in 
absolute ethanol as a 20 mg/ml stock solution and kept in small aliquots in dark at -
20¾. They were freshly diluted with complete RPMI medium for each experiment 
and the final concentration of ethanol in the culture medium never exceeded 0.1% 
(v/v). 
2) Green Tea Epicatechins: 
Green tea epicatechin isomers (-)-Epigallocatechin-3 -gallate (EGCG),(-)-
Epigallocatechin (EGC), (-) Epicatechin-3-gallate (ECG), and (-) Epicatechin (EC) 
with purity >95% were purchased from Sigma Chem. Co. (U.S.A.) They were 
dissolved in absolute ethanol as 80 mM stock solutions and kept in small aliquots in 
^ 
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dark at -20°C. They were freshly diluted with complete RPMI medium for each 
experiment and the final concentration of ethanol in the culture medium never 
exceeded 0.1% (v/v). 
� 
2.1.6 Recombinant Cytokines 
1) Recombinant Murine Interleukin-la (rmIL-la) and Recombinant Murine 
Interleukin-ip (rmIL-lp) 
Recombinant murine IL-la and IL-lp were purchased from R&D Systems Inc. 
They were recombinant proteins derived from E. coli and lyophilized aseptically 
from a sterile filtered solution containing 50 i^g of bovine serum albumin per |ug of 
cytokine in PBS. Their biological activity was measured in a cell proliferation assay 
using a murine helper T cell line D.10.G4.1. The specific activity was found to be 
around lxlO^ units/mg. The stock solutions (1 ^g/ml) were prepared in sterilized 
RPMI medium supplemented with 2% HI-FCS and stored as 250 jid aliquits at -70°C 
until use. 
2) Recombinant Murine Interleukin-3 (rmIL-3) 
Recombinant murine IL-3 was purchased from Pharmingen Co. It was a 
lyophilized recombinant protein derived from E. coli with a specific activity of lxlO^ 
units/mg. The biological activity was measured by the dose-dependent stimulation of 
thymidine uptake by the mouse IL-3 dependent cell line, MC-9. A stock solution of 
2xl0^ units/ml was prepared in sterilized RPMI medium supplemented with 2% HI-
\ 
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3) Recombinant Murine Tumor Necrosis Factor-a (rmTNF-a) 
Recombinant murine TNF-a was purchased from Pepro Tech EC Ltd. It was a 
� 
lyophilized recombinant protein derived from E. coli with specific activity of lxlO^ 
units/mg. The biological activity was determined by the cytolysis of murine L929 
cells in the presence of actinomycin-D. It was reconstituted in autoclaved distilled 
water to a concentration of 100 ^ig/ml and the solution was further diluted to 10 
^g/ml in sterilized RPMI medium supplemented with 2% HI-FCS. It was kept as 250 
^1 aliquots at -20°C until use. 
4) Recombinant Murine Interferon-y (rmIFN-y) 
Recombinant murine IFN-y was purchased from Pepro Tech EC Ltd. It was a 
lyophilized recombinant protein derived from E. coli with specific activity of lxlO^ 
units/mg. The biological activity was determined by a cytopathic effect inhibition 
assay with murine L929 cells challenged with the encephalomyocarditis (EMC) 
virus. It was reconstituted to a concentration of 1 ^ig/ml in sterilized RPMI medium 
supplemented with 2% HI-FCS and kept as 250 i^l aliquots at —20�C until use. 
5) Recombinant Murine Granulocyte-Macrophage Colony Stimulating Factor 
(rmGM-CSF) 
Recombinant murine GM-CSF was purchased from Boehringer Mannheim 
Biochemica. It was a sterile recombinant protein derived from E. coli and was 
dissolved at a concentration of 10,000 U/ml in PBS and BSA (bovine serum 
: albumin). The specific activity was 1x10? units/mg which was determined by , 
^ 
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Stimulation of cell proliferation with FDC-P1 cells (IL-3/GM-CSF dependent mouse 
hematopoietic progenitor cell line). It was reconstituted to a concentration of 1,000 
U/ml in sterilized RPMI medium supplemented with 2% HI-FCS and kept as 500 ^1 
� 
aliquots at -20°C until use. 
2.1.7 Vitamin Analogs 
1) All Trans Retinoic Acid (ATRA) 
All trans retinoic acid (ATRA) was purchased from Sigma Chemical Co. It was 
dissolved in dimethy-sulfoxide (DMSO) (Sigma Chemical Co.) as a stock solution of 
50 mM and kept in dark as 250 ^1 aliquots at -20°C until use. It was freshly diluted 
in complete RPMI medium for each experiment and the final concentration of 
DMSO in the culture medium never exceeded 0.001% (v/v). 
2) 1,25-Dihydroxy-Vitamin D3 (Vit D3) 
Vitamin D3 was purchased from Calbiochem-Novabiochem Co. A stock solution 
of 0.2 mM was prepared by dissolving in absolute ethanol. It was kept in dark as 100 
i^l aliquots at -70°C until use. Vitamin D3 was freshly diluted in complete RPMI 
medium for each experiment and the final concentration of ethanol in the culture 
medium never exceeded 0.001 % (v/v). 
2.1.8 Taxol (Baccatin III N-benzyl-P-phenyllisoserine ester) 
Taxol was purchased from Calbiochem-Novabiochem Co. It was a complex 
I diterpenoid containing a four-membered oxetane ring and an ester side chain, which was 
i 
isolated from the bark of Pacific yew tree, Taxus brevifolia in 1967. It was dissolved in 
^ 
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absolute ethanol as a 5 mM stock solution and kept in dark as 200 ^1 aliquots at -20°C 
until use. Taxol was freshly diluted in complete RPMI medium for each experiment and 
the final concentration of ethanol in the culture medium never exceeded 0.001% (v/v). 
*x 
2.1.9 18p-Glycyrrhetinic Acid (18p-GA) 
18p-Glycyrrhetinic acid was purchased from Aldrich Chemical Company Inc. It 
was dissolved in sterile DMSO as a 60 mM stock solution. The stock solution was stored 
in dark as 250 ^1 aliquots at -20�C until use. 
2.1.10 [methyl-'H] Thymidine ('H-TdR) 
^H-TdR with a specific activity of 2 Ci/mmol was purchased from Amersham 
Life Science Ltd. The stock solution was kept as 500 i^l aliquots at 4°C and was freshly 
diluted with complete RPMI medium to 25 |iCi/ml working solution. For cell labeling, 
20 i^l working solution was added to each well of the 96-well flat-bottomed microtiter 
plate. 
2.1.11 Liquid Scintillation Cocktail 
The OptiPhase ‘High’ safe-2 liquid scintillation cocktail was purchased from 
Wallac Scintillation Products. The cocktail was based on biodegradable solvents with 
dioctyl sulfosuccinate, sodium salts and poly(ethyleneglycol)mono(4-nonylphenyl)-ether. 
It was ready to use and stored in dark at room temperature. 
� 
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2.1.12 Reagents and Buffers for Flow Cytometery 
1) Annexin V-FITC 
� 
Annexin V-FITC is a conjugate of the purified recombinant Annexin V, a Ca�+ -
dependent phospholipid binding protein, with the fluorochrome FITC under 
optimum condition. It was purchased from Pharmingen International and was 
buffered in 50 mM Tris, pH 8, 80 mM NaCl, 1 mM EDTA, 0.09% (w/v) sodium 
azide and 0.2% BSA. Annexin V-FITC is a sensitive probe for identifying apoptotic 
cells. It binds to negatively charged phospholipid surfaces with a higher specificity 
for phosphatidylserine (PS) than most other phospholipids. It was stored in dark at 
4°C. 
( 
2) Annexin V binding Buffer, 10X Concentrate 
The 10x Annexin V binding buffer composed of 0.1 M HEPES/NaOH, pH 7.4， 
1.4 M NaCl, 25 mM CaCl2 was purchased from Pharmingen International. The 
solution was sterilized by filtration through a 0.2 i^m filter. To prepare the IX 
working solution, 1 part of the binding buffer was diluted with 9 parts of distilled 
water. The buffer was tested by using it in Annexin V binding assays and both 10x 
concentrate and working solution were stored at 4°C. 
3) Propidium Iodide (PI) DNA Staining Buffer 
The PI DNA staining buffer was freshly prepared in PBS which contained 400 
^ig/ml ribonuclease A (RNase A) (Boehringer Mannheim), 50 fig/ml propidium 
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0.1% trisodium citric acid (Sigma Chemical Co.) and 0.1% Triton X-100 (Sigma 
Chemical Co.). It was kept at 4°C until use. 
� 
4) FACSFlow Shealth fluid 
The shealth fluid is a ready-to-use product purchased from Becton Dickinson 
International. It is a balanced electrolyte solution containing sodium chloride, 
potassium chloride, disodium EDTA, sodium fluoride and anti-microbial agent. The 
solution was kept at room temperature. 
2.1.13 Reagents for DNA Extraction 
1) IGEPAL CA-630 Lysis Buffer 
The buffer was prepared in 50 mM Tris [hydroxylmethyl] amino methane (Tris)-
HC1, pH 7.5 with 3% non-ionic detergent IGEPAL CA-630 ((Octylphenoxy) 
polyethoxyethanol) and 20 mM EDTA. It was kept at room temperature. All 
chemicals were purchased from Sigma Chemicals Co and IGEPAL is a registered 
trademark ofPhone-Poulenc, Inc. 
2) Proteinase K 
It was a highly active subtilisin type of protease, which was purified from the 
mold Tritirachium album Limber and purchased from Boehringer Mannheim. The 
stock solution was prepared by dissolving it in autoclaved double distilled water to a 
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3) RNaseA 
The pancreatic RNase purchased from Boehringer Mannheim was dissolved at a 
concentration of 10 mg/ml in 10 mM Tris-HCl (pH 7.5) and 15 mM NaCl. The stock 
� 
solution was heated to 100°C for 15 minutes and then allowed to cool slowly to room 
temperature. It was stored as 500 i^l aliquots at -20°C until use. 
i 
4) 3 M Sodium Acetate Solution (NaOAC) 
Sodium acetate was purchased from Sigma Chemical Co. 24.61 g sodium acetate 
was dissolved in 100 ml double distilled water and sterilized by autoclaving at 12TC 
for 15 minutes. The solution was kept at room temperature. 
5) TioEo i Buffer 
The TioEo i buffer contained 10 mM Tris-HCl (pU 7.5) and 0.1 mM EDTA in 
distilled water. The solution was kept at room temperature. 
2.1.14 Reagents for Total RNA Isolation 
1) DEPC-treated Distilled Water 
Double distilled water was treated with 0.1% diethyl pyrocarbonate (DEPC) 
(Sigma Chemical Co.), and shaken thoroughly to disperse the DEPC. After standing 
ovemight, the solution was then autoclaved at 12TC for 15 minutes so as to destroy 
the remaining DEPC. 
63 
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2) Trizol Reagent 
It is a ready-to-use reagent for the isolation oftotal RNA from cells and tissue. It 
is a mono-phasic solution of phenol and guanidine isothiocyanate purchased from 
� 
GIBCO BRL Life Technologies Inc. It was stored in dark at 4°C. 
2.1.15 Reagents and Buffers for RT-PCR Study 
1) Moloney Murine Leukemia Virus Reverse Transcriptase (M-MLV RT) 
The M-MLV reverse transcriptase (GIBCO BRL Life Technologies Inc.) uses 
single-stranded RNA or DNA in the presence of a primer to synthesize a 
complementary DNA strand. This enzyme was stored in a buffer of 20 mM Tris-HCl 
pH 7.5, 1 mM dithiothreitol (DTT), 0.01% (v/v) NP-40, 0.1 mM disodium EDTA, 
0.1 M sodium chloride and 50% (v/v) glycerol at -20°C. It was isolated from E. coli 
and one unit of its activity was defined as the amount of enzyme that would 
incorporate 1 mole of deoxythymidine triphosphate (dTTP) into acid-precipitatable 
material in 10 minutes at 37�C, using poly(A) and oligo-dTi2.ig as template and 
primer respectively. 
2) First Strand Buffer (5X) 
The first strand buffer was purchased from GIBCO BRL Life Technologies Inc. 
as a 5X solution of 250 mM Tris-HCl (pH 8.3), 375 mM potassium chloride and 15 
mM magnesium chloride (MgCy. 
3) Oligo-dTi2.i8» Sodium Salt (pd(T)j2.i8, sodium salt) 
Oligo-dTi2_i8 was purchased from Promega Corporation. A stock solution of 1 
p,g/^ il was prepared in TjoEo i buffer and stored at -20°C. 
[ 6 4 
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4) Primer Pairs 
a) Human/Mouse Bak PCR Primer Pair 
The PCR primers specific for human and mouse Bak were synthesized by 
� 
GIBCO BRL Life Technologies. The vials contained 39 nmoles forward and reverse 
sequence primers having the annealing temperature of 55�C. The lyophilized primer 
pair was reconstituted in DEPC-treated double distilled water to a working 
concentration of 2.5 jiiM. The primers were stored as 500 i^l aliquots at -20°C. The 
predicted cDNA product size was 528 base pairs (bp) for human and mouse. The 
primer pair sequences were shown as follows: 
Forward sequence (5' to 3'): GCC CAG GAC ACA GAG GAG GTT TTC 
Reverse sequence (5' to 3'): AAA CTG GCC CAA CAG AAC CAC ACC 
b) HumanyHVIouse/Rat Bcl-x PCR Primer Pair 
The PCR primers specific for human, mouse and rat Bcl-x were synthesized by 
GIBCO BRL Life Technologies. The vials contained 49 nmoles forward sequence 
and 48 nmoles reverse sequence primers having the annealing temperature of 55�C. 
The lyophilized primer pair was reconstituted in DEPC-treated double distilled water 
to a working concentration of 2.5 i^M. The primers were stored as 500 i^l aliquots 
at -20°C. The predicted cDNA product size was 538 (long) and 349 (short) base 
pairs (bp) for human, mouse, and rat. The primer pair sequences were shown as 
follows: 
Forward sequence (5' to 3')： TGG CAA CCC ATC CTG GCA CCT 
Reverse sequence (5' to 3'): ACT GAA GAG TGA GCC CAG CAG AAC 
6 5 
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c) Human GADPH PCR Primer Pair 
The PCR primers specific for human glyceraldehyde-3 -phosphate dehydrogenase 
(GADPH) were synthesized by GIBCO BRL Life Technologies. The vials contained 
� 
49 nmoles forward sequence and 47 nmoles reverse sequence primers having the 
annealing temperature of 59°C. The lyophilized primer pair was reconstituted in 
DEPC-treated double distilled water to a working concentration of 2.5 i^M. The 
primers were stored as 500 |il aliquots at -20°C. The primer pair sequences were 
shown as follows: 
Forward sequence (5' to 3'): TGA AGG TCG GAG TCA ACG GAT TTG GT 
Reverse sequence (5' to 3，)： CAT GTG GGC CAT GAG GTC CAC CAC 
5) rRNasin Ribonuclease Inhibitor 
The rRNasin ribonuclease Inhibitor (Promega Corporation) is a recombinant 
protein derived from E. coli. This inhibitor is active over a broad pH range, but 
requires a minimium of 1 mM DTT to maintain activity. It was stored at -20°C in a 
buffer which contained 20 mM HEPES-potassium hydroxide (HEPES-KOH, pH 7.6), 
50 mM potassium chloride (KC1), 8 mM DTT and 50% (v/v) glycerol. It was 
supplied at a concentration of 40 units/^1. One unit was defined as the amount of 
rRNasin ribonuclease inhibitor required to inhibit 50% activity of 5 ng RNase A as 
measured by the inhibition ofhydrolysis of cytidine 2', 3'-cyclic monophosphate. 
6) T h e r m o p r i m e _ D N A Polymerase 
ThermoprimePius DNA Polymerase (Advanced Biotechnologies Ltd.) was a 
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polypeptide of approximately 94 kd which has 5' to 3, polymerisation-dependent 
exonuclease replacement activity, but lacks the 3’ to 5’ exonuclease activity. The 
enzyme was supplied with a 10X reaction buffer (Buffer IV) and a separated vial of 
� 
magnesium chloride (MgCy. They were stored at -20°C. One unit of enzyme was 
defined as the amount that would incorporate 10 nmoles of dNTPs into acid 
insoluble material in 30 minutes at ATC. 
7) Ultrapure dNTP set, 2‘-Deoxynucleoside 5'-Triphosphate, Sodium Salt 
The deoxynucleoside triphosphate (dNTP) set was purchased from Pharmacia 
Biotech.，with each nucleotide supplied as 100 mM solution in double distilled water 
(pH 7.5). Stock solution containing 10 mM of each dNTP was prepared in 1 mM 
Tris-HCl (pR 7.5) and stored at —20�C. 
2.1.16 Reagents and Buffers for Gel Electrophoresis 
1) Ethidium Bromide (EtBr) 
A stock solution (10 mg/ml) of ethidium bromide (Sigma Chemical Co.) was 
prepared by dissolving the EtBr in double distilled water. The working solution was 
prepared by diluting the stock solution by 1,000 fold. Both the stock and working 
solution were kept in dark at room temperature. 
2) Gel Loading Solution (5x) 
The gel loading solution was purchased from Sigma Chemical Co. It was a 5X 
solution containing 0.05% (w/v) bromophenol blue, 40% (w/v) sucrose, 0.1 M 
EDTA (pH 8.0) and 0.5% sodium dodecyl sulfate (SDS). The solution was used for 
non-denaturing agarose gel electrophoresis ofnucleic acids. 
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3) Tris-HCl Buffer (pH 7.5) 
Tris[hydroxylmethyl] amino methane (Tris) purchased from Sigma Chemicals 
Co. was prepared as 1 M stock solution in DEPC-treated double distilled water. The 
� 
buffer was adjusted to pH 7.5 with hydrochloric acid (HC1) and then autoclaved at 
i 2 r C for 15 minutes. It was stored at 4°C. 
4) Tris-Borate-EDTA (TBE) Electrophoresis Buffer (5x) 
The 5X TBE electrophoresis buffer stock was prepared by dissolving 54 g Tris, 
27.5 g boric acid and 20 ml 0.5 M EDTA in 1 litre double distilled water. The pH of 
the buffer was adjusted to 8.0. 0.5X working TBE buffer was prepared by diluting 
one part of the 5X stock TBE buffer with nine parts of double distilled water. Both 
of the working and stock solutions were kept at 4�C. 
5) Agarose Gel 
1% and 2% agarose gels were prepared by dissolving 10 g and 20 g agarose 
(Sigma Chemicals Co.) respectively in 1 liter 0.5X TBE buffer by heating at 70°C on 
a hot plate. The 1% agarose gel was used for RNA gel electrophoresis while the 2% 
agarose gel was used for DNA and PCR products gel electrophoresis. 
2.1.17 Reagents and Buffers for Western Blot Analysis 
1) 30% (w/v) Acrylamide Solution 
The acrylamide (30%) stock solution was prepared by dissolving 30 g 
acrylamide and 0.8 g N,N'-methylene-bis-acrylamide (Sigma Chemicals Co.) in 100 
ml double distilled water. It was light-protected and stored at 4°C. 
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2) 10% (w/v) Ammonium Persulfate (APS) 
Ammonium persulfate was purchased from Bio-Rad Lab. It was prepared by 
dissolving 0.5 g APS in 5 ml double distilled water. The solution was kept in 500 i^l 
� 
aliquots at -20°C until use. 
3) Cell Lysis Buffer 
The cell lysis buffer contained 20 mM Tris-HCl (pH 8.0), 120 mM sodium 
chloride, 1% (v/v) Triton X-100 (Sigam Chemicals Co.), 1 mM EGTA, 50 i^M 2-
mercaptoethanol and one tablet of complete protease inhibitor cocktail (Boehringer 
Mannheim) in 50 ml double distilled water. Each complete protease inhibitor 
cocktail when dissolved in 50 ml lysis buffer yielded 1 mM EDTA. It was a mixture 
of several protease inhibitors with a broad spectrum of activity on serine, cysteine 
and metalloproteases and calpains inhibitors. The cell lysis buffer was kept as 5 ml 
aliquots at -70°C until use. 
4) Coomassie Blue Staining and Destaining Solution 
The Coomassie blue staining and destaining solutions were used to stain and 
destain the SDS-polyacrylamide gel and PVDF Westem blotting membrane. The 
staining solution was prepared by mixing one part of 0.05% Coomassie blue (Bio-
Rad Lab.) in acetic acid, three parts of methanol and ten parts of double distilled 
water. For the destaining solution, it was prepared by mixing one part of acetic acid, 
three parts of methanol and ten parts of double distilled water. 
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5) Chromogenic Substrate 
The chromogenic substrate was used for the development of insoluble, blue color 
end product in colormetric method of Westem blot analysis when it was added to 
� 
alkaline phosphatase. It contained 0.1 M Tris-HCl (pH 9.0) (Sigma Chemicals Co.), 
100 mM sodium chloride, 5 mM magnesium chloride, 3 mg 5 -bromo-4-chloro-3 -
indolyphosphate (BCIP) (Sigma Chemicals Co.) in dimethylformamide and 3 mg 
nitroblue tetrazolium QSfBT) (Sigma Chemicals Co.). It was freshly prepared and 
protected from light. 
6) ECL Films (Hyperfilm ^^  ECL ^ )^ 
The Hyperfilm ™ ECL ™ was a high performance chemiluminescence film used 
for Westem blot analysis. It was purchased from Amersham Life Science and 
designed for processing in automatic processors at temperatures up to 38�C. The film 
was stored in dry place at 4°C and protected from light and noxious fumes. 
7) RPN 2108ECL Western Blotting Analysis System 
It was a Western blotting detection kit purchased from Amersham Pharmacia 
Biotech. The kit contained a detection reagent 1 (62.5 ml), detection reagent 2 (62.5 
ml), anti-mouse Ig secondary antibody (horseradish peroxidase-linked whole 
antibody from sheep, 100 fo,l), anti-rabbit Ig secondary antibody (horseradish 
peroxidase-linked whole antibody from donkey, 100 jid), and 5 g blocking reagent. 
The kit was used for the detection of either mouse or rabbit membrane bound 
primary antibodies and stored at 4°C. 
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8) Lower Buffer for Separating Gel 
It was a 1.5 M Tris-HCl buffer adjusted to pH 8.8 (Sigma Chemicals Co.) and 
kept at 4°C. 
� 
9) 2X SDS Sample Buffer 
2X SDS sample buffer containing P-mercaptoethanol and bromophenol blue 
(100 ml) was prepared by dissolving 1.51 g Tris base, 20 g glycerol, 10 ml 2-
mercaptoethanol and 4.6 g SDS in 80 ml double distilled water. The pH was adjusted 
to 6.8 with HC1, and the volume was then added up to 100 ml. Bromophenol blue 
was added to a final concentration of 0.006%. The sample buffer was stored at 4°C. 
All the reagents were purchased from Sigma Chemicals Co. 
10) N,N,N',N'-Tetra-methylethylenediamine (TEMED) 
TEMED was purchased from Bio-Rad Lab and stored at 4°C. It was used to 
initialize the polymerization of SDS-polyacrylamide gel. 
11)Prestained SDS-PAGE Standards 
The prestained SDS-PAGE standards were purchased from Bio-Rad Lab. and 
containing a blue dye attached to standard proteins including myosin (212,000), P-
galactosidase (122,000), bovine serum albumin (83,000)，ovalbumin (51,800), 
carbonic anhydrase (35,000), soybean trypsin inhibitor (28,400), lysozyme (20,000) 
and aprotinin (7,200). The standard proteins (total 625 i^g) were prepared in 33% 
(v/v) glycerol, 3% SDS, 10 mM Tris (pH 7.0)，10 mM DTT, 2 mM EDTA, 0.01% 
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12) PVDF Western Blotting Membranes 
The microporous polyvinylidene difluoride (PVDF) membrane (pore size: 0.45 
^m) was purchased from Boehringer Mannheim and stored at room temperature. 
� 
13) Primary Antibodies 
a) Rabbit Anti-Bak Polyclonal Antibody 
It was a rabbit polyclonal antibody raised against a recombinant protein 
corresponding to amino acids 1-211. The amino acid sequence represented the full 
length of Bak of human origin and the antibody reacted with Bak of mouse, rat and 
human origin. It was purchased from Santa Cruz Biotechnology, Inc. Each vial 
contained 200 i^g IgG in 1.0 ml of PBS with 0.1% sodium azide and 0.2% gelatin 
and was stored at 4°C. 
b) Rabbit Anti-Bcl-2 Polyclonal Antibody 
It was an immunoaffinity purified rabbit polyclonal antibody raised against an 18 
residue synthetic peptide AGRTGYDNREIVMKYIHY(C) based on the human and 
mouse Bcl-2 (residue 4-21) with the cysteine (C) residue added and coupled to KLH. 
It reacted with the a-isoform of Bcl-2 in human, mouse and rat origin. The antibody 
was purchased from StressGen Biotechnologies Corp. and stored as small aliquots at 
-70�C. Each vial contained 100 i^g immunoglobulin in borate buffered saline, pH 8.2 
{(25 mM sodium borate, 100 mM boric acid, 75 mM NaCl, 5 mM EDTA (disodium 
salt)}. 
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c) Rabbit Anti-Bcl-x,/L Polyclonal Antibody 
It was an affinity-purified rabbit polyclonal antibody raised against a peptide 
which mapped to the carboxyl terminus of Bcl-XL of human origin (identical to 
� 
corresponding mouse sequence). It reacted with Bcl-Xs and Bcl-XL ofhuman, mouse, 
rat origin and non cross-reactive with other apoptosis-associated proteins. The 
antibody was purchased from Santa Cruz Biotechnology Inc. and stored at 4�C. Each 
vial contained 200 i^g IgG in 1.0 ml of PBS with 0.1% sodium azide and 0.2% 
gelatin. 
d) Rabbit Anti-FAS Polyclonal Antibody 
It was a rabbit polyclonal antibody raised against a recombinant protein 
corresponding to amino acids 1-335 representing the full length of FAS (also 
designated APO-1 or CD95) of human origin. The antibody reacted with FAS of 
human, mouse and rat origin. It was purchased from Santa Cruz Biotechnology Inc. 
and stored at 4�C. Each vial contained 200 i^g IgG in 1.0 ml of PBS with 0.1% 
sodium azide and 0.2% gelatin. 
e) Rabbit Anti-FAS-L Polyclonal Antibody 
It was an affinity-purified rabbit polyclonal antibody raised against a 
recombinant protein corresponding to amino acids 100-278 which mapped to the 
carboxyl terminus of FAS-L of rat origin. It reacted with FAS-L of human, mouse, 
rat origin and non cross-reactive with other type II transmembrane proteins. The 
antibody was purchased from Santa Cruz Biotechnology, Inc. and stored at 4°C. 
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Each vial contained 200 i^g IgG in 1.0 ml ofPBS with 0.1% sodium azide and 0.2% 
gelatin. 
� 
f) Mouse Anti-c-Myc Monoclonal Antibody 
It was a mouse monoclonal IgG! antibody derived by the fusion of spleen cells of 
a BALB/c mouse immunized with recombinant c-Myc protein with Sp2 mouse 
myeloma cells. It reacted with c-Myc p67 of human, mouse, rat and chicken origin 
and non cross-reactive with N-Myc or L-Myc. The antibody was purchased from 
Santa Cruz Biotechnology, Inc. and stored at 4°C. Each vial contained 200 i^g mouse 
IgGi in 1.0 ml ofPBS with 0.1% sodium azide and 0.2% gelatin. 
g) Rabbit Anti-NFKB Polyclonal Antibody 
It was an affinity-purified rabbit polyclonal antibody raised against a peptide 
corresponding to the amino acid sequence mapped to the carboxyl terminus ofNpKB 
p65 of human origin (identical to corresponding mouse sequence). It reacted with 
NFKB p65 of human, mouse and rat origin and non cross-reactive with c-Rel p75 or 
Rel B p68. The antibody was purchased from Santa Cruz Biotechnology, Inc. and 
stored at 4�C. Each vial contained 200 i^g rabbit IgGj in 1.0 ml of PBS with 0.1% 
sodium azide and 0.2% gelatin. 
h) Mouse Anti-PKC6 Polyclonal Antibody 
It was a mouse polyclonal antibody raised against a sequence of amino acids 
114-289 ofhuman PKC5 protein. The antibody reacted with PKC6 ofhuman, mouse 
and rat origin. It was purchased from Transduction Laboratories and stored as small 
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aliquots at —20�C. Each vial contained 0.25 mg/ml mouse IgG2b in 50% glycerol, 20 
mM sodium phosphate pH 7.5, 150 mM sodium chloride, 1.5 mM sodium azide and 
1 mg/ml BSA. 
� 
14) Secondary Antibodies 
Goat anti-mouse alkaline phosphatase conjugated antibodies and goat anti-rabbit 
alkaline phosphatase conjugated antibodies were purchased from Pharmingen. The 
alkaline phosphatase conjugated to the antibody reacted with the chromogenic 
substrate in order to visualize the proteins being recognized by these antibodies. 
Both of them had a concentration of 1 mg/ml and were stored at 4°C. 
15) 5% Skimmed Milk Solution (Blocking Solution) 
5 g Nestle skimmed milk powder was freshly dissolved in 100 ml washing buffer. 
The solution was kept at 4°C and used as a blocking solution in Westem blot 
analysis. 
16) 10% Sodium Dodecyl Sulfate (SDS) Solution 
SDS was purchased from Sigma Chemical Co. 10 g SDS was dissolved in 100 
ml double distilled water and kept at room temperature. 
17)Tris-Glycine-SDS Electrophoresis Buffer (lOX) 
Tris-glycine-SDS electrophoresis buffer 10X concentrate (Sigma Chemicals Co.) 
contained 0.25 M Tris-HCl, pH 7.5, 1.92 M glycine and 1% SDS in double distilled 
water. It was filtered by a 0.2 i^m millipore filter and stored at 4�C. The 10X 
concentrate was freshly diluted to IX working buffer solution for SDS-PAGE. 
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18) Tris-Glycine Buffer (lOX) 
Tris-glycine buffer 10X concentrate (Sigma Chemicals Co.) contained 0.25 M 
Tris-HCl, pH 7.5 and 1.92 M glycine in double distilled water. It was filtered by a 
� 
0.2 i^m millipore filter and stored at 4°C. 
19) Tris-Glycine-Methanol Transfer Buffer (lOX) 
The transfer buffer was prepared by mixing 20% methanol in IX Tris-glycine 
buffer. The buffer solution was kept at 4°C. 
20) Upper Buffer for Stacking Gel 
It was a 0.5 M Tris-HCl buffer adjusted to pH 6.8 (Sigma Chemicals Co.) and 
kept at 4°C. 
21)Washing Buffer 
The washing buffer contained 10 mM Tris-HCl (pH 7.5), 100 mM sodium 
chloride and 0.1% (w/v) Tween 20 (Sigma Chemicals Co.). The solution was kept at 
4�C. 
7 6 
Chapter 2 Materials & Methods 
2.2 Methods 
2.2.1 Culture of the Leukemic Cell Lines 
� The murine and human leukemia cells lines were maintained in 10% FCS 
supplemented complete medium as continuous suspension cultures. For the human 
leukemia HL-60 and KG-1, they were maintained in complete RPMI medium 
supplemented with 20% FCS. All the cell lines were cultured in 25 or 75 cm^ tissue 
culture flasks and incubated at 37°C in a humidified incubator supplied with 5% carbon 
dioxide (CO2). The cell lines were subcultured at 2-3 day intervals or twice weekly 
depending on their doubling times. Cells in exponential growth phase were used for 
experiments and long term storage of cell lines was done by cryo-preservation in liquid 
nitrogen. 
2.2.2 Isolation, Preparation and Culture of Primary Mouse Cells 
1) Mouse Splenocytes 
BALB/c mice were sacrificed by cervical dislocation. Spleens were aseptically 
excised and washed twice with plain RPMI medium. Splenocytes were isolated from 
the spleens by cutting them into small piecies and gently pressing the tissue through 
a 200-gauge stainless steel sieve. After removing the debris and washing of the 
spleen cell suspension, viable lymphocytes were obtained by Ficoll-Paque gradient 
centrifugation (1300xg, 20 min., 18�C). The purified lymphocytes were then washed 
twice with plain RPMI medium and resuspended in complete medium. Splenocytes 
(5xlO^ cells/well) were cultured with or without mitogens (LPS or ConA) and green 
tea epicatechins at 37°C, 5% CO2 for 48 hours. 
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1) Mouse Bone Marrow Cells 
BALB/c mice were sacrificed by cervical dislocation. The femurs were excised 
and washed twice with plain RPMI medium. They were then put into a 60 mm 
� 
culture dish (Corning) containing cold complete RPMI medium. By using a 1 ml 
syringe fitted with a 25-gauge needle, the marrow plugs were flushed into complete 
RPMI medium. Cells were then washed once with plain RPMI medium. Bone 
marrow cells were separated from the red blood cells and dead cells by Ficoll-Paque 
gradient centrifugation (1300xg, 20 min., 18�C). The bone marrow cells were then 
washed twice with plain RPMI medium and resuspended in complete RPMI medium. 
Bone marrow cells (2xl0^ cells /well) were cultured with or without growth factors 
(IL-3 or GM-CSF) and green tea epicatechins at 37�C, 5% CO2 for 72 hours. 
2.2.3 Determination of Cell Viability 
Trypan blue exclusion test was used to determine the number of viable cells in 
cultures. Cells were cultured with different concentrations of drug or combination of 
drugs being tested. The viability of the cells was then determined after different 
incubation time. 10 ^1 cells suspension was mixed with 10 i^l of 0.4% trypan blue 
solution. The viable cells were visible as clear cell bodies while the dead cells were 
stained blue. By counting the number of dead cells, the results were expressed as the 
mean percentage of cytotoxicity 士 S.E. of triplicate cultures. The percentage cytotoxicity 
was calculated as follows: 
% cytotoxicity = (no. of dead cells/ no. of total cells counted) x 100% 
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2.2.4 [3fi[]-TdR Incorporation Assay 
Different leukemia cells in quadruplicates, with the indicated cell number, were 
incubated with or without different concentrations of purified green tea epicatechins and � 
other drugs in the wells of 96-well flat-bottomed microtiter plates at 37�C for 48 hours 
inside a humidified 5% CO2 incubator. The cells were then pulsed with 0.5 i^Ci of 
3H]-TdR in 20 i^l complete medium from 6 to 18 hours. After one freezing and thawing 
cycle, the cells were harvested onto a glass microfiber filter. The radioactivity, in counts 
per minute (cpm), was measured by the Beckman LS6000 liquid scintillation counter. 
The results were expressed as the percentage inhibition of [3H]-TdR incorporation, using 
the untreated cells as a control (Leung et al, 1994). The percentage inhibition of [ ^ -
TdR incorporation was calculated as follows: 
% inhibition = {(cpm of control - cpm of test sample)/ cpm of control} x 100% 
2.2.5 Cell Morphology Study 
To assess the capability of purified green tea epicatechins to induce cellular 
differentiation, WEHI-3B JCS cells (lxlO^ cells/ml) and HL-60 cells (5xlO^ cells/ml) 
were incubated with different concentrations of EGCG in 25 cm^ culture flasks at 3TC 
for 3 days and 4 days respectively. As an additional group, freshly prepared purified 
green tea epicatechins at one half concentration were replenished to the culture medium 
of HL-60 cells everyday from day 2 to day 4. Cell morphology was then examined by 
the preparation of cytospin smears. 
Leukemia cells (5 xlO^ cells) treated with green tea epicatechins were fixed onto 
a microscopic slide by cytocentrifugation at 500 rpm for 5 minutes using the Shandon 
Cytospin 3 centrifuge (Shadon Scientific Ltd., U.K.). The cells were allowed to be air-
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dried. Then they were stained with each Hemacolor staining solution for 15 seconds and 
destained under running tap water. Finally, the air-dried cells on the slides were mounted 
with neutral mounting medium, Canada Balsam (Sigma Chemicals Co.) and the cell � 
morphology was examined under the light microscope. 
2.2.6 Apoptosis Study 
1) DNA Fragmentation Analysis 
DNA fragmentation is one of the characteristics of apoptosis. Apoptotic DNA 
fragments were isolated from the apoptotic cells by the method of Herrmann et al. 
(1994). Leukemia cells (5xlO^ cells/ml) were incubated with appropriate 
concentrations of purified green tea epicatechin in 75 cm^ culture flask at 37°C for 
different periods of time and the untreated cells were acted as a control. Cells (2xl0^) 
were harvested and washed once with cold PBS by centrifugation at 250xg for 5 
minutes. The cell pellets were then treated with 200 i^l IGEPAL CA-630 lysis buffer 
for 10 minutes at 37°C. The samples were centrifuged at l,OOOxg for 5 minutes to 
collect the supematants containing the apoptotic DNA fragments. 50 jid 5% SDS was 
added and the supematants were incubated with 0.4 ^ig/^l RNase A at 56°C for 1.5 
hours to remove the cellular RNA. 1.5 ^ig/^l proteinase K was then added at 56°C for 
further 1.5 hours to remove the proteins. The DNA was then precipitated with 0.1 
volume of 3 M sodium acetate and 2.5 volumes of absolute ethanol. After 
centrifugation, the DNA pellets were being washed with 70% ethanol and absolute 
ethanol followed by vacuum drying with a speed vacuum concentrator (Savant 110 
Speed-Vac®). The dried pellets were resuspended in 20 ^1 TjoEo.i buffer and 
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incubated at 65�C for 5 minutes. Finally The resuspended DNA was subjected to gel 
electrophoresis as described in Section 2.2.8.4. 
� 
2) Annexin V-FITC Analysis by Flow Cytometry 
Annexin V-FITC assay was used to quantify the percentage of cells undergoing 
apoptosis. It relies on the property of cells to lose membrane asymmetry in the early 
phases of apoptosis. Leukemia cells (5xlO^ cells/ml) were incubated with 
appropriate concentrations of purified green tea epicatechin in 75 cm^ culture flask at 
37°C for different periods of time and the untreated cells were acted as a control. 
Cells (lxl06) were harvested and washed twice with cold PBS by centrifugation at 
250xg for 5 minutes. The cells were then resuspended in IX binding buffer at a 
concentration of lxlO^ cells/ml and 100 i^l of the cell solution (lxlO^ cells) were 
transferred to 5 ml culture tubes. 5 i^l of Annexin V-FITC and 10 i^l of PI were 
added to the cell solutions. The cell solutions were then mixed and incubated in dark 
for 15 minutes at room temperature. After that, 400 i^l of IX binding buffer was 
added to each tube and the samples were analyzed immediately by the FACSort flow 
cytometer using the Lysys II program. 
2.2.7 Animal Studies 
1) In Vivo Tumorigenicity Assay 
JCS cells (1.2xl0^ cells/ml) and L1210 cells (1.5xlO^ cells/ml) were incubated 
with EGCG (0-30 i^M) for 8 hours at 37�C. The cells were being collected and 
washed three times with plain RPMI medium. Viable JCS cells (3xlO^) and L1210 
cells (5x106) in 0.3 ml RPMI medium were injected intraperitoneally (i.p.) into each 
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BALB/c mouse in groups of five. Leukemia cells were recovered from the peritoneal 
cavity ofmice and counted at day 5 post-tumor inoculation (Leung et al, 1994). 
� 
2) Hemagglutination Assay of/w Vivo Antibody Formation 
Normal saline or freshly prepared EGCG (10 and 40 mg/kg) in 0.2 ml was 
injected intraperitoneally into each BALB/c mouse (five mice per group) on day 1，2, 
4, 5. On day 3, all mice were immunized intravenously with 4xl0^ SRBC in 0.2 ml 
PBS. The serum from each mouse was collected separately and heat-inactivated 
(56�C, 30 min.) at day 7 after immunization. Two-fold serial dilutions of immune 
sera were made with PBS in 96-well round-bottomed microtiter plates in a final 
volume of 50 |al. An equal volume of 0.5% (v/v) SRBC was then added to each well. 
The plates were allowed to stand at room temperature for at least 2 hours and the 
end-points of hemagglutination were recorded. The titer of serum was expressed as 
the reciprocal of highest dilution of the serum which gave a positive result of 
hemagglutination. 
2.2.8 Gene Expression Study 
1) Isolation of Total Cellular RNA 
Leukemia cells (lxlCT) were first treated with appropriate concentrations of 
purified green tea epicatechins for different periods of time at 37°C. The cells were 
collected by centrifugation at 250xg for 5 minutes at 4°C. Washing of the cells was 
avoided to eliminate the chance of mRNA degradation. The cells were lysed by 
adding 1 ml TRIZOL reagent (1 ml TRIZOL for 5-lOxlO^) with vigorous shaking. 
The cell lysate solutions were incubated at room temperature for 5 minutes to permit 
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the complete dissociation of nucleoprotein complexes. 200 i^l chloroform per 1 ml 
TRIZOL reagent was added to the samples and then shaked vigorously for 15 
seconds. The samples were allowed to stand at room temperature for about 3 minutes 
� 
and were centrifuged at 12,000xg for 15 minutes at 4�C. Following centrifugation, 
the upper aqueous phase containing RNA (�400 i^l) was being transferred to another 
new micro-centrifuge tube. 500 |il isopropanol was then added to precipitate the 
RNA. The samples were incubated at -20°C overnight and, after that, they were 
centrifuged at 12,000xg at 4�C for 10 minutes. The supematants were discarded and 
the RNA pellets were washed with 1 ml 75% ethanol per 1 ml TRIZOL. The 
samples were centrifuged at 7,500xg at 4�C for 5 minutes. The supematants were 
removed by aspiration and the RNA pellets were air-dried for about 5 minutes. The 
RNA pellets were dissolved in 30 i^l DEPC-treated water and stored at -70�C until 
use.lOO fold dilution ofRNA was prepared and the concentration of the diluted RNA 
was determined by measuring the absorbance (A) at 260 nm. Small aliquots of RNA 
with a working concentration of 0.5 ^g/^il were prepared with DEPC-treated water 
and stored at -70�C. The purity was assessed by measuring the ratio of A j^eJ i^m (it 
should have a value ranged from 1.0 to 2.0) and the integrity of RNA was checked 
by running l^il total RNA on a 1% agarose gel stained with ethidium bromide. 
2) Reverse Transcription (RT) 
Each sample of total cellular RNA was incubated at 65�C for 5 minutes before 
being used in the synthesis of cDNA. 1 i^g of the total RNA was mixed with a 
reaction mixture containing 40 units of rRNasin ribonuclease inhibitor, IX first 
strand buffer, 0.5 mM ofeach dNTP, 10 mM DTT, 0.1 ^g oligo-dT12.i8 and 200 units 
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ofM-ML reverse transcriptase. The RNA mixture was incubated at 37�C for 1 hour 
and 99�C for 5 minutes. The reaction was terminated by chilling the samples on ice, 
and the resulting cDNA was stored at —20�C until use. 
� 
3) Polymerase Chain Reaction (PCR) 
The cDNA samples prepared by reverse transcription were first boiled for 5 
minutes followed by chilling on ice immediately. For each sample, 0.1 ^g cDNA in 
2 |il was mixed with a 23 ^1 reaction mixture containing IX PCR buffer, 1.5 mM 
MgCl2, 0.2 mM dNTPs, 1 unit of Thermoprime^'"' DNA polymerase, and 0.2 i^M of 
each sense and anti-sense oligonucleotide primer in a PCR tube. A negative control 
with no cDNA sample was prepared to check for any contaminations. The reaction 
mixtures in PCR tubes were then put to a thermocycler, GeneAmp PCR System 
9700 (Perkin-Elmer Co.), which was programmed with certain rounds of 
temperature cycling. The samples were subjected to an initial denaturation at 94°C 
for 5 minutes in the first cycle. Then 25-30 thermal cycles with denaturation at 94°C 
for 30 seconds, annealing at 55�C for 1 minute and elongation at 72�C for 1 minute. 
In the last cycle, one more step in elongation for 5 minutes was performed to 
complete the reaction. The amplified PCR products were then stored at -20�C until 
use. The annealing temperature and the number of PCR cycles were varied and 
optimized empirically for each primer set and the amount of RNA used in PCR 
amplification was normalized by comparing with the amplification of GAPDH 
mRNA. 
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4) Agarose Gel Electrophoresis 
The PCR products were analyzed by 2% agarose gel electrophoresis. 5 pil PCR 
sample was mixed with 1 i^l 5X gel loading buffer. The mixture was subjected to 
� 
electrophoresis in 0.5X TBE electrophoresis buffer on 2% agarose gel at a constant 
voltage of 100 volts for 2-3 hours. 0.5 i^g of 100 bp DNA ladder (GIBCO BRL Life 
Technologies Inc.) was loaded as a size marker. After electrophoresis, the gel was 
stained with 1 ^g/ml ethidium bromide solution for 5 minutes and was destained 
with distilled water for 15 minutes. The stained gel was visualized and analyzed by 
the Bio-Rad Gel Doc 2000 under UV illumination. 
2.2.9 Protein Expression Study 
1) Treatment ofCells and Extraction of Proteins 
HL-60 cells (5xlO^) were treated with EGCG (0-30 i^M) for different periods of 
time (12, 24, 48 hours) at 37�C. The cells were harvested and washed twice with cold 
PBS by centrifuging at 250xg for 5 minutes at 4�C. Cell viability was determined by 
trypan blue exclusion assay and 5xlO^ viable cells were mixed and vortexed with 
0.25 ml cell lysis buffer (i.e. 2xl0^ cells/ml) for 10 seconds. After one cycle of 
freezing and thawing, the cell lysate was sonicated in a water bath sonicator for 15 
minutes and then spun at 14,000 rpm for 5 minutes at 4°C in an Eppendorf centrifuge. 
The supernatant was collected in small aliquots and stored at -70�C. 
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2) Quantification ofProteins 
The protein concentration of the cell lysates was determined by Bradford protein 
assay. Standard bovine serum albumin (BSA) solutions at 2 ^ig/ml, 4 ^ig/ml, 6 ^ig/ml, 
� 
8 ^ig/ml, and 10 ^ig/ml were prepared with double distilled water in triplicate with 1 
mg/ml BSA stock. 2 ^1 protein samples were diluted with double distilled water. 800 
^1 BSA standards or protein samples were mixed with 200 i^l Bradford reagent (Bio-
Rad Lab.) by vortexing. They were allowed to stand at room tempersture for 5 
minutes and the absorbance at 595 nm was recorded using Bradford reagent as a 
blank. A standard curve was constructed by plotting the absorbance versus the 
concentration of BSA standards. The concentrations of the protein samples were 
determined from the standard curve and 20 i^g of the protein was subjected to SDS-
PAGE. 
3) Western Blotting Analysis 
SDS-PAGE was carried out to separate the proteins according to the molecular 
weights. The proteins were first normalized and 20 i^g of the protein was mixed with 
2X protein loading buffer. The protein samples were then boiled for 5 minutes and 
loaded onto the SDS-polyacrylamide gel with 5% stacking gel. 4 ^1 of pre-stained 
protein markers were also loaded and the gel was run under constant voltage of 100 
volts for 2-3 hours. The percentage of acrylamide added in the running gel was 
varied according to the molecular weight of the target protein being separated. A 
higher molecular weight protein needed a lower percentage of acrylamide gel. Table 
2.1 showed the composition of the chemical reagents needed for various percentages 
of SDS-polyacrylamide gel. 
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Table 2.1 Composition of the SDS-polyacrylamide gel 
5 % Stacking Gel (3 ml) Separating Gel (5ml) 
. 7.5% I 10% I 12^T" 
Distilled wato 1.677 ml 2.4 ml 2 ml 1.65 ml 
Lower Buffer - 1.25 ml 1.25 ml 1.25 ml 
Upper Buffer 0.75 ml - _ -
30% Acryl 0.5 ml 1.25 ml 1.65 ml 2 ml 
Stock 
~"10% S D S ~ 0.03 ml 0.025 ml 0.025 ml 0.025 ml 
~ 1 0 % A P S ~ 0.04 ml 0.075 ml 0.075 ml 0.075 ml 
TEMED — ^ 1.25 i^l 1.25 i^l 1.25 i^l 
After electrophoresis, the stacking gel was cut and removed. The gel was washed 
by distilled water and soaked in transfer buffer for 5 minutes. Three pieces of filter 
paper (3 MM Whatman chromatography papers) soaked with transfer buffer were 
placed on the semi-dry electroblotter (Bio-Rad Lab.). One piece ofPVDF membrane 
was activated by soaking with 100% methanol and covered the filter papers. The gel 
was carefully placed on the membrane and three more pieces of filter papers soaked 
with transfer buffer were covered on the gel again. Finally, air bubbles were 
excluded by rolling a glass tube on the surface of filter paper. The proteins were 
allowed to transfer for 45-60 minutes at 16 V. After the protein transfer, the 
membrane was removed and incubated with 5% skimmed milk at room temperature 
for at least 1 hour to block the non-specific sites for probing. Primary antibody 
probing the target protein was incubated at a ratio of 1 to 5,000 with the membrane 
in the presence of 5% skimmed milk at 4°C overnight. After washing the membrane 
with washing buffer for 30 minutes, alkaline-phosphatase-conjugated secondary 
antibody (1:5,000 dilution) in 5% skimmed milk was incubated with the membrane 
for 1 hour at room temperature. The membrane was further washed for 30 minutes 
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with washing buffer. Finally, the specific protein bands can be visualized by the 
addition of chromogenic substrate for 1-3 minutes. 
� 
4) ECL Assay 
Apart from the chromogenic substrate, the protein bands could be visualized by 
the ECL assay with the use of another secondary antibody. After blotting with 
primary antibody, the PVDF membrane with transferred proteins was washed for 30 
minutes. Horseradish peroxidase-linked secondary antibody (1:5,000 dilution) in 5% 
skimmed milk was incubated with the membrane for one hour at room temperature. 
After a final round of washing, the membrane was subjected to ECL Assay. One ml 
of reagent 1 and reagent 2 were mixed and poured onto a piece of parafilm. The 
membrane was then immersed to the reagent mixture and allowed to react for 1 
minute. Excess solution was removed. The membrane was covered with Glad Wrap 
and was placed on an ECL film in dark room for different periods of exposure time 
(30 s, 1 min, 2 min, 5 min, 10 min and 30 min). Finally the film was developed and 
the specific protein bands could be visualized. 
2.2.10 Statistical Analysis 
In most cases, each experiment was performed at least twice and the results of 
only one representative experiment were presented. The data were expressed as 
arithmetic mean 士 standard error. The student's t-test was used for statistical analysis. 
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3.1 Introduction 
In recent years, there has been an increasing interest in the studies of the diverse 
bk)logical activities and therapeutic potentials of various plant phytochemicals (Craig, 
1999; Rowland, 1999). Accumulating evidence has demonstrated that many 
phytochemicals possess potent anti-carcinogenic and anti-tumor activities (Bradlow et 
al., 1999). The anti-carcinogenic activity was found to be closely related to their anti-
oxidative properties (Yang et al, 1997). In exerting their anti-tumor activity, some of 
these bioactive compounds act by stimulating the immune response (Xiang & Li, 1993; 
Choy et al., 1994; Wong et al., 1994) whereas others act directly on the tumor cells and 
inhibit their growth through the induction of cellular differentiation or apoptosis (Jing et 
al., 1993; Mak et al., 1996; Fung et al., 1997). Due to their low toxicity, plant 
phytochemicals have become the major sources for effective novel anti-cancer agents 
that may function through various unique mechanisms ofaction (Pezzuto, 1997). 
Tea is a significant source of nonnutrient phytochemicals generally classified as 
flavonoids and the major constituents of tea are polyphenols. Most of them are known as 
flavan-3-ol or tea catechins (Ho et al., 1993). Recent researches have shown that green 
tea catechins exhibit diverse biological effects, including anti-oxidative, anti-
inflammatory, hypolipidemic, anti-microbial, anti-carcinogenic and anti-tumor activities 
(ILSI North America Technical Committee on Food Components for Health Promotion, 
1999). In addition, green tea polyphenol (GTP) or EGCG (the major constituent of green 
tea catechins) have been shown to possess growth-inhibitory and apoptosis-inducing 
effects on a variety of human cancer cells in vitro (Yang et al., 1998c & 2000). For 
example, Zhao et al (1997) demonstrated that tea polyphenols could induce apoptosis in 
the human promyelocytic leukemia HL-60 cells. More recently, Otsuka et al (1998) 
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reported that EGCG exhibited a strong inhibitory effect on the DNA synthesis of both 
human and mouse leukemic cell lines in vitro but it had little inhibitory effect on the 
colony forming ability of the normal hematopoietic progenitor cells. The in vivo � 
inhibitory effect of green tea catechins on the growth of established tumors had also 
been reported. For examples, Wang et al (1992) demonstrated that GTP or EGCG given 
intraperitonealy (i.p.) inhibited the growth and caused partial regression of established 
skin papilloma in CD-1 mice. On the other hand, Liao et al (1995) showed that i.p. 
injections of EGCG but not ECG inhibited the growth of human prostate and breast 
tumor cells in athymic nude mice. 
Although the accumulating evidence has shown that green tea catechins can 
inhibit the growth of tumor cells both in vitro and in vivo, however the precise 
mechanisms by which green tea catechins can exert their effects on the tumor cells and 
the relationship between their chemical structures and anti-tumor activity remain poorly 
understood. In this chapter, the differential effects of different tea extracts and individual 
green tea epicatechin isomers on the survival, proliferation and apoptosis of various 
human and murine leukemic cell lines were examined. Attempts had been made to 
compare the cytotoxic and anti-proliferative activities of various epicatechin isomers on 
different leukemic cell lines. Finally, the effect of EGCG on the tumorigenicity of 
leukemia cells in syngeneic mice was also studied. 
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3.2 Results 
3.2.1 The Effects of Tea Extracts on Various Leukemia Cells 
32.1.1 Differential Anti-proliferative Effect of Different Tea Extracts on 
Various Leukemic Cell Lines In Vitro 
The growth-inhibitory effect of different tea extracts on various leukemia cells 
was evaluated. Various leukemic cell lines, including the myeloid leukemia cells and 
lymphoid leukemia cells, with appropriate cell density were incubated with different 
concentrations (0-30 ^ig/ml) of green tea, oolong tea and black tea extracts for 48 hours. 
The DNA synthesis, which was proportional to the proliferation of cells, was measured 
by the ^ -TdR incorporation assay. It was found that all the tea extracts could 
significantly inhibit the proliferation ofHL-60 cells (Figure 3.1), JCS cells (Figure 3.2), 
Ml cells (Figure 3.3) and L1210 cells (Figure 3.4) in a dose-dependent manner. Also, 
different cell lines showed differential sensitivity to individual tea extract. Table 3.1 
summarized the estimated value of 50% inhibitory concentration (IC50) and optimal 
inhibitory concentration of different tea extracts on each leukemic cell line being studied. 
It can be concluded that the green tea and oolong tea extracts have a similar potency that 
is higher than the black tea extract. The murine T-lymphocytic leukemia L1210 cells 
were found to be the most sensitive cells in which > 50% inhibition of the growth was 
seen at a concentration of 5 |xg/ml (Figure 3.4). The sensitivity of leukemia cells being 
studied in response to different tea extracts is in the descending order ofL1210 > HL-60 
>JCS>M1. 
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3.2.1.2 Differential Cytotoxic Effect of Different Tea Extracts on the Murine 
Lymphocytic Leukemia L1210 Cells in Vitro 
In view of the observation that all three tea extracts exhibited the most potent 
� 
anti-proliferative activity on the murine lymphocytic leukemia L1210 cells (with IC50 
ranged from 2-3.5 ^ig/ml), therefore, the in vitro cytotoxic effect of green tea, oolong tea 
and black tea extracts on the L1210 cells was also determined by the trypan blue 
exclusion test after 48 hours of incubation. The results in Figure 3.5 showed that all the 
tea extracts exhibited only a slight cytotoxic effect (< 15% cytotoxicity) on the murine 
lymphoid leukemia L1210 cells at a concentration of 5 |ig/ml. However, significant 
cytototoxicity to L1210 cells was seen at higher concentrations (> 10 ^ig/ml). Moreover, 
green tea and oolong tea extracts have a similar cytotoxicity to L1210 cells in which 
more than 80% cells were killed at 10 |ig/ml. For the black tea extract, it has the lowest 
cytotoxicity among the three tea extracts. 
3.2.1.3 Induction ofApoptosis in HL-60 Cells by Different Tea Extracts in Vitro 
Apart from the differential cytotoxic and anti-proliferative activities, different tea 
extracts were further tested for their ability to induce apoptosis in the human 
promyelocytic leukemia HL-60 cells in vitro. Apoptosis is characterised by a number of 
biochemical and morphological changes. One of them is the occurrence of 
intemucleosomal DNA fragmentations. This is mediated by the action of endogenous 
endonucleases in which the DNA was cut into fragments of 180-200 base pairs in length 
(Saraste & Pulkki，2000). A characteristic DNA ladder can be observed after separating 
the DNA by agarose gel electrophoresis (Herrmann et al, 1994). 
^ 
Chapter 3 Anti-tumor Activities 
As shown in Figure 3.6, apoptotic DNA fragmentations occurred in HL-60 cells 
after incubation with the green tea, oolong tea, or the black tea extracts for 8 hours. No 
DNA ladder was observed in the untreated cells. Among the three tea extracts tested, the � 
apoptotic effect of the green tea and oolong tea extracts seemed to be more potent than 
that of the black tea extract. 
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Figure 3.1: Anti-proliferative effect of various tea extracts on the human 
promyelocytic leukemia HL-60 cells. HL-60 cells (5xlO^ cells/ml) were incubated with 
different concentrations (0-30 ^ig/ml) of green tea extract (GTE), oolong tea extract 
(OTE) and black tea extract (BTE) at 37�C for 48 hours. Cultures were then pulsed with 
0.5 p,Ci of3H-TdR for 8 hours before harvest. Radioactivity in counts per minute (cpm) 
was measured using a liquid scintillation counter. Results were expressed as % 
inhibition of 3H-TdR incorporation, using the untreated cells as a control. Each point 
represents the mean 士 S.E. ofquadruplicate cultures. The basal ^ -TdR incorporation of 
the untreated HL-60 cells was 17742 士 870 cpm. 
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Figure 3.2: Anti-proliferative effect of various tea extracts on the murine myeloid 
leukemia WEHI-3B JCS cells. JCS cells (lxlO^ cells/ml) were incubated with different 
concentrations (0-30 ^ig/ml) of green tea extract (GTE), oolong tea extract (OTE) and 
black tea extract (BTE) at 37�C for 48 hours. Cultures were then pulsed with 0.5 ^Ci of 
3H-TdR for 8 hours before harvest. Radioactivity in counts per minute (cpm) was 
measured using a liquid scintillation counter. Results were expressed as % inhibition of 
3H-TdR incorporation, using the untreated cells as a control. Each point represents the 
mean 士 S.E. of quadruplicate cultures. The basal ^H-TdR incorporation of the untreated 
JCS cells was 107801 士 4661 cpm. 
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Figure 3.3: Anti-proliferative effect of various tea extracts on the murine 
myeloblastic leukemia Ml cells. Ml cells (5xlO^ cells/ml) were incubated with 
different concentrations (0-30 ^ig/ml) of green tea extract (GTE), oolong tea extract 
(OTE) and black tea extract (BTE) at 37�C for 48 hours. Cultures were then pulsed with 
0.5 i^Ci of3H-TdR for 8 hours before harvest. Radioactivity in counts per minute (cpm) 
was measured using a liquid scintillation counter. Results were expressed as % 
inhibition of ^H-TdR incorporation, using the untreated cells as a control. Each point 
represents the mean 士 S.E. ofquadruplicate cultures. The basal 3H-TdR incorporation of 
the untreated Ml cells was 57303 士 1514 cpm. 
9 6 




、 1 1 0 0 f^^——“——“ “ “ if 
S 4 0 - / + G T E 
•S / / + O T E 
| - f + B T E 
0 * 1 1 1 1 
0 1 0 2 0 3 0 4 0 
Concentration of Tea Extract (p, g^nJi) 
Figure 3.4: Anti-proliferative effect of various tea extracts on the murine 
lymphocytic leukemia L1210 cells. L1210 cells (lxlO^ cells/ml) were incubated with 
different concentrations (0-30 ^ig/ml) of green tea extract (GTE), oolong tea extract 
(OTE) and black tea extract (BTE) at 37�C for 48 hours. Cultures were then pulsed with 
0.5 |iCi of 3H-TdR for 8 hours before harvest. Radioactivity in counts per minute (cpm) 
was measured using a liquid scintillation counter. Results were expressed as % 
inhibition of ^H-TdR incorporation, using the untreated cells as a control. Each point 
represents the mean 士 S.E. of quadruplicate cultures. The basal ^H-TdR incorporation of 
the untreated Ml cells was 45789 士 1256 cpm. 
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Table 3.1: The estimated IC50 values and optimal inhibitory concentrations of 
various tea extracts on different leukemic cell lines 
"^ °^^ Green Tea Extract^ °^  Oolong Tea Extract Black Tea Extract 
� 
I Optimal ~ ~ ~ ~ ~ Optimal Optimal , IQoVaIue IC5„Value ICsoVaIue 
Cell Line concentration Concentration Concentration 
(^ g/ml) * (ng/mI) * (^ g/ml) * 
OigAnl># (^ /^ml># OigAnl)# 
WEHI-3B JCS 8 B 9 E 1 ^ T\ 
m rL5 i5 rrs is i9 25 
E m o ^ ro 2 5 3 ro 
SEI^S 6 r53 63 i45 9 20 
* IC50Value is the estimated concentration of tea extract which can cause 50% inhibition 
of3H-TdR incorporation in specified experimental conditions. 
# Optimal concentration is the estimated concentration of tea extracts in which the 
inhibition ofleukemic cell proliferation reaches a plateau. 
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Figure 3.5: Differential cytotoxic effect of various tea extracts on the murine 
lymphocytic leukemia L1210 cells. L1210 cells (lxlO^cells/ml) were incubated with 
different concentrations (0-30 ^ig/ml) of green tea extract (GTE), oolong tea extracts 
(OTE) and black tea extract (BTE) at 37�C for 48 hours. Cell viability was determined 
by the trypan blue exclusion test, and the results were expressed as mean % of viable 
cells 士 S.E. of triplicate cultures. 
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Figure 3.6 Induction of DNA fragmentation in the human promyelocytic leukemia 
HL-60 cells by different tea extracts. HL-60 cells (2xl0^ cells) were incubated at 37®C 
with green tea extracts (GTE), oolong tea extracts (OTE), or the black tea extracts (BTE) 
at 10 ^g/ml for 8 hours. Apoptotic DNA fragments were isolated by mild detergent 
IGEPAL CA-630 lysis buffer，and were analyzed by electrophoresis on 2% agarose gel 
stained with ethidium bromide. 
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3.2.2 The Effects of Purified Green Tea Epicatechin Isomers on 
Various Leukemic Cell Lines 
� In the previous section (Section 3.2.1), different tea extracts including green tea, 
oolong tea and black tea had been shown to exhibit significant cytostatic activity on 
various types of leukemia cells in vitro. In addition, the green tea and oolong tea extracts 
were found to have a higher potency than the black tea extract. Since the composition of 
green tea has been well-defined, and the various epicatechin isomers are commerically 
available in relatively pure forms (> 95% purity), therefore, in the present study, the 
effects of the purified green tea epicatechin isomers (EGCG, EGC, ECG and EC) on 
various human and murine leukemia cells were studied. 
3.2.2.1 In Vitro Anti-proliferative Effect of Green Tea Epicatechin Isomers on 
Various Human and Murine Leukemic Cell Lines 
The differential anti-proliferative effect of different green tea epicatechin isomers 
on various leukemic cell lines was first examined. Different leukemia cells with 
appropriate cell density were incubated with different concentrations of various green 
tea epicatechin isomers for 48 hours. The proliferation of cells was then measured by the 
3H-TdR incorporation assay. The leukemic cell lines being studied included the murine 
and human myeloid leukemias EoL-1 (Figure 3.7), HL-60 (Figure 3.8)，K562 (Figure 
3.9)，KG-1 (Figure 3.10)，JCS (Figure 3.11) and Ml (Figure 3.12). In addition, the 
murine lymphoid leukemia L1210 (Figure 3.13), MBL-2 (Figure 3.14) and YAC-1 
(Figure 3.15) and the more matured macrophage-like tumors P388D1 (Figure 3.16) and 
PU5-1.8 (Figure 3.17) were included in this study. Among the four green tea epicatechin 
isomers being studied, EGCG and EGC were found to be the most potent isomers which 
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significantly inhibited the proliferation of all the cell lines being tested in a dose-
dependent manner. However, the cell lines being tested had different sensitivity to 
EGCG and EGC. As summarized in Table 3.2, the IC50valuesofEGCG and EGC for the � 
cell lines tested ranged from 9-67 i^M and from 7-44 i^M respectively. It can be seen that 
HL-60 and L1210 cells are the most sensitive leukemic cell lines with an IC50value of � 
7-10 i^M. On the other hand, the macrophage-like tumor PU5-1.8 was found to be the 
most resistant cell line with IC50 values of 67 i^M and 44 |iM for EGCG and EGC 
respectively. Kinetic studies using a well-characterized mouse myeloid leukemic cell 
line JCS showed that both EGCG and EGC inhibited the proliferation of the leukemia 
cells in a time-dependent manner (Figure 3.18 and 3.19). 
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Figure 3.7: Differential anti-proliferative effect of various epicatechin isomers on 
the human eosinophilic leukemia Eol-l cells. Eol-l cells (5xlO^ cells/ml) were 
incubated with various concentrations (0-70 ^M) of green tea epicatechin isomers at 
37°C for 48 hours. Cultures were then pulsed with 0.5 |iCi o f ^ - T d R for 8 hours before 
harvest. Radioactivity in counts per minute (cpm) was measured using a liquid 
scintillation counter. Results were expressed as % inhibition of ^-TdR incorporation, 
using the untreated cells as a control. Each point represents the mean 士 S.E. of 
quadruplicate cultures. 
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Figure 3.8: Differential anti-proliferative effect of various epicatechin isomers on 
the human promyelocytic leukemia HL-60 cells. HL-60 cells (5xlO^ cells/ml), were 
incubated with various concentrations (0-35 p,M) of green tea epicatechin isomers at 
37T for 48 hours. Cultures were then pulsed with 0.5 i^Ci of ^-TdR for 8 hours before 
harvest. Radioactivity in counts per minute (cpm) was measured using a liquid 
scintillation counter. Results were expressed as % inhibition of ^H-TdR incorporation, 
using the untreated cells as a control. Each point represents the mean 士 S.E. of 
quadruplicate cultures. 
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Figure 3.9: Differential anti-proliferative effect of various epicatechin isomers on 
the human chronic myelogenous leukemia K562 cells. K562 cells (2.5xl0^ cells/ml) 
were incubated with various concentrations (0-35 i^M) of green tea epicatechin isomers 
at 37�C for 48 hours. Cultures were then pulsed with 0.5 i^Ci of ^H-TdR for 8 hours 
before harvest. Radioactivity in counts per minute (cpm) was measured using a liquid 
scintillation counter. Results were expressed as % inhibition of ^-TdR incorporation, 
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Figure 3.10: Differential anti-proliferative effect of various epicatechin isomers on 
the human acute myelogenous leukemia KG-1 cells. KG-1 cells (5xlO^ cells/ml) were 
incubated with various concentrations (0-70 |iM) of green tea epicatechin isomers at 
37°C for 48 hours. Cultures were then pulsed with 0.5 |iCi o f ^ - T d R for 8 hours before 
harvest. Radioactivity in counts per minute (cpm) was measured using a liquid 
scintillation counter. Results were expressed as % inhibition of ^H-TdR incorporation, 
using the untreated cells as a control. Each point represents the mean 士 S.E. of 
quadruplicate cultures. 
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Figure 3.11: Differential anti-proliferative effect of various epicatechin isomers on 
the murine myelomonocytic leukemia JCS cells. JCS cells (lxlO^ cells/ml) were 
incubated with various concentrations (0-35 |iM) of green tea epicatechin isomers at 
37°C for 48 hours. Cultures were then pulsed with 0.5 i^Ci of^H-TdR for 8 hours before 
harvest. Radioactivity in counts per minute (cpm) was measured using a liquid 
scintillation counter. Results were expressed as % inhibition of ^H-TdR incorporation, 
using the untreated cells as a control. Each point represents the mean 士 S.E. of 
quadruplicate cultures. 
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Figure 3.12: Differential anti-proliferative effect of various epicatechin isomers on 
the murine myeloblastic leukemia Ml cells. Ml cells (5xlO^ cells/ml) were incubated 
with various concentrations (0-35 ^M) of green tea epicatechin isomers at 37�C for 48 
hours. Cultures were then pulsed with 0.5 ^Ci of ^H-TdR for 8 hours before harvest. 
Radioactivity in counts per minute (cpm) was measured using a liquid scintillation 
counter. Results were expressed as % inhibition of ^H-TdR incorporation, using the 
untreated cells as a control. Each point represents the mean 士 S.E. of quadruplicate 
cultures. 
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Figure 3.13: Differential anti-proliferative effect of various epicatechin isomers on 
the murine lymphocytic leukemia L1210 cells. L1210 cells (lxlO^ cells/ml) were 
incubated with various concentrations (0-35 i^M) of green tea epicatechin isomers at 
37�C for 48 hours. Cultures were then pulsed with 0.5 i^Ci of^H-TdR for 8 hours before 
harvest. Radioactivity in counts per minute (cpm) was measured using a liquid 
scintillation counter. Results were expressed as % inhibition of ^H-TdR incorporation, 
using the untreated cells as a control. Each point represents the mean 士 S.E. of 
quadruplicate cultures. 
134 
Chapter 3 Anti-tumor Activities 
120 n 
+ E G C G 
� % 100 - + E G C • — — M • • • 
S ^ E C G / / 
卜 + E c /y , 
”-/ / / 
t / / / 1 ： ： ^ ^ ^ 
^ A ^ ¾ ^ ' ^ 20 30 40 
-20 J 
Concentration of Epicatechin Isomer (^iM) 
L 
Figure 3.14: Differential anti-proliferative effect of various epicatechin isomers on 
the murine T cell lymphoma MBL-2 cells. MBL-2 cells (lxlO^ cells/ml) were 
incubated with various concentrations (0-35 i^M) of green tea epicatechin isomers at 
37°C for 48 hours. Cultures were then pulsed with 0.5 i^Ci of^H-TdR for 8 hours before 
harvest. Radioactivity in counts per minute (cpm) was measured using a liquid 
scintillation counter. Results were expressed as % inhibition of ^ -TdR incorporation, 
using the untreated cells as a control. Each point represents the mean 士 S.E. of 
quadruplicate cultures. 
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Figure 3.15: Differential anti-proliferative effect of various epicatechin isomers on 
the murine T cell lymphoma YAC-1 cells. YAC-1 cells (2.5xl0^ cells/ml) were 
incubated with various concentrations (0-35 ^M) of green tea epicatechin isomers at 
37�C for 48 hours. Cultures were then pulsed with 0.5 i^Ci of^H-TdR for 8 hours before 
harvest. Radioactivity in counts per minute (cpm) was measured using a liquid 
scintillation counter. Results were expressed as % inhibition of ^H-TdR incorporation, 
using the untreated cells as a control. Each point represents the mean 士 S.E. of 
quadruplicate cultures. 
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Figure 3.16: Differential anti-proliferative effect of various epicatechin isomers on 
the murine macrophage-like tumor P388D1 cells. P388D1 cells (5xlO^ cells/ml) were 
incubated with various concentrations (0-35 |iM) of green tea epicatechin isomers at 
37T for 48 hours. Cultures were then pulsed with 0.5 |iCi o f ^ - T d R for 8 hours before 
harvest. Radioactivity in counts per minute (cpm) was measured using a liquid 
scintillation counter. Results were expressed as % inhibition of ^-TdR incorporation, 
using the untreated cells as a control. Each point represents the mean 土 S.E. of 
quadruplicate cultures. 
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Figure 3.17: Differential anti-proliferative effect of various epicatechin isomers on 
the murine macrophage-like tumor PU5-1.8 cells. PU5-1.8 cells (2.5xl0^ cells/ml) 
were incubated with various concentrations (0-70 |nM) of green tea epicatechin isomers 
at 37�C for 48 hours. Cultures were then pulsed with 0.5 i^Ci of ^H-TdR for 8 hours 
before harvest. Radioactivity in counts per minute (cpm) was measured using a liquid 
scintillation counter. Results were expressed as % inhibition of ^H-TdR incorporation, 
using the untreated cells as a control. Each point represents the mean 士 S.E. of 
quadruplicate cultures. 
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Table 3.2: The estimated IC50 values and optimal inhibitory concentrations of 
EGCG and EGC on different leukemic cell lines 
^ EGCG E ^ 
Tumor Cell Line o ? t I ^ Opt imal“ 
ICsoValue ICgoValue 
Concentration Concentration 
( _ * ( _ * 
(jiM) # (HM) # 
EoL-1 M l 60 T6 30 
HL-60 9：5 lS 7 r5 
“ “ ^ rT5 25 n 3 25 
Myeloid Tumors 
~ ~ ^ 42 ^ 26 50 
~ " ^ rL5 20 r ^ l5 
Ml 20 l0 YJ3 25 
° Emo 9 B r 15 
Lymphoid 
MBL-2 IX5 20 9 f5 
Tumors 
YAC-1 rT5 r5 8 ^ f 5 
Macrophage-like°~~P388D1 ^ >35 26 >35 
Tumors PU5-1.8 67 ^ 44 ^75 
* IC50 value is the estimated concentration of green tea epicatechin isomer which can 
cause 50% inhibition of^H-TdR incorporation in specified experimental conditions. 
# Optimal concentration is the estimated concentration of tea epicatechin isomer in 
which the inhibition of leukemic cell proliferation reaches a plateau. 
H 4 
Chapter 3 Anti-tumor Activities 
120 n 
1 ^ : 
I 40_ / / ^ 1 2 h o u r s 
% / A ^ - 24 hours 
I 20 - / y _ ^ 48 hours 
� 0 i ^ 1 1 1 i 
0 10 20 30 40 j 







Figure 3.18: Kinetic studies on the anti-proliferative effect of EGCG on the murine 
myeloid leukemia JCS cells. JCS cells (lxlO^ cells/ml) were incubated with various 
concentrations (0-35 i^M) of EGCG at 37�C for different time intervals (12, 24, 48 
hours). Cultures were then pulsed with 0.5 i^Ci of ^H-TdR for 8 hours before harvest. 
Radioactivity in counts per minute (cpm) was measured using a liquid scintillation 
counter. Results were expressed as % inhibition of ^H-TdR incorporation, using the 
untreated cells as a control. Each point represents the mean 士 S.E. of quadruplicate 
cultures. 
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Figure 3.19: Kinetic study on the anti-proliferative effect of EGC on the murine 
myeloid leukemia JCS cells. JCS cells (lxlO^ cells/ml) were incubated with various 
concentrations (0-35 i^M) ofEGC at 37�C for different time intervals (12, 24, 48 hours). 
Cultures were then pulsed with 0.5 i^Ci of ^H-TdR for 8 hours before harvest. 
Radioactivity in counts per minute (cpm) was measured using a liquid scintillation 
counter. Results were expressed as % inhibition of ^H-TdR incorporation, using the 
untreated cells as a control. Each point represents the mean 士 S.E. of quadruplicate 
cultures. 
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3.2.2.2 In Vitro Cytotoxic Effect of Green Tea Epicatechin Isomers on Various 
Human and Murine Leukemic Cell Lines 
Apart from exhibiting differential cytostatic activity on various leukemic cell 
、 
lines, the cytotoxicity of different green tea epicatechin isomers to these cell lines was 
also examined, using the trypan blue exclusion test after 48 hours of incubation. Similar 
to the experiments on the anti-proliferative effect, various human and murine leukemic 
cell lines including EoL-1 (Figure 3.20), HL-60 (Figure 3.21), K562 (Figure 3.22), KG-
1 (Figure 3.23), JCS (Figure 3.24), Ml (Figure 3.25), L1210 (Figure 3.26), MBL-2 
(Figure 3.27), YAC-1 (Figure 3.28) and PU5-1.8 (Figure 3.29) were studied. The results 
showed that among the four green tea epicatechin isomers tested, EC and ECG were 
found to exhibit little, if any, cytotoxicity on various leukemic cell lines at 
concentrations up to 30 i^M. The only exceptions are the murine T cell lymphoma MBL_ 
2 and YAC-1 cells, in which ECG exerted a significant cytotoxic effect (~ 70% and � 
55% cytotoxicity respectively) at a concentration of 30 i^M. In contrast, the other 
epicatechin isomers EGCG and EGC were found to exhibit significant cytotoxic effect 
on various leukemic cell lines in a dose-dependent manner. The 50% cytotoxicity (C50) 
values for EGCG and EGC were summarized in Table 3.3. Among the cell lines being 
tested, L1210 cells were demonstrated to be the most sensitive to the cytotoxic effect of 
EGCG and EGC followed by JCS cells whereas PU5-1.8 cells were found to be the most 
resistant to the cytotoxic effect of both EGCG and EGC. Kinetic studies using the 
murine myeloid leukemia JCS cells showed that both EGCG and EGC exhibit their 
cytotoxic effect in a time-dependent manner (Figure 3.30 and 3.31). 
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Figure 3.20: Differential cytotoxic effect of various green tea epicatechin isomers on 
the human eosinophilic leukemia Eol-l cells. Eol-l cells (5xlO^ cells/ml) were 
incubated with various concentrations (0-70 i^M) of different green tea epicatechin 
isomers at 37°C for 48 hours. Cell viability was determined by the trypan blue exclusion 
test, and the results were expressed as mean % of viable cells 士 S.E. of triplicate cultures. 
H 8 
Chapter 3 Anti-tumor Activities 
120 n 
、 
100 11 , • ^ 一 • • 
^ ^ ^ ^ f ^ ^ c T ^ 
§ 80 - ^^k ^ ^ 
| 6 0 - ^ ^ = ¾ ^ 
t> + E G C G * T ^ S | 
^ 40 - ^ - E C 
+ EGC 
20 - + E C G 
0 \ 1 1 1 1 
0 10 20 30 40 
Concentration of Epicatechin Isomer (p,M) 
Figure 3.21: Differential cytotoxic effect ofvarious green tea epicatechin isomers on 
the human promyelocytic leukemia HL-60 cells. HL-60 cells (5xl0^ cells/ml) were 
incubated with various concentrations (0-35 i^M) of different green tea epicatechin 
isomers at 37°C for 48 hours. Cell viability was determined by the trypan blue exclusion 
test, and the results were expressed as mean % of viable cells 士 S.E. of triplicate cultures. 
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Figure 3.22: Differential cytotoxic effect of various green tea epicatechin isomers on 
the human chronic myelogenous leukemia K562 cells. K562 cells (2.5xl0^ cells/ml) 
were incubated with various concentrations (0-35 i^M) of different green tea epicatechin 
isomers at 37°C for 48 hours. Cell viability was determined by the trypan blue exclusion 
test, and the results were expressed as mean % of viable cells 士 S.E. of triplicate cultures. 
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Figure 3.23: Differential cytotoxic effect ofvarious green tea epicatechin isomers on 
the human acute myelogenous leukemia KG-1 cells. KG-1 cells (5xl0^ cells/ml) were 
incubated with various concentrations (0-70 |iM) of different green tea epicatechin 
isomers at 37°C for 48 hours. Cell viability was determined by the trypan blue exclusion 
test, and the results were expressed as mean % of viable cells 土 S.E. of triplicate cultures. 
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Figure 3.24: Differential cytotoxic effect ofvarious green tea epicatechin isomers on 
the murine myelomonocytic leukemia JCS cells. JCS cells (lxlO^ cells/ml) were 
incubated with various concentrations (0-35 i^M) of different green tea epicatechin 
isomers at 37°C for 48 hours. Cell viability was determined by the trypan blue exclusion 
test, and the results were expressed as mean % of viable cells 士 S.E. of triplicate cultures. 
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Figure 3.25: Differential cytotoxic effect ofvarious green tea epicatechin isomers on 
the murine myeloblastic leukemia Ml cells. Ml cells (5xlO^ cells/ml) were incubated 
with various concentrations (0-35 ^M) of different green tea epicatechin isomers at 37°C 
for 48 hours. Cell viability was determined by the trypan blue exclusion test, and the 
results were expressed as mean % of viable cells 士 S.E. of triplicate cultures. 
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Figure 3.26: Differential cytotoxic effect ofvarious green tea epicatechin isomers on 
the murine lymphocytic leukemia L1210 cells. L1210 cells (lxlO^ cells/ml) were 
incubated with various concentrations (0-35 |iM) of different green tea epicatechin 
isomers at 37°C for 48 hours. Cell viability was determined by the trypan blue exclusion 
test, and the results were expressed as mean % of viable cells 士 S.E. of triplicate cultures. 
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Figure 3.27: Differential cytotoxic effect ofvarious green tea epicatechin isomers on 
the murine T cell lymphoma MBL-2 cells. MBL-2 cells (lxlO^ cells/ml) were 
incubated with various concentrations (0-35 ^M) of different green tea epicatechin 
isomers at 37°C for 48 hours. Cell viability was determined by the trypan blue exclusion 
test, and the results were expressed as mean % of viable cells 士 S.E. of triplicate cultures. 
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Figure 3.28: Differential cytotoxic effect ofvarious green tea epicatechin isomers on 
the murine T cell lymphoma YAC-1 cells. YAC-1 cells (2.5xl0^ cells/ml) were 
incubated with various concentrations (0-35 i^M) of different green tea epicatechin 
isomers at 37°C for 48 hours. Cell viability was determined by the trypan blue exclusion 
test, and the results were expressed as mean % of viable cells 士 S.E. of triplicate cultures. 
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Figure 3.29: Differential cytotoxic effect of various green tea epicatechin isomers on 
the murine macrophage-like leukemia PU5-1.8 cells. PU5-1.8 cells (5xlO^ cells/ml) 
were incubated with various concentrations (0-70 fj,M) of different green tea epicatechin 
isomers at 37°C for 48 hours. Cell viability was determined by the trypan blue exclusion 
test, and the results were expressed as mean % of viable cells 士 S.E. of triplicate cultures. 
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Table 3.3: The estimated C50Values of EGCG and EGC on different leukemic cell 
lines 
Tumor Cell Line EGCG E ^ 
C50VaIue (^iM) * C50Value (\iM) * 
EoL-1 47 26.5 
HL-60 33 33 
Myeloid i 5w 30 22 
Tumors KG-1 ^ 44 
^ r ^ m 
m 30 r93 
L i 2 i 0 l4i5 9 
Lymphoid 
MBi:^ r9 r s 3 
Tumors 
v I c ^ ^ ^ ~ 
= ^ ^ ^ = ^ ^ ^ = = ^ ^ = = ^ ^ = ^ ^ = = ^ ^ = = = = ^ ^ ^ ^ ^ ^ = ^ = ^ ^ ^ ^ ^ ^ ^ ^ = ^ ^ ^ = ^ ^ = = = ^ ^ ^ ^ ^ = 
Macrophage-
PU5-1.8 >70 >70 
like Tumor 
^ ^ ^ ^ ; ; ^ ^ ^ ^ ^ ; ^ ^ ^ ; ; : ^ ^ ^ ^ ^ : : ^ ^ ^ ; ^ : ^ ; ^ ^ ^ ^ ^ ^ ^ ; ^ j ^ ^ ^ 7 — ^ ^ — — ^ — ~ ^ ^ ^ ^ ^ ^ — ^ ^ ^ ^ ^ ^ — ~ ~ - * ^ •“ •“ ‘ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ — i i i - - ^ ^ - ^ - ^ ^ ^ - ^ ^ ^ - ^ ^ ^ ^ ^ - ^ ^ ^ ^ ^ - ^ - ^ ^ ^ - ^ ^ - " ^ ^ ^ — ^ ^ — — * — ^ ^ 
* C50 value is the estimated concentration of tea epicatechin isomer that will result in 
50% cytotoxicity of the leukemia cells in specified experimental conditions. 
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Figure 3.30: Kinetic studies on the cytotoxic effect of EGCG on the murine myeloid 
leukemia JCS cells. JCS cells (lxlO^ cells/ml) were incubated with different 
concentrations (0-35 i^M) of EGCG at 37�C for different time intervals (12, 24, 48 
hours). Cell viability was determined by the trypan blue exclusion test, and the results 
were expressed as mean % of viable cells 士 S.E. of triplicate cultures. 
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Figure 3.31: Kinetic studies on the cytotoxic effect of EGC on the murine myeloid 
leukemia JCS cells. JCS cells (lxlO^ cells/ml) were incubated with different 
concentrations (0-35 i^M) ofEGC at 37�C for different time intervals (12, 24, 48 hours). 
Cell viability was determined by the trypan blue exclusion test, and the results were 
expressed as mean % of viable cells 士 S.E. oftriplicate cultures. 
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3.2.2.3 Effects of Green Tea Epicatechins Isomers on the Differentiation of 
Myeloid Leukemia Cells 
� In previous sections our results have demonstrated that green tea epicatechin 
isomers such as EGCG and EGC exhibited potent differential anti-proliferative and 
cytotoxic effects on various leukemia cells. In the present study, the ability of various 
green tea epicatechin isomers to induce differentiation on myeloid leukemia cells in 
vitro was investigated by examining the cellular morphological changes on the 
cytocentrifuge smear preparations. 
In the first set of experiments, the human myeloid leukemia HL-60 cells and the 
murine myeloid leukemia JCS cells were incubated with different concentrations of 
EGCG (10 and 15 ^M) at 37�C for 4 and 3 days respectively. As shown in Figure 3.32, 
EGCG failed to induce observable differentiation on both HL-60 and JCS cells under the 
prescribed experimental conditions. Most of the cells had the morphology comparable to 
the control untreated cells and remained undifferentiated at the blast stage with large and 
centralized nuclei. 
In the second set of experiments, the ability of other green tea epicatechin 
isomers to trigger differentiation of the HL-60 cells was examined. Results in Figure 
3.33 showed that all other green tea epicatechin isomers, including EGC, ECG and EC, 
failed to trigger the differentiation of myeloid leukemia cells. 
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Figure 3.32: Effect of EGCG on the morphology of myeloid leukemia cells. HL-60 
cells (5xl0^ cells/ml) and JCS cells (lxlO^ cells/ml) were incubated with EGCG at 37¾ 
for 4 and 3 days respectively. The cells were then cytocentrifuged onto the microscopic 
slides, and were stained with Hemacolor stain solutions. (A) Untreated HL-60 cells; (B) 
HL-60 cells treated with 10 fiM EGCG; (C) Untreated JCS cells; and (D) JCS cells 
treated with 15 i^M EGCG (Magnification x 400). 
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Figure 3.33: Effects of green tea epicatechin isomers on the morphology of myeloid 
leukemia cells. HL-60 cells (5xl0^ cells/ml) were incubated with 30 i^M green tea 
epicatechin isomers at 37°C for 4 days. The cells were then cytocentrifuged onto the 
microscopic slides, and were stained with Hemacolor stain solutions. (A) Untreated HL-
60 cells; (B) EGC-treated HL-60 cells; (C) ECG-treated HL-60 cells and (D) EC-treated 
HL-60 cells (Magnification x 400). 
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3.2.2.4 Apoptosis-inducing Effect of Different Green Tea Epicatechin Isomers 
on HL-60 and JCS Cells 
In the present study, the ability of various green tea epicatechin isomers to 
、 
induce apoptosis in different leukemic cell lines was examined. Among the cell lines 
being tested, including the human myeloid leukemias HL-60, KG-1, Eol-land K562 
cells, the murine myeloid leukemias JCS and Ml and the murine lymphocytic leukemia 
L1210 cells, apoptosis could only be observed in the HL-60 and JCS cells. As shown in 
Figure 3.34 and Figure 3.35, apoptotic DNA ladders could only be found in HL-60 and 
JCS cells treated with 15 ^M EGCG or EGC. There was no DNA ladder observed in the 
ECG and EC treated HL-60 and JCS cells. The apoptosis-inducing effect of EGCG and 
EGC at different time intervals was further studied. It was found that apoptotic DNA 
ladders started to appear after 4 hours of treatment with 15 [iM EGCG or EGC (Figure 
3.36 and 3.37). In HL-60 cells, the amount of fragmented DNA increased as the 
incubation time increased from 4 to 12 hours in both EGCG and EGC-treated cells. In 
JCS cells, the amounts of fragmented DNA in both EGCG- and EGC-treated cells 
increased to a maximum after 8 hours of incubation. 
The morphological features of apoptotic HL-60 cells were also examined on 
cytospin preparations of the leukemia cells. Shrinking cells containing fragmented and 
condensed nuclei were observed after treatment of HL-60 cells with 15 i^M EGCG 
(Figure 3.38B) or EGC (Figure 3.38C) for 8 hours. 
The induction of apoptosis was also analyzed quantitatively by flow cytometry 
with Annexin V-FITC and propidium iodide (PI) binding. Cells that stained positive for 
m 
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Annexin V-FITC and negative for PI were undergoing apoptosis. Cells that stained 
positive for both Annexin V-FITC and PI were either at the end stage of apoptosis, 
undergoing necrosis, or were already dead. For the normal and viable cells, both � 
Annexin V-FITC and PI stains were negative. As shown in Figure 3.39, the apoptosis-
inducing effect of EGCG in HL-60 cells was dose-dependent in which the number of 
apoptotic cells increased with the concentration of EGCG. A positive control indicating 
the dead or necrotic cells was shown in Figure 3.39D, in which the viable cells 
decreased sharply and most of the dead cells appeared in the upper right quarter of the 
dotplot. 
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Figure 3.34: Effects of different green tea epicatechin isomers on the induction of DNA 
fragmentation in HL-60 ceUs. HL-60 cells (5xlO^ cells/ml) were incubated with EGCG, EGC, 
ECG, EC or (+)-catechin (15 ^M) at 37°C for 8 hours. Apoptotic DNA fragments were isolated 
by mild detergent IGEPAL CA-630 lysis buffer, and were analyzed by electrophoresis on 2% 
agarose gel stained with ethidium bromide. 
Lane 1: 100bp DNA ladder Lane 4: EGC-treated HL-60 cells 
Lane 2: Untreated HL-60 cells Lane 5: ECG-treated HL-60 cells 
Lane 3: EGCG-treated HL-60 cells Lane 6: EC-treated HL-60 cells 
Lane 7: (+)-catechin-treated HL-60 cells 
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Figure 3.35: Effects of dliferent green tea epicatechin isomers on the induction of DNA 
fr^mentation in JCS celk. JCS cells (4xl0^ cells/ml) were incubated with various epicatechin 
isomers (15 )nM) at 37°C for 5 hours. Apoptotic DNA fragments were isolated by mild detergent 
IGEPAL CA-630 lysis buffer, and were analyzed by electrophoresis on 2% agarose gel stained 
with ethidium bromide. 
Lane 1: 100bp DNA ladder Lane 4: EGC-treated JCS cells 
Lane 2: Untreated JCS cells Lane 5: ECG-treated JCS cells 
Lane 3: EGCG-treated JCS cells Lane 6: EC-treated JCS cells 
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Figure 3.36: Kinetic studies on the induction of DNA fragmentation in HL-60 celk by 
EGCG and EGC. HL-60 cells (5xlO^ cells/ml) were incubated with (A) EGCG and (B) EGC at 
a concentration of 15 |uM at 37°C for different periods of time (from 2 to 24 hours). Apoptotic 
DNA fragments were isolated by mild detergent IGEPAL CA-630 lysis buffer, and Were 
analyzed by electrophoresis on 2% agarose gel stained with ethidium bromide. 
Lane A1: 1 OObp DNA ladder Lane B1: 1 OObp DNA ladder 
Lane A2: Treated with EGCG for 2 hours Lane B2: Treated with EGC for 2 hours 
Lane A3: Treated with EGCG for 4 hours Lane B3: Treated with EGC for 4 hours 
Lane A4: Treated with EGCG for 8 hours Lane B4: Treated with EGC for 8 hours 
Lane A5: Treated with EGCG for 12 hours Lane B5: Treated with EGC for 12 hours 
Lane A6: Treated with EGCG for 24 hours Lane B6: Treated with EGC for 24 hours 
Lane A7: Untreated cells (24 hours) Lane B7: Untreated cells (24 hours) 
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Figure 3.37: Kinetic studies on the induction ofDNA fragmentation in JCS celLs by EGCG 
and EGC. JCS cells (4xl0^ cells/ml) were incubated with (A) EGCG and (B) EGC at a 
concentration of 15 p.M at 3TC for different periods of time (from 2 to 24 hours). Apoptotic 
DNA fragments were isolated by mild detergent IGEPAL CA-630 lysis buffer, and were 
analyzed by electrophoresis on 2% agarose gel stained with ethidium bromide. 
Lane A1: 1 OObp DNA ladder Lane B1: 1 OObp DNA ladder 
Lane A2: Treated with EGCG for 2 hours Lane B2: Treated with EGC for 2 hours 
Lane A3: Treated with EGCG for 4 hours Lane B3: Treated with EGC for 4 hours 
Lane A4: Treated with EGCG for 8 hours Lane B4: Treated with EGC for 8 hours 
Lane A5: Treated with EGCG for 12 hours Lane B5: Treated with EGC for 12 hours 
Lane A6: Treated with EGCG for 24 hours Lane B6: Treated with EGC for 24 hours 
Lane A7: Untreated cells (24 hours) Lane B7: Untreated cells (24 hours) 
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Figure 3.38: Expression of apoptotic morphology in EGCG- and EGC-treated 
HL-60 cells. HL-60 cells (5xlO^ cells/ml) were incubated with (A) ethanol as the 
solvent control; (B) 15 ^M EGCG; (C) 15 i^M EGC at 37�C for 8 hours. The cells were 
cytocentrifiaged onto the microscopic slides, and were stained with Hemacolor stain 
solutions. Arrows indicate the apoptotic cells (Magnification x 400). 
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Figure 3.39: Annexin V-FITC analysis of apoptotic HL-60 cells by flow cytometry. 
HL-60 cells (5xlO^ cells/ml) were incubated with different concentrations (10 or 20 ^M) 
of EGCG at 37�C for 4 hours. EGCG-treated cells (lxlO^ cells/ml) were then stained 
with Annexin V-FITC and propidium iodide in binding buffer. The stained cells (lxlO^ 
cells) were analyzed for fluorescence intensity using the FACSort flow cytometer. (A) 
Untreated HL-60 cells; (B) HL-60 cells treated with 10 i^M EGCG; (C) HL-60 cells 
treated with 20 |iM EGCG; (D) HL-60 cells treated with 1 mg/ml digitonin before 
staining as a positive control. 
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3.2.2.5 Effect of EGCG on the In Vivo Tumorigenicity of Leukemia JCS and 
L1210 Cells 
� Since EGCG is the most abundant green tea epicatechin isomer and exhibits 
potent anti-proliferative and apoptosis-inducing activities on a variety of leukemic cell 
lines, therefore, the effect of EGCG on the in vivo tumorigenicity of two murine 
leukemic cell lines was investigated. JCS cells (1.2xl0^ cells/ml) and L1210 cells 
(1.5xlO^ cells/ml) were incubated with different concentrations of EGCG (0-30 ^M) for 
8 hours at 37�C. The cells were washed with RPMI medium and then injected 
intraperitoneally into syngeneic BALB/c mice. Leukemia cells recoverable from the 
peritoneal cavity of mice were counted at day 5 post-inoculation. Results in Figure 3.40, 
showed that pre-treatment of both JCS and L1210 cells with EGCG in vitro could 
significantly decrease the leukemic cell growth in syngeneic mice in a dose-dependent 
manner, indicating that EGCG can reduce the tumorigenicity of the leukemia cells in 
vivo. 
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Figure 3.40: Effects of//i vitro treatment leukemia cells with EGCG on their tumorigenicity 
in BALB/c mice. (A) JCS cells (1.2xl0^ cells/ml) were incubated with different concentrations 
(15 and 20 |xM) ofEGCG for 8 hours at 37°C. (B) L1210 cells (1.5xlO^cells/ml) were incubated 
with different concentrations (20 and 30 ^M) of EGCG for 8 hours at 37°C. The cells were 
washed three times with RPMI medium. 3xlO^ viable JCS cells and 5xlO^ viable L1210 cells 
were injected intraperitoneally into BALB/c mice in groups of five. Leukemia cells recoverable 
from the peritoneal cavity of mice were counted at day 5 post-tumor inoculation. 
Significantly different from untreated cells: * P<0.003. 
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3.3 Discussion 
In this chapter, the direct anti-tumor effects of green tea, oolong tea and black tea 
extracts on the growth of various types of leukemia cells were first studied. Using ^H-
TdR incorporation assay, all three tea extracts were found to exhibit potent anti-
proliferative effect on various leukemia cells in a dose-dependent manner. Among the 
leukemia cells being studied, the murine lymphocytic leukemia L1210 cells were found 
to be the most sensitive one, with IC50 values of 3.5, 2 and 3 ^ig/ml for green tea, oolong 
tea and black tea extracts respectively. The observed growth-inhibitory effect of tea 
extracts on L1210 leukemia cells cannot be attributed directly or solely to the cytotoxic 
effect ofthe tea extracts on the leukemia cells, as our results showed that the tea extracts 
exhibited little, if any, cytotoxicity on the L1210 cells at a concentration of 5 ^g/ml. On 
the other hand, all the tea extracts were found to have apoptosis-inducing effect on the 
human myeloid leukemia HL-60 cells. Our results are consistent with that of Zhao et al 
(1997) who previously demonstrated that tea polyphenols could induce apoptosis in HL-
60 cells in a dose- and time-dependent manner. Since green tea is reported to have 
diverse beneficial effects, its composition is well-defined and the various epicatechin 
isomers are readily available, therefore, in this chapter, the direct anti-tumor activities of 
various green tea epicatechin isomers were further studied. 
Among the green tea epicatechin isomers being examined, EGC and EGCG, two 
major constituents of the green tea catechins, were found to exhibit potent anti-
proliferative activity on various leukemic cell lines in a dose-dependent manner. 
Interestingly, the other two epicatechin isomers, EC and ECG, were found to be 
relatively inactive. The present results are similar to others who showed that EGCG 
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could inhibit the growth of a wide variety of human and murine cancer cell lines, 
including hepatoma, erythroleukemia, melanoma, carcinoma of the prostate, liver, breast, 
colon, and lung etc. (Lea et aL, 1993; Yang et aL, 1998c & 2000). Our results also � 
showed that different leukemic cell lines had different sensitivities to the growth 
inhibitory effect of EGCG and EGC. Interestingly, the more matured macrophage-like 
tumors are relatively resistant to both EGCG and EGC whereas the murine lymphocytic 
leukemia L1210 cells and the myeloid leukemia JCS and HL-60 cells are very sensitive 
to the anti-proliferative effect of EGCG and EGC. The underlying mechanisms for the 
differential growth-inhibitory effect of EGC and EGCG on leukemia cells remain 
obscure. Liang et al. (1997) demonstrated that EGCG could exhibit a sealing effect on 
tumor cells by blocking the EGF binding to its receptors and inhibited its tyrosine kinase 
activity in the human epidermoid carcinoma cell line A43. Besides, Zhen et al. (1991) 
found that green tea extract was an active nucleoside transport inhibitor, which could 
prevent the supply of nucleosides for DNA synthesis. Despite of these findings, the 
molecular mechanisms by which EGCG and EGC could exert their differential anti-
proliferative effects on various types of leukemia cells remain to be further elucidated. 
Apart from the differential anti-proliferative effect, EGC and EGCG were also 
found to exhibit potent cytotoxic effect on various types of leukemia cells, especially at 
higher concentrations. In contrast, EC and ECG were found to exhibit, little, if any, 
cytotoxicity on various types of leukemia cells. It has been reported that EGC can 
decrease tumor cell viability by the stimulation of protein tyrosine kinase (PTK) and the 
reduction of sulfhydryl (SH) groups in tumor cells (Kennedy et al, 1998 & 1999). 
However, others studies have demonstrated the suppression of tyrosine kinase activity 
by both EGC and EGCG. (Liang et al., 1997; Lu et ^sf/.,1998). Therefore, more 
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researches are required to further elucidate the mechanisms by which the epicatechin 
isomers could exert their cytotoxic effect on tumor cells. One recent report showed that 
green tea catechins could significantly reduce the membrane fluidity by interacting with � 
the lipid bilayers (Tsuchiya, 1998). Perhaps the reduction of membrane fluidity may 
directly contribute to the differential cytotoxicity of green tea catechin on tumor cells. 
Among the four major green tea epicatechin isomers, EGCG and EGC were 
shown to be the most effective in exerting cytostatic and cytotoxic effects on various 
leukemia cells. Similarly, others had demonstrated that EGCG exhibited the strongest 
antioxidative activity among the green tea catechins tested (Chen & Ho, 1995). 
Moreover, Hu et al. (1993) showed that the mitogenic effect of EGCG on B cells might 
be related to its special structure, the presence of the galloyl group. Whether the galloyl 
group might be critical in the biological activities of green tea catechins awaits further 
investigations. Therefore, more efforts are needed to elucidate the structure-function 
relationship of green tea epicatechin isomers and to define the underlying mechanisms 
by which EGCG and EGC could exert their cytostatic and cytotoxic effects on the 
leukemia cells. 
Previous works in our laboratory have demonstrated that plant flavonoids could 
exhibit potent differentiative-inducing activity in vitro (Kong, 1997). It is of interest to 
examine whether green tea epicatechins can also induce cellular differentiation. Our 
results showed that all four epicatechin isomers failed to trigger the myeloid leukemia 
HL-60 cells to undergo morphological differentiation. On the other hand, our 
preliminary experiments indicated that with repeated replenishment of the myeloid 
leukemia cells with green tea epicatechin isomers, such a protocol could, to certain 
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extent, induce HL-60 cells to undergo morphological differentiation. Whether the failure 
of green tea epicatechin isomers to induce cell differentiation is related to their 
instability at physiological pH remains to be established. � 
Previous study had demonstrated that EGCG could induce apoptosis in HL-60 
cells in a time- and dose-dependent manner (Tung, 1999). In the present study, the 
effects ofvarious green tea epicatechin isomers to induce apoptosis in different leukemia 
cells were examined and the results showed that both EGC and EGCG could induce 
apoptosis in HL-60 and JCS cells in a dose-and time-dependent manner. Our data is in 
agreement with the finding of Saeki et al (2000) who showed that it is the 5'-hydroxyl 
group in the B-ring of the epicatechin isomers that contribute to the apoptosis-inducing 
ability. Other studies had shown that EGCG induced apoptosis in tumor cells was 
mediated by the production of H2O2 and by inhibition of DNA topoisomerase II (Xie & 
Wang, 1992; Yang et al, 1998). A recent mechanistic study has revealed that EGCG can 
induce apoptosis via the activation of caspase-3 (Islam et al., 2000). However, the 
cellular and molecular mechanisms by which EGCG can cause apoptosis of tumor cells 
remain poorly understood. It may be due to the modulation of the signalling pathways or 
the expression of certain genes such as c-fos, c-jun, c-myc and bcl-2 (Pandey et al, 1995; 
Ahmad et al； 1997; Chen et al., 1998; Osuka et al., 1998). Therefore, the effects of 
EGCG on the expression of growth-related and apoptosis-regulatory proteins on 
leukemia cells will be investigated in the next chapter. 
Previous work in our laboratory demonstrated that EGCG could reduce the 
clonogenicity of both HL-60 and JCS cells in vitro in a dose-dependent manner (Tung, 
1999). Beside, GTCs were also found to inhibit the growth of two transplantable tumors, 
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EAT and JCS, in vivo. In the present study, the effects of EGCG on the tumorigenicity 
of two transplantable leukemia JCS and L1210 cells in syngeneic mice were investigated. 
Similar to the in vitro findings, our data showed that treatment of leukemia cells in vitro � 
with EGCG could significantly reduce the in vivo growth of the leukemia cells. 
However, whether direct administration of EGCG to the tumor-bearing mice could 
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4.1 Introduction 
Cancer has long been the number one killer in humans worldwide (Schottenfeld 
及 Fraumenic, 1996). A number of conventional cancer therapies such as surgery, 
chemotherapy and radiotherapy are unsatisfactory that might result in multi-drug 
resistance, suffered from a lot of limitations or accompanied with many undesirable side 
effects (Boik, 1996). Therefore, there is a pressing need to search for new drugs and to 
establish new therapeutic strategies that are safe and effective for cancer treatments. In 
recent years, a number of physiological compounds and natural products including 
steroid hormones, vitamin analogs, cytokines and plant phytochemicals, etc have been 
identified to have the ability to induce differentiation, apoptosis and inhibition on the 
growth of certain cancer cells (Alcain & Buron, 1994; Leung et al., 1994; Chan et al., 
1997; Bunce et al； 1997; Fung et al, 1997; Lopez-Lluch et al； 1998; James et al., 1999; 
Suganuma et al., 1999; Pae et al., 1999). It is believed that they can act either alone or in 
combinations with one another in cancer therapy. It is well known that many myeloid 
leukemic cell lines can be induced to undergo differentiation in response to various 
physiological and non-physiological differentiation inducers such as all-trans retinoic 
acid (ATRA), 1,25-dihydroxyvitamin D3 (Vit D3) and Bufalin (Zhang et al., 1992; James 
et al., 1999). A novel approach for the treatment of leukemia is the differentiation 
therapy in which immature leukemia cells are induced to attain a mature phenotype 
when exposed to differentiation inducers alone or in combination with other 
chemotherapeutic or chemopreventive drugs. One successful example is the use of all-
trans-retinoic acid in the treatment of AML (Sachs, 1996). 
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Cytokines are potential candidates for the differentiation therapy of leukemia. 
Cytokines such as TNF-a, IFN-y, IL-1, IL-4 and IL-6 have been shown to induce the in 
vitro differentiation of myeloid leukemia cells into mature macrophages or granulocytes � 
either individually or synergistically with other cytokines or inducers (Zhang et al., 1992; 
Mak et al； 1993; Leung et al., 1994; Chan et aL, 1997). For examples, IL-4 could act 
synergistically with TNF-a to inhibit the proliferation and to induce monocytic 
differentiation of the murine WEHI-3B JCS cells (Leung et al., 1994). Moreover, the 
combination of IFN-y and Vit. D3 was found to act in synergy in inducing the 
differentiation of HL-60 and U937 cells (Zhang et al, 1992). It is believed that the 
understanding of the roles and functions of these physiological inducers and cytokines 
can provide some insights for the investigation of the action mechanisms of other 
potential anti-tumor agents. 
Over the past decade, numerous studies reported that green tea catechins have 
significant anti-carcinogenic and anti-oxidative activities, which suggest that green tea 
catechins may be a useful cancer chemopreventive agent in the human populations. 
More recent studies indicated that green tea catechins exhibit diverse anti-tumor 
activities on a number of human cancers including cancers of the breast, liver, lung, 
stomach, skin, colon, prostate gland and leukemia (Liang et al., 1997; Okabe et «/.,1997 
& 1999; Otsuka et al., 1998; Yang et al,, 1998c & 2000). The anti-tumor activities were 
mainly found to be mediated through the induction of cell cycle arrest and apoptosis. For 
examples, Ahmad et al. (1997) demonstrated that EGCG inhibited the growth ofhuman 
epidermoid carcinoma cells (A431) by induction of apoptosis and cell cycle arrest at Go_ 
Gi phase. Moreover, Gupta et al (2000) showed that EGCG could induce cell cycle 
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arrest at Go-Gi phase and apoptosis in both androgen-sensitive and androgen-insensitive 
human prostate carcinoma cells. Mechanistic studies have revealed that the 
dysregulation of cell cycle by EGCG was mediated by the inhibition of cyclin-dependent � 
kinase 2 and 4 activities as well as the induction of cdk inhibitors p21 and p27 (Liang et 
al., 1999; Gupta et al., 2000). Despite of these findings, the precise molecular 
mechanisms by which green tea epicatechin isomers can exert their anti-proliferative and 
apoptotic effects on tumor cells and the signal transduction pathways that might be 
involved have not yet been fully elucidated. 
In this chapter, the effects of EGCG in combinations with various inducers, 
including vitamin analogs, hematopoietic cytokines (IL-1, IFN-y and TNF-a), and 
phytochemicals (Taxol, ISp-glycyrrhetinic acid and other green tea epicatechin isomers) 
in regulating the proliferation ofhuman and murine myeloid leukemia cells were studied. 
Moreover, to further elucidate the molecular mechanisms by which EGCG could inhibit 
proliferation and to induce apoptosis in the human leukemia HL-60 cells, the expression 
of certain growth-related and apoptosis regulatory genes and proteins were studied by 
RT-PCR and Westem blot analysis respectively. 
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4.2 Results 
4.2.1 Combining Effect of EGCG and Physiological Differentiation Inducers on 
the Proliferation ofHL-60 and JCS Cells 
、 
Leukemia cells can be induced to undergo differentiation by a number of 
physiological differentiation inducers such as all-trans retinoic acid (ATRA) and 1,25-
dihydroxyvitamin D3 (Vit D3). In this set of experiments, the ability of ATRA and Vit D3 
to synergise the anti-proliferative effect of EGCG on human and murine leukemia cells 
was examined. Leukemia cells were incubated with different concentrations of EGCG 
and inducers for 48 hours. The combining effect was measured by the M-TdR 
incorporation assay using untreated cells as a control. 
As shown in Figure 4.1, JCS cells were found to be more sensitive to ATRA than 
HL-60 cells. At 10 ^M ATRA, up to 60% inhibition of proliferation was observed in 
JCS cells but the same concentration of ATRA could only inhibit the proliferation of 
HL-60 cells by 40%. Addition of ATRA could enhance the anti-proliferative effect of 
EGCG in both HL-60 and JCS cells but the effect was mainly additive rather than 
synergistic. On the other hand, results in Figure 4.2 showed that Vit D3 alone could 
significantly inhibit the proliferation of leukemia cells. The response of HL-60 cells to 
Vit D3 was much less than that of JCS cells. Vit D3 alone at 5 nM could inhibit JCS cell 
proliferation by 80% while in HL-60 cells, 500 nM Vit D3was required to reduce the 
proliferation of HL-60 cells by 60%. At the concentrations of Vit D3 and EGCG tested, 
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Figure 4.1: Effect ofEGCG and all-trans retinoic acid (ATRA) on the proliferation ofHL-
60 and JCS cells. (A) HL-60 cells (5xlO^ cells/ml) and (B) JCS cells (lxlO^ cells/ml) were 
incubated with EGCG alone (0-30 i^M) or in the presence ofEGCG and ATRA (5 and 10 juM) at 
3TC for 48 hours. Cultures were then pulsed with 0.5 fxCi of ^-TdR for 8 and 6 hours for 
HL-60 cells and JCS cells respectively before harvest. Radioactivity in cpm was measured using 
i ^
 . 
； a liquid scintillation counter. Results were expressed as % inhibition of ^H-TdR incorporation, 
p. j 
using the untreated cells as a control. Each point represents the mean 士 S.E. of quadruplicate 
cultures. 
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Figure 4.2: Effect of EGCG and 1,25-dihydroxyvitamin D3 fVit D3) on the proliferation of 
HL-60 and JCS cells. (A) HL-60 cells (5xlO^ cells/ml) and (B) JCS cells (lxlO^ cells/ml) were 
？: 
^ incubated with EGCG alone (0-30 jitM) or in the presence ofEGCG and Vit D3 (500 and 200 nM 
t 
I 
I for HL-60, or 1 and 5 nM for JCS cells) at 37�C for 48 hours. Cultures were then pulsed with 0.5 
I 
p,Ci of 3H-TdR for 8 and 6 hours for HL-60 cells and JCS cells respectively before harvest. 
Radioactivity in cpm was measured using a liquid scintillation counter. Results were expressed 
as % inhibition of ^ - T d R incorporation, using the untreated cells as a control. Each point 
represents the mean 士 S.E. of quadruplicate cultures. 
^ 4 ； 
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4.2.2 Combining Effect of EGCG and Cytokines on the Proliferation of JCS Cells 
A number of growth factors or cytokines have been reported to have the ability 
to induce differentiation or apoptosis in leukemia cells either alone or in synergy. In this � 
part of the experiments, the modulatory effect of a number of cytokines on the anti-
proliferative effect of EGCG for the murine myeloid leukemia JCS cells was 
investigated. JCS cells were incubated with different concentrations of EGCG and 
various cytokines including IL-la, IL-ip, IFN-y and TNF-a at 37�C for 48 hours. The 
combining effect was measured by ^H-TdR incorporation assay using untreated cells as a 
control. 
As shown in Figure 4.3 and Figure 4.4, IL-la and IL-ip alone exhibited 
significant inhibitory effect on the proliferation of JCS cells (20-40%) at concentrations 
of 1 and 10 ng/ml. They did not show any synergistic activity when combined with 
EGCG. An additive inhibitory effect of IL-la and IL-lp on JCS cell proliferation was 
observed when combined with EGCG and this effect was declined when the 
concentration of EGCG was increased. 
On the other hand, IFN-y and TNF-a were found to synergise the anti-
proliferative effect of EGCG on JCS cells. As shown in Figure 4.5, IFN-y alone 
exhibited a small inhibitory effect (-10 %) on the proliferation of JCS cells even at a 
concentration of 500 U/ml. However, it was found that IFN-y significantly enhanced the 
anti-proliferative effect of EGCG at concentration ranging from 10 to 20 i^M. At 20 ^M 
of EGCG, addition of 100 U/ml IFN-y could almost completely inhibit the proliferation 
on JCS cells. In other concentrations of EGCG, IFN-y gave only an additive effect on 
lJ5 
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the proliferation of JCS cells. Similar results were also obtained with TNF-a when 
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Figure 4.3: Effect of EGCG and IL-la on the proliferation ofJCS cells. JCS cells (lxlO^ 
cells/ml) were incubated either with EGCG alone (0-30 ^M) or in the presence of EGCG and 
IL-la (1 and 10 ng/ml) at 37°C for 48 hours. Cultures were then pulsed with 0.5 |aCi of^H-TdR 
for 6 hours before harvest. Radioactivity in cpm was measured using a liquid scintillation 
counter. Results were expressed as % inhibition of ^-TdR incorporation, using the untreated 
cells as a control. Each point represents the mean 士 S.E. of quadruplicate cultures. 
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Figure 4.4: Effect of EGCG and IL-ip on the proliferation of JCS cells. JCS cells (lxlO^ 
cells/ml) were incubated either with EGCG alone (0-30 \xM) or in the presence of EGCG and 
IL-lp(l and 10 ng/ml) at 3TC for 48 hours. Cultures were then pulsed with 0.5 ^Ci of^-TdR 
for 6 hours before harvest. Radioactivity in cpm was measured using a liquid scintillation 
counter. Results were expressed as % inhibition of ^H-TdR incorporation, using the untreated 
cells as a control. Each point represents the mean 土 S.E. of quadruplicate cultures. 
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Figure 4.5: Effect of EGCG and mV-y on the proliferation of JCS cells. JCS cells (lxlO^ 
cells/ml) were incubated either with EGCG alone (0-30 pM) or in the presence of EGCG and 
IFN-y (100 and 500 U/ml) at 37�C for 48 hours. Cultures were then pulsed with 0.5 ^Ci o f ^ -
TdR for 6 hours before harvest. Radioactivity in cpm was measured using a liquid scintillation 
counter. Results were expressed as % inhibition of ^-TdR incorporation, using the untreated 
cells as a control. Each point represents the mean 士 S.E. of quadruplicate cultures. 
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Figure 4.6: Effect of EGCG and TNF-a on the proliferation of JCS cells. JCS cells (lxlO^ 
cells/ml) were incubated either with EGCG alone (0-30 ^M) or in the presence of EGCG and 
TNF-a (50 and 100 U/ml) at 37�C for 48 hours. Cultures were then pulsed with 0.5 ^Ci of3H-
TdR for 6 hours before harvest. Radioactivity in cpm was measured using a liquid scintillation 
counter. Results were expressed as % inhibition of ^H-TdR incorporation, using the untreated 
cells as a control. Each point represents the mean 士 S.E. of quadruplicate cultures. 
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4.2.3 Combining Effect of EGCG and Other Phytochemicals on the Proliferation 
ofHL-60 and JCS Cells 
In the present study, the effects of EGCG in combining with other 
� 
phytochemicals including Taxol, 18p-glycyrrhetinic acid (GA) and other green tea 
epicatechin isomers (EC and ECG) were examined. 
As shown in Figure 4.7, Taxol alone at low concentrations (1-4 nM) 
significantly inhibited the proliferation ofboth JCS and HL-60 cells in a dose-dependent 
manner. HL-60 cells were more resistant than the JCS cells to the anti-proliferative 
activity of Taxol. The addition of Taxol enhanced the anti-proliferative effect of EGCG 
on both cell lines but the effect was additive rather than synergistic. 
On the other hand, 1 Sp-glycyrrhetinic acid (GA) significantly inhibited (-30 -
40% inhibition) the proliferation of HL-60 and JCS cells at a concentration of 140 jiiM 
and 50 ^iM respectively (Figure 4.8 & 4.9). In HL-60 cells, GA alone at 70 |uM did not 
show any anti-proliferative activity but it acted in synergy to inhibit the proliferation of 
HL-60 cells when combined with EGCG at a concentration of 10|uM. However, no 
synergistic effect could be observed at higher concentrations of EGCG. At a higher 
concentration of GA (140 nM), the synergistic effect with EGCG was much more 
pronounced (Figure 4.8). In contrast, GA failed to exhibit any synergistic activity with 
• 
EGCG in the inhibition of JCS cell proliferation at all concentrations of EGCG being 
tested (Figure 4.9). 
1 
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EGCG, the major constituent of GTCs, was combined with either EC or ECG, 
the other minor components of GTCs to see whether different components in the green 
tea catechins could act in synergy with each other. As shown in Figure 4.10, EC alone � 
was only slightly inhibitory on the proliferation of HL-60 cells. Moreover, EC could 
only slightly enhance the anti-proliferative effect of EGCG on HL-60 cells. On the other 
hand, ECG (15 ^iM) was found to synergise the anti-proliferative effect of EGCG on 
HL-60 cells, (Figure 4.11) especially at lower concentrations o fEGCG (2.5 and 5 ^iM). 
,, 
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Figure 4.7: Effect ofEGCG and Taxol on the proliferation ofHL-60 and JCS cells. (A) HL-
60 cells (5x104 cells/ml) and (B) JCS cells (lxlO^cells/ml) were incubated with EGCG alone (0-
30 ^M) or in the presence of EGCG and Taxol (3 and 4 nM for HL-60 cells, or 1 and 2 nM for 
JCS cells) at 37�C for 48 hours. Cultures were then pulsed with 0.5 ^Ci of^H-TdR for 8 and 6 
hours for HL-60 and JCS cells cells respectively before harvest. Radioactivity in cpm was 
measured using a liquid scintillation counter. Results were expressed as % inhibition of ^ -TdR 
incorporation, using the untreated cells as a control. Each point represents the mean 士 S.E. of 
quadruplicate culture. 
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Figure 4.8: Effect of EGCG and ISP-glycyrrhetinic acid (18p_GA) on the proliferation of 
HL-60 cells. HL-60 cells (5xlO^cells/ml) were incubated either with EGCG (0-30 ^M) or in the 
presence of EGCG and lSp-GA (70 and 140 |iM) at 37�C for 48 hours. Cultures were then 
pulsed with 0.5 ^Ci of ^H-TdR for 8 hours before harvest. Radioactivity in cpm was measured 
using a liquid scintillation counter. Results were expressed as % inhibition of 3H-TdR 
incorporation, using the untreated cells as a control. Each point represents the mean 士 S.E. of 
quadruplicate cultures. 
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Figure 4.9: Effect of EGCG and ISP-glycyrrhetinic acid (18p-GA) on the proliferation of 
JCS cells. JCS cells (lxlO^ cells/ml) were incubated either with EGCG (0-30 i^M) or in the 
presence ofEGCG and lSP-GA (25 and 50 ^M) at 37°C for 48 hours. Cultures were then pulsed 
with 0.5 ^Ci of 3H-TdR for 6 hours before harvest. Radioactivity in cpm was measured using a 
liquid scintillation counter. Results were expressed as % inhibition of ^H-TdR incorporation, 
using the untreated cells as a control. Each point represents the mean 士 S.E. of quadruplicate 
cultures. 
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Figure 4.10: Effect ofEGCG and EC on the proliferation ofHL-60 cells. HL-60 cells (5xlO^ 
cells/ml) were incubated with EGCG alone (0-30 ^iM) or in combination with EC (15 and 30 |iM) 
at 37°C for 48 hours. Cultures were then pulsed with 0.5 ^Ci of ^H-TdR for 8 hours before 
harvest. Radioactivity in cpm was measured using a liquid scintillation counter. Results were 
expressed as % inhibition of^H-TdR incorporation, using the untreated cells as a control. Each 
point represents the mean 士 S.E. of quadruplicate cultures. 
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Figure 4.11: Effect of EGCG and ECG on the proliferation of HL-60 cells. HL-60 cells 
(5xlO^ cells/ml) were incubated with EGCG alone (0-30 ^M) or in combination with of ECG 
(15 |iM) at 37�C for 48 hours. Cultures were then pulsed with 0.5 i^Ci o f ^ - T d R for 8 hours for 
before harvest. Radioactivity in cpm was measured using a liquid scintillation counter. Results 
were expressed as % inhibition of ^ -TdR incorporation, using the untreated cells as a control. 
Each point represents the mean 士 S.E. of quadruplicate cultures. 
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4.2.4 Modulatory Effects of EGCG on the Expression of Apoptosis-regulatory 
Genes in HL-60 Cells 
� In Chapter 3, the ability of EGCG to inhibit leukemic cell growth and to induce 
apoptosis of the myeloid leukemia cells have been discussed. However, the genes that 
might be involved in regulating the EGCG-induced apoptosis are far from being 
understood. The bcl-2 family genes including the anti-apoptotic genes (such as bcl-2 and 
bcl-Xj) as well as the pro-apoptotic genes (such as bax and bak) have been reported to 
play important roles in regulating the mitochondria-dependent apoptosis (Reed, 1998). 
In the present study, the modulatory effect o fEGCG on the apoptotic gene expression in 
the human promyelocytic leukemia HL-60 cells was investigated by means of the RT-
PCR method, using specific primer pairs for bcl-XL and bak. HL-60 cells (lxlO^ cells) 
were incubated with 15 ^iM EGCG for different periods of time (15, 30, 120, 240 
minutes). HL-60 cells treated with ethanol for 240 minutes were used as the control. 
Total cellular RNAs were isolated by TRIZOL reagent and the samples were subjected 
to reverse transcription in which RNAs were primed with oligo-dT to synthesize cDNA. 
The amount of RNA was normalized by comparison with the amplification of 
glyceraldehyde-3 -phosphate dehydrogenase (GAPDH) mRNA (Figure 4.12 C). Besides, 
a negative control with no cDNA template was included to detect the presence of any 
contaminant in the PCR process. The amplified apoptosis-related cDNA products were 
analyzed by agarose gel electrophoresis. As shown in Figure 4.12A, the bak gene 
expression was increased in a time-dependent manner. Moreover, the expression of bcl-
X[ gene in EGCG-treated HL-60 cells was first increased after 15 — 30 minutes of 
treatment but became decreased significantly at 4 hours of treatment (Figure 4.12B). 
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Figure 4.12: Analysis of apoptosis-regulatory gene expression in EGCG-treated HL-60 
cells by RT-PCR. HL-60 cells (lxlO^ cells) were either incubated with 15 i^M EGCG at 37°C 
for different time intervals (15, 30’ 120, 240 minutes) or treated with ethanol for 240 minutes as 
a control. Total RNAs were extracted by TRIZOL reagent with the method described in Chapter 
2 Section 2.2.8. The RNAs were reverse transcribed and amplified by PCR for 25 cycles using 
specific primer pairs. The PCR products were then analyzed on ethidium bromide stained 2% 
agarose gel. The amount of PCR products was semi-quantified by densitometry. The value at the 
bottom of each band represents the relative intensity after normalization with respect to GADPH. 
M: 100 bp DNA markers 
Lane 1: HL-60 cells treated with ethanol control 
Lane 2: HL-60 cells treated with EGCG for 15 min. 
Lane 3: HL-60 cells treated with EGCG for 30 min. 
Lane 4: HL-60 cells treated with EGCG for 120 min. 
Lane 5: HL-60 cells treated with EGCG for 240 min. 
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4.2.5 Modulatory Effect of EGCG on the Expression of Growth-related and 
Apoptosis-regulatory Proteins in HL-60 Cells 
In the previous section, the effect of EGCG on the transcription of certain 
� 
apoptosis-related genes has been studied. However, whether these transcripts would be 
translated to their corresponding functional proteins to exert their effects within target 
cells was not examined. Since the growth and survival of tumor cells are often regulated 
by the expression of a number of growth-related genes such as c-myc, NpKB, and PKC 
and apoptosis-regulatory genes such as bcl-2, bak, and fas etc., therefore, attempts had 
been made to study the expression of these gene products in EGCG-treated HL-60 
leukemia cells by Western blot analysis. 
HL-60 cells (5xl0^ cells/ml) were incubated with different concentrations of 
EGCG (0-30 ^iM) at 37�C for 48 and 72 hours. The treated HL-60 cells (lxlO^ cells) 
were lysed with 250 i^l lysis buffer. The protein content of each sample was determined 
and normalized by Bradford protein assay. The same amount of protein was then 
subjected to SDS-PAGE at 100 V and the separated proteins in the duplicated gel were 
stained with Coomassie blue (Figure 4.13). Proteins in another gel were transferred to a 
PVDF membrane by semi-dry transfer at 16 V for 45 minutes. The proteins blotted onto 
the membrane were probed with specific primary antibody and then with the enzyme 
conjugated secondary antibody. The expression of protein was detected by the color 
-i 
change of the chromogenic substrate (Figure 4.14) or detected by an ECL detection 
assay (Figure 4.15 and 4.16). In the latter case, the amount of protein on the membranes 
was compared by staining with Coomassive blue after doing the detection assay (Figure 
4.17). 
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As shown in Figure 4.14, the expression of growth-related proteins such as 
protein kinase C 5 (PKC-5) and the oncogene protein product c-Myc was found to be 
upregulated by EGCG in HL-60 cells in a dose-dependent manner after 72 hours of � 
treatment. For the effect of EGCG on the expression of apoptosis-related proteins, it can 
be seen that the expression of Bak protein in HL-60 cells was slightly increased but the 
expression of Bcl-2 protein was significantly suppressed in a dose-dependent manner 
after 48 hours of treatment with EGCG (Figure 4.15). On the other hand, there was no 
obvious change in the expression of Bd-Xi after 48 hours of treatment with EGCG 
(Figure4.15). 
Apart from the effect on the Bcl-2 protein family, the expressions of the Fas 
antigen and Fas ligand are also known to be involved in the triggering of the apoptotic 
process (Nagata, 1994). As shown in Figure 4.16, the expressions of both Fas and Fas-
ligand (Fas-L) in HL-60 cells were greatly enhanced in a dose-dependent manner after 
48 hours of treatment with EGCG. Besides, it was found that the expression of the p65 
subunit o f nuclear factor K B Q S [ F K B ) w a s also significantly increased in EGCG treated 
HL-60 cells (Figure 4.16). 
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Figure 4.13: Coomassie blue staining of the proteins separated by SDS-PAGE^ Proteins in 
10% SDS-polyacrylamide gel were subjected to coomassie blue staining for 30 min^t^s and to 
destaining for 30 minutes at room temperature. The proteins separated by SDS-PAGE were used 
for detection of (A) PKC-5 and (B) c-Myc protein. 
M: Broad range protein markers 
Lane 1: Untreated HL-60 cells 
Lane 2: HL-60 cells treated with 10 |uM EGCG for 72 hours 
Lane 3: HL-60 cells treated with 20 ^M EGCG for 72 hours 
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Figure 4.14: Analysis of growth-related protein expressions in EGCG-treated HL-60 cells 
by Western blot analysis. HL-60 cells (5xlO^ cells/ml) were either incubated with different 
concentrations (10 and 20 |xM) of EGCG or treated with ethanol as a control for 72 hours at 
37°C. The proteins of each sample were extracted and analyzed by Westem blot as described in 
Chapter 2 Section 2.2.9. The protein was probed with specific primary antibody followed by AP-
conjugated secondary antibody and then visualized by adding a chromogenic substrate. The 
value at the bottom of each band represents the relative intensity as determined by densitometry. 
M: Broad range protein markers 
Lane 1: HL-60 cells treated with solvent control 
Lane 2: HL-60 cells treated with 10 jiiM EGCG 
Lane 3: HL-60 cells treated with 20 fxM EGCG 
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Figure 4.15: Analysis of apoptosis-regulatory protein expressions in EGCG-treated HL-60 
cells by Western blot analysis. HL-60 cells (5xl0^ cells/ml) were treated with different 
concentrations of EGCG (0，10，20 and 30 ^M) for 48 hours at 37°C. The proteins of each 
sample were extracted and analyzed by Western blot as described in Chapter 2 Section 2.2.9. 
The proteins were probed with specific primaty antibody followed by horseradish peroxidase-
conjugated secondary antibody and visualized by the ECL assay. The value at the bottom of each 
band represents the relative intensity as determined by densitometty.. 
Lane 1: HL-60 cells treated with solvent control 
Lane 2: HL-60 cells treated with 10 ^M EGCG 
Lane 3: HL-60 cells treated with 20 ^M EGCG 
Lane 4: HL-60 cells treated with 30 i^M EGCG 
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Figure 4.16: Analysis of Fas, Fas ligand and nuclear factor KB protein expressions in 
EGCG-treated HL-60 cells by Western blot analysis. HL-60 cells (5xlO^ cells/ml) were 
treated with different concentrations ofEGCG (0, 10，20 and 30 fiM) for 48 hours at 37°C. The 
proteins of each sample were extracted and analyzed by Westem blot as described in Chapter 2 
Section 2.2.9. The proteins were probed with specific primaty antibody followed by horseradish 
peroxidase-conjugated secondaty antibody and visualized by the ECL assay. The value at the 
bottom of each band represents the relative intensity as determined by densitometry. 
Lane 1: HL-60 cells treated with solvent control 
Lane 2: HL-60 cells treated with 10 ^M EGCG 
Lane 3: HL-60 cells treated with 20 ^M EGCG 
Lane 4: HL-60 cells treated with 30 i^M EGCG 
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Figure 4.17: Coomassie blue staining of the proteins after transferring onto PVDF 
membranes. The proteins on the membranes were probed with specific primaty and secondary 
antibodies. After visualization and documentation of the protein bands, the membranes were 
subjected to coomassie blue staining for 30 minutes and then destaining for 30 minutes at room 
temperature. 
M: Broad range protein markers 
Lane 1: HL-60 cells treated with solvent control for 48 hours 
Lane 2: HL-60 cells treated with 10 ^M EGCG for 48 hours 
Lane 3: HL-60 cells treated with 20 ^M EGCG for 48 hours 
Lane 4: HL-60 cells treated with 30 |uM EGCG for 48 hours 
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4.3 Discussion 
In differentiation therapy of leukemia, a combination of various differentiation-
and apoptosis inducers was usually used in which they can work through different 
signaling pathways and synergistically lowering the concentration of each other 
resulting in a higher therapeutic efficacy (Zhang et al., 1992). In Chapter 3, we 
described the differential cytotoxic effect, anti-proliferative effect and apoptosis-
inducing abilityof EGCG. Our results indicate that EGCG can act as an effective anti-
tumor agent for cancer chemotherapy. One recent study demonstrated the synergistic 
effect ofblack tea polyphenol thearubigin and genistein on the growth ofhuman prostate 
tumor PC-3 cells via cell cycle arrest (Sakamoto, 2000). Besides, it had been reported 
that EGCG could act in synergy with sulindac, tamoxifen and curcumin to inhibit the 
growth of certain cancer cells (Khafif et al., 1998; Suganuma et al., 1999). In the present 
study, the possible synergistic anti-tumor effects of EGCG in combinations with other 
therapeutic agents were further investigated. In particular, the combination effects of 
EGCG with vitamin analogs, cytokines and other phytochemicals on the proliferation of 
both human and murine myeloid leukemia cells were examined. In addition, the 
molecular mechanisms by which EGCG could exert its effects on the myeloid leukemia 
cells were also studied. 
The combination effects of EGCG with all-trans retinoic acid (ATRA) and 1,25-
dihydroxyvitamin D3 (Vit D3) on the proliferation of the human myeloid leukemia HL-60 
cells and murine myeloid leukemia JCS cells were examined. Many studies have shown 
that ATRA and Vit D3 are potent inducers of leukemia differentiation (James et al., 
1999). They have potential use in the differentiation therapy of leukemia. Vit D3 can 
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induce the monocytic differentiation of both malignant and normal hematopoietic cells 
through modulating the expression of some oncogenes such as c-myc and c-fos (Bunce et 
al., 1997) while ATRA can promote the normal differentiation of hematopoietic cells � 
(Kizaki et al., 1993). Results in our study showed that both ATRA and Vit D3 
significantly enhanced the anti-proliferative effect of EGCG on both HL-60 and JCS 
cells. However, they failed to exhibit cooperative or synergistic effect on the growth-
inhibitory activity of EGCG in both HL-60 and JCS cells. Our present finding clearly 
shows co-treatment with EGCG and vitamin analogs resulted in a higher anti-leukemic 
activity against the myeloid leukemia cells. The combination of EGCG and vitamin 
analogs might be useflil for the treatment of some forms of leukemia. 
Apart from the combining effects with vitamin analogs, the cooperative effects 
between EGCG and cytokines on the inhibition of leukemic cell growth were also 
studied. It was reported that exogenous IL- l a and IL-lp could inhibit the proliferation 
and induce the monocytic differentiation of JCS cells either alone or synergistically with 
TNF-a (Chan et al., 1997). Meanwhile, previous finding demonstrated that flavone 
could act in synergy with IL-1 to inhibit the growth and induce the monocytic 
differentiation of JCS cells (Kong, 1998). In contrast, our data showed that the 
combination of either IL- l a or IL-ip with EGCG could only enhance its anti-
proliferative effect on JCS cells in an additive manner. Whether EGCG can enhance the 
differentiation-inducing effect of I L - l a o r IL-P on JCS cells requires further 
investigation. On the other hand, both IFN-y and TNF-a act in synergy with EGCG in 
inhibiting the proliferation of murine myeloid leukemia JCS cells. A relatively low dose 
( � 2 0 ^iM) o fEGCG could achieve nearly complete inhibition on the growth ofleukemia 
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cells in the presence of these cytokines. A previous report had demonstrated that 
TNF-a could inhibit the growth and induce the differentiation of JCS cells into 
macrophage-like cells (Mak et al, 1993). Besides, the differentiation inducing effect of � 
TNF-a was mediated via the production of IL-1 (Chan et al, 1997). Similarly, IFN_ 
ywas also reported to have the ability to inhibit growth and induce monocytic 
differentiation of the JCS cells (Mak et al, 1993). Interestingly, a previous study had 
demonstrated a good response of the CML patients when treated with I F N - a alone or in 
combination with a low dose of IFN-y or TNF-a (Wandl et al., 1992). Our results, 
though rather preliminary, suggest that the combinations of IFN-y or TNF-a with EGCG 
may have potential therapeutic value in the treatment of some forms of myeloid 
leukemia. However, whether EGCG will act in synergy with both IFN-y and TNF-a to 
induce cellular differentiation is still unknown and the action mechanisms o fhow EGCG 
exerts its synergistic anti-proliferative effect with IFN-y and TNF-a still await further 
elucidation. 
The combining effects of EGCG with certain phytochemicals including Taxol, 
18p-glycyrrhetinic acid and other minor constituents of green tea epicatechins were also 
examined in this study. Taxol is an anti-cancer drug which can inhibit the growth of 
various leukemia cells by triggering apoptosis (Al-alami et al., 1998). It has been used 
for the treatment of leukemia but have a number of side effects due to its toxicity at 
higher concentrations (Kunitoh et al., 1998). More recently, Taxol has been shown to 
have synergistic effects with ATRA and Vit D3 in the inhibition of leukemic cell 
proliferation (Leung, 1999). Therefore, it is of interest to examine whether EGCG can 
act in synergy with Taxol so as to reduce the dose of Taxol used in leukemia treatment. 
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Our results showed that Taxol did not exhibit any synergistic effect with EGCG but an 
additive effect was observed for both HL-60 and JCS leukemia cells. On the other hand, 
18p-glycyrrhetinic acid acted in synergy with EGCG in inhibiting the proliferation of � 
the human myeloid leukemia HL-60 cells but not for the murine myeloid leukemia JCS 
cells. A recent study demonstrated that consumption of glycyrrhizin and glycyrrhetinic 
acid has a protecting effect on the immune functions of gamma-ray-irradiated mice (Lin 
et al., 1999). Therefore, our results further suggest that combination of EGCG with 
18 p-glycyrrhetinic acid might have a therapeutic potential as well as a protective effect 
for leukemic patients undergoing radiotherapy. 
Suganuma et al. (1999) found that co-treatment o fPC-9 human lung cancer cells 
with green tea epicatechin isomers such as EGCG and EC, ECG and EC or EGC and EC 
resulted in synergistic enhancement of apoptotic tumor cell death. Our present results 
also showed that ECG but not EC could act in synergy with EGCG to inhibit the 
proliferation of the HL-60 cells. The reason why ECG can enhance the anti-proliferative 
activity of EGCG remains obscure. Our findings together with other investigators 
suggested that total green tea catechins might be more effective than individual 
epicatechin isomers for cancer prevention or treatment in humans. 
To further elucidate the possible molecular mechanisms of how EGCG could 
exert its anti-proliferative and apoptosis-inducing effects, the expressions of certain 
growth-related proteins and apoptosis-regulatory genes and proteins in EGCG-treated 
HL-60 cells were studied. The bcl-2 gene family plays an important role in regulating 
apoptosis. It consists of a number of apoptosis-suppressing (such as bcl-2 and bcl-Xj) 
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and apoptosis-promoting genes (such as bax and bak). The Bcl-2 proteins act in 
homodimers or heterdimers with Bax to control apoptosis. Decreasing Bcl-2 results in 
higher Bax/Bax or Bax/Bcl-2 ratios that enhance and trigger apoptosis by cytochrome c � 
release from mitochondria (Kroemer, 1997; Reed 1998). As shown in Figure 4.12 and 
Figure 4.15, the expression of bak was increased while bcl-2 was down regulated in 
EGCG-treated HL-60 cells. Recently, it has been reported that the EGCG-induced 
apoptosis in the human chondrosarcoma cells was mediated by the activation of caspase-
3 (Islam et al., 2000). Moreover, Wang et al. (1999) showed that apigenin and related 
flavonoids induced apoptosis in HL-60 cells through cytochrome c release and activation 
of caspase-9 and caspase-3. Therefore, the induction of apoptosis in EGCG-treated HL-
60 cells might be mediated via the release of mitochondrial cytochrome c into the 
cytosol, which is controlled by the Bcl-2 protein family. However, whether EGCG can 
affect the mitochondrial integrity resulting in the release of cytochrome c and 
subsequent activation of apoptosis protease activating factor-1 (Apaf-1) and caspases in 
HL-60 cells remain to be determined. 
Besides the Bcl-2 protein family, EGCG was also found to significantly up-
regulate the expression of Fas, Fas ligand (FasL), c-Myc and the transcription factor 
nuclear factor KB (NFKB) in HL-60 cells (Figure 4.14 and 4.16). In addition to cytotoxic 
T cells and NK cells, FasL is also highly expressed in acute leukemia cells for the 
suppression of and escape from the anti-tumor immune responses (Buzyn et aL, 1999; 
Lickliter et al., 1999). Our results also suggested that the EGCG-induced apoptosis in 
HL-60 cells might be mediated through the binding of Fas and FasL. The up-regulation 
of Fas might also increase the susceptibility of the leukemia cells to the anti-tumor 
immunity mediated by cytotoxic T cells and NK cells fNfagata, 1994). However, whether 
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the induced Fas and FasL in EGCG-treated HL-60 cells will function in an autocrine 
marnier to mediate apoptosis awaits further investigation. 
� 
NFKB is a transcription factor that regulates various cellular responses including 
inflammation, proliferation and apoptosis (May & Ghosh, 1998). Kasibhatla et al. (1999) 
and Hsu et al. (1999) demonstrated that NpKB could activate the FasL expression in T-
lymphocytes. Besides, a study also identified a NFKB site in the FasL promoter 
(Kasibhatla et al. 1999). Interestingly, our results also showed an increase in expression 
of both NFKB and FasL in EGCG-treated HL-60 cells. This increased expression of 
NFKB might contribute to the enhanced expression of FasL in HL-60 cells since NFicB 
activation was a regulator of human granulocyte apoptosis in vitro (Ward et al., 1999). 
In contrast to our results, a recent report demonstrated that induction of apoptosis and 
cell cycle arrest in the human epidermoid carcinoma A431 cells by EGCG was mediated 
via the inhibition of NFKB (Ahmad et al., 2000). However, several studies showed an 
activation ofNpKB during apoptosis ofHL-60 cells (Boland et al., 1997; Granville et al., 
2000). Therefore, the involvement of NFKB involved in the apoptosis of HL-60 cells 
triggered by EGCG remains to be resolved. 
The oncogene product c-Myc is a transcription factor that was described to have 
a dual role in controlling cell proliferation and apoptosis (Hoffman & Liebermann, 
1998). It has a key role in the induction of apoptosis in myeloid cells (Askew et al., 1991; 
Malde & Collins 1994; Cole & McMahon，1999). Our results showed that in EGCG-
induced apoptosis of HL-60 cells, there was an up-regulation of c-Myc protein 
expression, which might be closely associated with the function ofBcl-2. Previous work 
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had demonstrated that Bcl-2 could inhibit the c-w3;c-induced apoptosis without affecting 
the c-myc mitogenic function (Bissonnette et al., 1992; Fanidi et al., 1992). A recent 
report found that c-Myc could enhance the expression ofFasL in activated T cells and T � 
cell lines (Brunner et al., 2000). In line with these findings, our results also showed that c-
Myc was upregulated in EGCG-treated HL-60 cells while there was an increased 
expression of FasL and down-regulation of Bcl-2, suggesting that these gene products 
may play a role in regulating the apoptotic process induced by EGCG. 
The control of the signal transduction pathway in EGCG-treated HL-60 cells was 
also investigated by studying the expression of PKC-6 in EGCG-treated HL-60 cells. 
Activation of PKC-5 has been shown to induce apoptosis (Corss, 2000). Lord et aL 
(1995) demonstrated that HL-60 cells could be induced to undergo apoptosis by 
bistratene A, a marine compound that specifically activates PKC-6. Similar to that of 
bistratene A, EGCG was also found to enhance the expression of PKC-5 protein in 
apoptotic HL-60 cells. This implied that EGCG might exert its action through the up-
regulation of PKC-5 which is a Ca�+- independent isozyme ofPKC. More recently, it has 
been reported that the translocation of PKC-5 from cytoplasm to mitochondria results in 
the release of cytochrome c and apoptosis (Majumder et aL, 2000). Besides, Pongracz et 
al. (1999) demonstrated that it was caspase 3 which proteolytically activated PKC-5 in 
spontaneous apoptosis of neutrophils. EGCG has been reported to have the ability to 
activate caspase 3 (Islam et aL, 2000), however, whether this activation of caspase 3 by 
EGCG is mediated by the translocation ofPKC-6 with the consequence of cytochrome c 
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Chapter 5 Effects on Hematopoietic cells 
5.1 Introduction 
Many plant phytochemicals such as flavonoids have been found to have diverse 
immunomodulatory activities that might affect our health. It was reported that a number 
of plant polyphenols could inhibit the proliferation and IL-2 production of human 
lymphocytes (Atlum et aL, 1991; Devi and Das, 1993). On the other hand, green tea 
catechins (GTCs) were found to exhibit a stimulatory effect on the proliferation and 
functions of various types of immune cells including phagocytes, splenic lymphocytes, 
NK cells and LAK cells (Sakagami et al., 1992; Zenda et al., 1997; Tung, 1999). These 
immunomodulatory effects might account for the anti-tumor activity of green tea 
catechins. Therefore, it is of great interest to examine the mechanisms by which green 
tea catechins can exert their effects on the immune cells. 
Previous work by Hu et al. (1993) demonstrated that the major green tea 
epicatechin isomers EGCG and EGC exhibited strong mitogenic activity for mouse 
splenic B-cells but not for splenic T-cells and thymocytes in vitro. They further showed 
that EGCG could enhance both the spontaneous and LPS-induced proliferation of 
splenic B-cells at low concentrations but a suppressive effect was observed at high 
concentrations (Hu et al., 1993). On the contrary, more recent studies in our laboratory 
showed that total green tea catechins (GTCs) could only slightly enhance the 
proliferation of mouse splenocytes but exerted significant co-mitogenic activity on both 
splenic T-and B-cells, both in vitro and in vivo (Tung, 1999). In Chapter 3, we showed 
that the two major components of GTCs, namely EGCG and EGC, exhibited potent anti-
proliferative activity on a number of tumor cell lines. Since EGCG is the major 
constituent in GTCs, therefore, in this chapter, we report the in vitro mitogenic and co-
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mitogenic activities of EGCG on mouse splenic lymphocytes were investigated. Besides, 
the in vivo effect of EGCG on the induction of a primary humoral antibody response in 
mice was also studied in order to examine whether it could affect the functions of B-� 
lymphocytes in vivo, 
Hematopoiesis is known to play a pivot role in the immune system by regulating the 
production of immune cells in response to different stress or physiological challenges. 
Suppressed hematopoiesis would result in anemia or immunodeficiency while 
uncontrolled hematopoiesis might cause leukemia. The effect of green tea catechins on 
hematopoiesis or hematopoietic progenitor cells has not yet been flilly understood. A 
recent study revealed that EGCG did not suppress the colony formation in normal 
hematopoietic progenitor cells at low concentrations but became suppressive at high 
concentrations (Otsuka et al； 1998). Apart from lymphocytes, it is also of considerable 
interest to further study the modulatory effect of green tea catechins on hematopoietic 
progenitor cells. Therefore, in this chapter, attempts were made to study the in vitro 
effects of EGCG on the growth and differentiation of mouse bone marrow cells. 
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5.2 Results 
5.2.1 In Vitro Effects of EGCG on Murine Lymphocytes 
5.2.1.1 In Vitro Effect o fEGCG on the Proliferation ofMurine Splenocytes 
The mitogenic activity of EGCG on splenic lymphocytes was measured by the 
standard ^H-TdR incorporation assay. BALB/c splenocytes (2-5xl0^ cells/well) were 
freshly isolated from spleen and incubated with different concentrations o fEGCG for 48 
hours. The results in Figure 5.1 showed that EGCG did not exhibit a significant 
stimulatory effect on the proliferation of splenocytes at concentrations up to 35 juM. The 
level of3H-TdR incorporation is similar to the control group. 
5.2.1.2 In Vitro Effect of EGCG on the Mitogen-induced Proliferation of Murine 
Splenocytes 
To study the possible co-mitogenic effects of EGCG, BALB/c splenocytes were 
incubated with various concentrations of EGCG in the presence of mitogens at their 
optimal and suboptimal concentrations. Con A was used as a T-cell mitogen while LPS 
was used as a B-cell mitogen. As shown in Figure 5.2, the addition of mitogens 
significantly enhanced the proliferation of splenocytes. Similar to the results of 
mitogenic activity, EGCG failed to exhibit any significant co-mitogenic activity on 
murine splenocytes. In fact EGCG inhibited the mitogen-induced proliferation of 
splenocytes in a dose-dependent manner (Figure 5.2). 
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Figure 5.1: In vitro effect of EGCG on murine splenic lymphocyte proliferation. BALB/c 
splenocytes (2xl0^ cells/well) were incubated with various concentrations (0-35 ^M) of EGCG 
and the corresponding ethanol solvent controls at 2>TC for 48 hours. Cultures were then pulsed 
with 0.5 ^Ci of3H-TdR for 8 hours before harvest. Radioactivity in counts per minute (cpm) was 
measured using a liquid scintillation counter. Each point represents the mean 士 S.E. of 
quadruplicate cultures. 
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Figure 5.2: In vitro effect of EGCG on Con A- and LPS-induced splenocytes proliferation. 
BALB/c splenocytes (2xl0^ cells/well) were incubated with various concentrations of EGCG (0-
35 p,M) in the presence of (A) Con A or (B) LPS at pre-determined suboptimal (0.25 jiig/ml for 
ConA and 0.5 p,g/ml for LPS) and optimal (1.5 ^ig/ml for both Con A and LPS) concentrations. 
After 48 hours of incubation at 37°C, cultures were then pulsed with 0.5 ^Ci of 3H-TdR for 8 
hours before harvest. Radioactivity in counts per minute (cpm) was measured using a liquid 
scintillation counter. Each point represents the mean 士 S.E. of quadruplicate cultures. 
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5.2.1.3 Cytotoxic Effect ofEGCG on Murine Lymphocytes 
To investigate whether EGCG can exhibit any cytotoxic effect on mouse 
splenocytes, BALB/c splenocytes were incubated with various concentrations of EGCG � 
(0-35 ^iM) in 96-well flat-bottomed microtiter plate in a total volume of 0.2 ml at 37°C 
for 48 hours. The cytotoxic effect of EGCG was measured by the trypan blue exclusion 
test. As shown in Figure 5.3, EGCG did not exhibit any significant cytotoxic activity on 
the murine splenocytes in vitro at all concentrations (0-35 ^iM) tested when compared 
with the ethanol solvent control. 
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Figure 5.3: In vitro effect of EGCG on the viability of murine splenic lymphocytes. BALB/c 
splenocytes (5xlO^ cells/well) were incubated with various concentrations (0-35 ^M) of EGCG 
and the corresponding ethanol solvent controls at 37�C for 48 hours. Cell viability was 
determined by trypan blue exclusion test, and the results were expressed as mean % of viable 
cells 士 S.E. of triplicate cultures. 
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5.2.2 Primary Humoral Immune Response to SRBC in EGCG-treated Mice 
Previous study demonstrated that EGCG enhanced both the spontaneous and 
LPS-induced proliferation of splenic B cells in vitro (Hu et al., 1993). However, the in � 
vivo effect of EGCG on B-cell response was not investigated. In the present study, the in 
vivo B-cell function was assessed by measuring the production of antibody to a T-
dependent antigen (SRBC). BALB/c mice were either treated intraperitoneally with 
different doses of EGCG (10 and 40 mg/kg body weight) or PBS for 5 successive days. 
Mice were immunized with 4xl0^ SRBC by intravenous (i.v.) injection on day 3. The 
serum hemagglutinating antibody titer was determined at 7 days post immunization. The 
results shown in Table 5.1 indicated that EGCG failed to enhance the primary antibody 
response against SRBC in mice. There was no difference in the antibody titer of the 
control group and the EGCG-treated groups at 7 days post immunization. 
Table 5.1 Humoral antibody response to SRBC in mice treated with EGCG 
Treatment of mice 丄 Serum hemagglutinating antibody titer ^ 
7 days 
PBS l20 
10 mg/kg EGCG 320 
40 mg/kg EGCG 320 
1 BALB/c mice in groups of four were treated with either PBS or EGCG from day 1 to 
day 5. On day 3, all mice were immunized with 4xlO^RBC. 
2 The hemagglutinating antibody titer was expressed as the reciprocal of the highest 
dilution of serum which gave a positive result of hemagglutination. 
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5.2.3 In Vitro Studies of the Effects of EGCG on Murine Bone Marrow Cells 
5.2.3.1 Effects o fEGCG on the In Vitro Proliferation ofMurine Bone Marrow Cells 
Apart from studying the effects of EGCG on the proliferation of mouse splenic 
� 
lymphocytes, it is of interest to study their effects on the proliferation of hematopoietic 
progenitor cells. BALB/c bone marrow cells were freshly isolated and incubated with 
various concentrations of EGCG or the corresponding ethanol control for 72 hours. As 
shown in Figure 5.4, EGCG exhibited a significant stimulatory effect on the 
proliferation of murine bone marrow cells. Maximal stimulation was seen at a 
concentration of 15 p,M but declined slightly when the concentration of EGCG was 
increased. 
5.2.3.2 The Combining Effect of EGCG and Growth Factors on the In Vitro 
Proliferation of Murine Bone Marrow Cells 
To further study the influence of EGCG on the growth factor driven growth of 
bone marrow cells, BALB/c bone marrow cells were cultured with EGCG in the 
presence of hematopoietic growth factors (IL-3 or GM-CSF) at their optimal and 
suboptimal concentrations. It was found that the addition of both IL-3 and GM-CSF 
could significantly induce the proliferation of bone marrow cells in a dose-dependent 
manner (Figure 5.5 and 5.6). However, EGCG suppressed both IL-3- and GM-CSF-
induced proliferation of bone marrow cells in a dose-dependent manner (Figure 5.5 and 
5.6). The suppressive effect of EGCG was more pronounced when IL-3 was used as the 
growth factor for the bone marrow cells. 
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Figure 5.4: In vitro effect of EGCG on bone marrow proliferation. BALB/c bone marrow 
cells (lxlO^ cells/well) were incubated with various concentrations (0-35 i^M) of EGCG and the 
corresponding ethanol solvent controls at 37�C for 72 hours. Cultures were then pulsed with 0.5 
p,Ci of 3H-TdR for 18 hours before harvest. Radioactivity in counts per minute (cpm) was 
measured using a liquid scintillation counter. Each point represents the mean 士 S.E. of 
quadruplicate cultures. 
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Figure 5.5: Combining effect of EGCG and IL-3 on the proliferation of murine bone 
marrow cells. BALB/c bone marrow cells (lxlO^ cells/well) were incubated with various 
concentrations (0-35 |xM) of EGCG in the presence of IL-3 at pre-determined suboptimal 
(1 U/ml) and optimal (20 U/ml) concentrations. After 72 hours of incubation at 37�C, cultures 
were then pulsed with 0.5 |xCi of ^ -TdR for 18 hours before harvest. Radioactivity in counts 
per minute (cpm) was measured using a liquid scintillation counter. Each point represents the 
mean 士 S.E. of quadruplicate cultures. 
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Figure 5.6: Combining effect of EGCG and GM-CSF on the proliferation of murine bone 
marrow cells. BALB/c bone marrow cells (lxlO^ cells/well) were incubated with various 
concentrations (0-35 |xM) of EGCG in the presence of GM-CSF at pre-determined suboptimal 
(1 U/ml) and optimal (20 U/ml) concentrations. After 72 hours of incubation at 37�C, cultures 
were then pulsed with 0.5 |uCi of^H-TdR for 18 hours before harvest. Radioactivity in counts 
per minute (cpm) was measured using a liquid scintillation counter. Each point represents the 
mean 士 S.E. of quadruplicate cultures. 
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5.2.3.3 In Vitro Cytotoxic Effect o fEGCG on Murine Bone Marrow Cells 
Since EGCG is the major constituent of green tea catechins, therefore, the 
possible cytotoxic effect of EGCG on the murine bone marrow cells grown in the � 
absence or the presence of growth factors was measured by the trypan blue exclusion 
assay. As shown in Figure 5.7, EGCG did not exhibit any significant cytotoxic effect on 
the murine bone marrow cells in vitro at all concentrations (0-35 |iM) tested when 
compared with the ethanol solvent controls. Similarly, EGCG exhibited no apparent 
cytotoxicity to bone marrow cells grown in the presence o fbo th optimal and suboptimal 
concentrations of growth factors (Figure 5.8). The results indicated that the suppressive 
effect of EGCG on the growth factor induced proliferation of bone marrow cells might 
not be attributed to the direct cytotoxic effect o fEGCG on the bone marrow cells. 
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Figure 5.7: In vitro effect of EGCG on the viability of murine bone marrow cells. BALB/c 
bone marrow cells (lxlO^ cells/well) were incubated with various concentrations (0-35 ^M) of 
EGCG and the corresponding ethanol solvent controls at 37�C for 72 hours. Cell viability was 
determined by trypan blue exclusion test, and the results were expressed as mean % of viable 
cells 士 S.E. of triplicate cultures. 
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Figure 5.8: In vitro effect of EGCG on the viability of murine bone marrow cells grown in 
the presence of growth factors. BALB/c bone marrow cells (lxlO^ cells/well) were incubated 
with various concentrations (0-35 i^M) of EGCG in the presence of (A) IL-3 at pre-determined 
suboptimal (1 U/ml) and optimal (20 U/ml) concentrations or (B) GM-CSF at pre-determined 
suboptimal (10 U/ml) and optimal (20 U/ml) concentrations at 3TC for 72 hours. Cell viability 
was determined by trypan blue exclusion test, and the results were expressed as mean % of 
viable cells 士 S.E. of triplicate cultures. 
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5.2.4 Effect of EGCG on the Differentiation of Murine Bone Marrow Cells 
As shown in the previous section, EGCG alone was found to stimulate the 
proliferation of murine bone marrow cells in vitro. In this study, the ability of EGCG to � 
enhance the growth and to trigger differentiation of the normal hematopoietic progenitor 
cells was investigated. As shown in Figure 5.9, most of the untreated bone marrow cells 
remained at the blast stage having large and central nuclei with a small proportion of 
cytoplasm, which are characteristics of undifferentiated cells. When the bone marrow 
cells were treated with EGCG, morphological changes were observed with the 
appearance of granules and an increase in cytoplasm/nucleus ratio in the cells. 
5.2.5 Combining Effect of EGCG and Growth Factors on the Morphology of 
Murine Bone Marrow Cells 
In Section 5.2.3.2, EGCG was found to antagonize the growth-promoting effect 
of both IL-3 and GM-CSF without apparent cytotoxicity on the bone marrow cells. In 
the present study, the morphology of bone marrow cells treated with EGCG and growth 
factors was examined. The results from Figure 5.10 and 5.11 showed that IL-3 and GM-
CSF alone triggered the growth and differentiation ofbone marrow cells with significant 
morphological changes when compared with the control cells shown in Figure 5.9. 
These changes were seen in a dose-dependent manner where cells were found to be 
extensively differentiated at higher concentrations of the growth factors. At a suboptimal 
concentration ofbo th IL-3 (1 U/ml) and GM-CSF (10 U/ml), treatment ofbone marrow 
cells with 35 |xM ofEGCG did not reveal any apparent morphological changes. However, 
at an optimal concentration of IL-3 (20 U/ml) and GM-CSF (100 U/ml), the proportion 
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Figure 5.9: Morphological changes of EGCG-treated murine bone marrow cells. BALB/c 
bone marrow cells (5xlO^ celL'ml) were incubated with the ethanol solvent control or different 
concentrations (10-35 ^M) ofEGCG at 37°C for 72 hours. The cells were cytocentrifuged onto 
microscopic slides and were stained with Hemacolor solution. The bone marrow cells were 
cultured in medium with (A) ethanol control, (B) 10 ^M EGCG, (C) 20 i^M EGCG and (D) 35 
|xM EGCG (The differentiated cells were indicated by arrows) (Magnification x 400). 
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Figure 5.10: Combining effect of EGCG and D^3 on the morphology of murine bone 
marrow cells. BALB/c bone marrow cells (5xlO^ cell/ml) were incubated with different 
concentrations (1 U/ml and 20 U/ml) of n,-3 and/or 35 juM EGCG at 37�C for 72 hours. The 
cells were cytocentrifuged onto microscopic slides and were stained with the Hemacolor 
solutions. The bone marrow cells were cultured in medium with (A) 1 U/ml D^-3; (B) 1 U/ml IL-
3 and 35 ^M EGCG; (C) 20 U/ml K^-3; (D) 20 U/ml and 35 ^M EGCG (Magnification x 400). 
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Figure 5.11: Combining effect of EGCG and GM-CSF on the morphology of murine bone 
marrow cells. BALB/c bone marrow cells (5xlO^ cell/ml) were incubated with different 
concentrations (10 and 100 U/ml) ofGM-CSF and/or 35 jiiM EGCG at 37°C for 72 hours. The 
cells were cytocentrifuged onto microscopic slides and were stained with the Hemacolor 
solutions. The bone marrow cells were cultured in medium with (A) 10 U/ml GM-CSF; (B) 10 
U/ml GMCSF and 35 i^M EGCG; (C) 100 U/ml GM-CSF; (D) 100 U/ml GMCSF and 35 jiiM 
EGCG (Magnification x 400). 
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5.3 Discussion 
� G r e e n tea catechins (GTCs) have been reported to have diverse physiological and 
pharmacological activities including anti-oxidative, anti-carcinogenic and anti-tumor 
activities and that they might play a role in the prevention of cardiovascular disease and 
cancer. The green tea polyphenols and the major component EGCG in particular, have 
been shown to exhibit growth-inhibitory and cytotoxic effects on wide variety of tumor 
cell lines (Yang et aL, 1998c & 2000). However, there are very few studies regarding the 
effects of GTCs on normal cells and the immunomodulatory effect of green tea 
epicatechin isomers remains poorly understood. Earlier works in our laboratory 
demonstrated that GTCs exhibited modulatory activities on several immune cell types 
including B-and T-lymphocytes, macrophages, NK cells and LAK cells, both in vitro 
and in vivo (Tung, 1999). The results suggested that such immunomodulatory effects of 
GTCs are, at least in part, due to their anti-tumor activities in vivo. Therefore, in this 
chapter, we report the effects of EGCG on murine splenic lymphocytes and bone 
marrow cells. The objective is to see whether the major constituents of GTCs can 
directly affect the growth and differentiation of these cells. 
In the present study, EGCG was found to have little, if any, cytotoxic effects on 
both murine splenocytes and bone marrow cells. The results further supported that the 
cytotoxicity of EGCG was much more specific for cancer cells rather than normal cells 
(Chen et al., 1998). On the other hand, EGCG did not exhibit observable mitogenic and 
co-mitogenic activities on murine splenic lymphocytes but inhibited the mitogen-
induced splenocytes proliferation at higher concentrations. On the other hand, Hu et al. 
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(1993) showed that EGCG could enhance both the spontaneous and mitogen-induced 
proliferation of splenic B cells but not T-cells at lower concentrations (1-20 ^iM) but 
suppressed them at a higher concentration (100 ^iM). The discrepancy may be explained � 
by the works performed by Zenda et al (1997)，who showed that the mitogenic activity 
of EGCG was dependent on the presence of red blood cells (RBC). They found that 
EGCG had to first attach to the membrane of RBC, which then stimulated the B cell 
proliferation. Since in our experiments the red blood cells were largely removed from 
the splenocytes after Ficoll-paque centrifugation, therefore, EGCG failed to enhance the 
proliferation of splenocytes. More recently, GTCs were shown to exhibit both in vitro 
mitogenic and co-mitogenic activities on splenic B- and T-cells at low concentrations 
but inhibited their proliferation at higher concentrations (Tung, 1999). The activities 
appear to be contributed by the combining effects of green tea epicatechin isomers 
within GTCs. However, the mechanism for the suppression of the mitogen-induced 
proliferation of splenic lymphocytes at high concentrations of EGCG or GTCs is 
unknown and requires further investigations. 
Apart from the in vitro studies on splenic lymphocytes, the in vivo effect of EGCG 
on the B-cell function was also investigated. In consistent with our earlier results on 
GTCs (Tung. 1999), EGCG exhibited very little, if any, effect on the primary humoral 
antibody response to a T-dependent antigen in vivo. Our finding indicated that EGCG 
may not have any stimulatory effect on B-cells in vivo under the prescribed experimental 
conditions. 
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Interestingly, our results showed that EGCG could enhance the proliferation of 
murine bone marrow cells in vitro. Besides, EGCG alone was also able to induce the 
morphological differentiation of the bone marrow cells in the absence of exogenously � 
added hematopoietic growth factors. On the other hand, EGCG was found to suppress 
the proliferation of bone marrow cells triggered by growth factors. In addition, the 
morphological differentiation o fbone marrow cells induced by an optimal concentration 
of growth factors was also reduced by treatment with EGCG. The reason for the 
inhibitory effect o f E G C G on the growth factor-induced proliferation and differentiation 
of bone marrow cells is unclear. One hypothesis is that this is due the sealing effect of 
EGCG. It was found that EGCG could suppress the extracellular signals and cell 
proliferation via EGF receptors binding in human A431 epidermoid carcinoma cells 
(Liang et aL, 1997). Therefore, EGCG might interfere or block the growth factors 
signaling in bone marrow cells in response to hematopoietic growth factors such as IL-3 
and GM-CSF. On the other hand, further investigations are required to elucidate the 
possible mechanisms for the stimulatory effect of EGCG on hematopoietic progenitor 
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Chapter 6 Conclusions & Future Perspectives 
Green tea catechins (GTCs) are naturally occurring polyphenolic compounds 
isolated from green tea, which consist of four major epicatechin isomers, namely, 
epigallocatechin gallate (EGCG), epigallocatechin (EGC), epicatechin gallate (ECG) � 
and epicatechin (EC). They have been found to have diverse physiological and 
pharmacological activities, and of great potential in the chemoprevention of various 
cancers. There is increasing evidence showing that GTCs can inhibit the growth of a 
variety of human or murine cancer cells both in vitro and in vivo (Lea, 1993; Ahmad et 
al, 1997; Okabe et al； 1997; Otsuka et al., 1998; Yang et al., 1998c & 2000). However, 
the precise mechanisms by which GTCs can exert their growth-inhibitory effect on 
cancers and the relationship between their chemical structures and anti-tumor activity 
are poorly understood. 
In the present study, different purified green tea epicatechin isomers were found 
to exhibit differential anti-proliferative and cytotoxic activities on various leukemic cell 
lines in a dose-dependent manner. Among the four green tea epicatechin isomers tested, 
EGCG and EGC were found to be the most potent. They were shown to exert significant 
anti-proliferative activity on various leukemia cells at the non-cytotoxic concentrations. 
The in vivo tumorigenicity of leukemia JCS cells and L1210 cells was also markedly 
reduced by treating the cells with EGCG in vitro. These findings suggested the possible 
use of green tea epicatechin isomers in leukemia therapy. However, the molecular 
mechanisms by which EGCG and EGC can modulate the proliferation and survival of 
leukemia cells are far from being understood. One possible reason was suggested by 
Zhen et al (1991) who proposed that GTCs can act as nucleoside transport inhibitors, 
which prevent the utilization of exogenous nucleosides for DNA synthesis during 
proliferation ofcancer cells. Besides, another hypothesis is that EGCG or EGC can exert 
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their effects through the interaction with the growth factor receptors on the leukemia 
cells (Otsuka et aL, 1998). However, the molecular events and signal transduction 
pathways following this interaction have not been elucidated and require further � 
investigation. In addition, results from the present study have shown that the anti-
proliferative activity of EGCG on leukemia cells was significantly enhanced by the 
presence of differentiation inducers (ATRA and Vit D3), cytokines (IL-1, IFN-y and 
TNF-a), or other plant phytochemicals (Taxol, 18p-GA). Among them, cytokines such 
as IFN-y and TNF-a exhibited a synergistic effect with EGCG in inhibiting the growth 
of the murine myeloid leukemia JCS cells. These findings suggested that green tea or 
green tea epicatechin isomers might be a potential candidate to be used in combinations 
with other cancer-preventive or therapeutic agents for the prevention and treatment of 
cancer. However, whether green tea epicatechins can act in synergy with other 
physiological compounds in triggering the differentiation of myeloid leukemia cells has 
yet to be determined. 
Apart from the anti-proliferative and cytotoxic activities, the present study 
showed that EGCG and EGC but not ECG and EC could trigger apoptosis in both the 
human myeloid HL-60 leukemia cells and the murine myeloid leukemia JCS cells in 
vitro with intemucleosomal DNA fragmentation. By comparing with their chemical 
structures, the apoptosis-inducing ability or the growth-inhibitory activity exerted by 
EGCG and EGC on tumor cells might be due to the presence of 5'-hydroxyl group in the 
B ring. This structure-function relationship was also demonstrated by Saeki et al (2000) 
and Wang et al. (1999) who compared the apoptosis-inducing activity on a number of 
structurally-related flavonoids and catechin compounds. However, how this structure 
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work could lead to apoptosis in tumor cells is still unknown. EGCG was also found to 
induce apoptosis specifically in cancer cells but not for their normal counterparts and the 
mechanism of this differential apoptotic response might be the results of its ability to � 
enhance c-fos and c-myc gene expressions in cancer cells (Chen et al； 1998). 
Interestingly, other studies had shown that EGCG triggered apoptosis in tumor cells via 
the production of H2O2 and inhibition of DNA topoisomerase II (Xie & Wang，1992; 
Yang et al., 1998). Until now, the underlying molecular mechanisms and the signaling 
pathways by which EGCG can induce apoptosis in leukemia cells have not yet been 
fully elucidated. 
Our preliminary mechanistic studies demonstrated that Bcl-2 expression was 
suppressed with an enhancement of Bak expression in EGCG-treated HL-60 cells. Since 
recent work have shown that EGCG could activate caspase-3 mediated apoptosis in 
certain human cancer cells (Islam et aL, 2000), it would be of interest to examine 
whether the apoptosis induced by EGCG in HL-60 cells might be mediated through the 
release of cytochrome c followed by the activation of caspase-9 and caspase-3. On the 
other hand, the expressions of other growth-related and apoptosis-regulatory proteins 
including Fas, Fas-L, c-Myc and nuclear factor kappa B QSTpKB) were found to be 
significantly upregulated in apoptotic HL-60 cells after treatment with EGCG. Our 
results suggest that the EGCG-induced apoptosis of the HL-60 cells might be mediated 
by the death signals initiated by the Fas and Fas-L binding. Moreover, the activation or 
induction of NpKB gene expression by EGCG might lead to activation of certain 
apoptotic genes which then trigger apoptosis. However, the role of NpKB in the 
induction of apoptosis in leukemia cells remains largely elusive, as it had been 
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demonstrated that the EGCG-induced apoptosis and cell cycle arrest in other human 
tumor cells were mediated by the inhibition ofNpKB (Ahmad et al., 2000). Therefore, it 
is of interest to further investigate the possible roles of EGCG in affecting the functions � 
of NFKB, which may be a target for the future cancer treatments. The expression of 
PKC-5 in HL-60 cells was enhanced by the treatment with EGCG. Activation of 
PKC-5 may be one of the signaling pathways through which HL-60 undergone apoptosis 
(Cross, 2000). Whether EGCG can affect the expression of other PKC isozymes and the 
effect of EGCG in the intracellular translocation of PKC are important issues that await 
ftiture investigation. Since a large number of genes or gene products are involved in the 
regulation of apoptosis, future work should be done to identify the genes that may be 
instrumental to the EGCG-induced apoptosis. It has been well documented that the 
induction of apoptosis is closely associated with the dysregulation of cell cycle. Several 
studies have shown that EGCG could induce cell cycle arrest in a number of tumor cells 
(Ahmad et al., 1997; Khafif et aL, 1997; Okabe et al., 1997; Gupta et al, 2000). Our 
previous finding also demonstrated that the EGCG-induced apoptosis in HL-60 cells was 
accompanied by the cell cycle arrest at G0/G1 phase (Tung, 1999). It had been 
suggested that EGCG might trigger cell cycle arrest by the inhibition of cyclin-
dependent kinase (cdk) and the induction of cdk inhibitors p21 and p27 (Liang et al., 
1999). Obviously, more research work are needed to define the roles of the cell cycle 
regulatory molecules (cyclins and cdks) in mediating the anti-proliferative and 
apoptosis-inducing effects ofEGCG on leukemia cells. 
Apart from the induction of apoptosis and cell cycle arrest, the growth-inhibitory 
effect ofEGCG in leukemia might be due to its ability to induce terminal differentiation 
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in the leukemia cells. Some naturally occurring flavonoids had been reported to possess 
differentiation-inducing capacity (Wantanabe et al, 1989; Constaninou et al, 1990). 
Previous works in our laboratory had demonstrated that flavone and 3-hydroxyflavone � 
were capable of inducing the differentiation of JCS cells into mature macrophage-like 
cells (Kong, 1997). Our results indicated that a single exposure of leukemia cells to 
EGCG in vitro failed to trigger differentiation in both HL-60 and JCS cells. Interestingly 
enough, we found that repeated replenishment of HL-60 cells in vitro with freshly 
prepared green tea epicatechin isomers, including EGCG, EGC, ECG and EC, could 
induce cellular differentiation with increased granularity and morphological changes 
(data not shown). In view of these findings, the differentiation-inducing ability ofEGCG 
and other epicatechin isomers on leukemia cells is worthy of f tohe r investigation. In 
particular, whether green tea epicatechin isomers can lead to terminal differentiation or 
lead to lineage-specific differentiation remains to be elucidated. 
Apart from studies on the leukemia cells, we have also examined the effects of 
EGCG on normal mouse hematopoietic progenitor cells. Interestingly, the growth and 
differentiation of mouse bone marrow cells were significantly enhanced by the presence 
of EGCG in vitro. Our results suggest that EGCG might have beneficial effects on the 
hematopoietic stem cells especially for the recovery of hematopoiesis after radiotherapy. 
In view of this finding, it is of interest to know whether EGCG can enhance 
erythropoiesis which has an important implication for the treatment of anemia. Quite 
unexpectedly, EGCG was found to inhibit the growth factor-induced proliferation of 
bone marrow cells. Therefore, more animal experiments are needed in order to see 
whether EGCG can enhance the hematopoietic process in vivo. 
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In conclusion, results obtained in this study have shown that EGCG and EGC 
exerted direct anti-tumor activity by inhibiting the proliferation and survival as well as 
inducing apoptotic cell death of both murine and human leukemia cells. The growth-� 
inhibitory effect of EGCG in the murine myeloid leukemia JCS cells could be 
synergistically enhanced by cytokines such as IFN-y and TNF-a. In addition, the 
EGCG-induced apoptotic cell death in the human myeloid leukemia HL-60 cells was 
mediated through modulating the expressions of a number of growth-related and 
apoptosis-regulatory genes and proteins, including the downregulation of Bcl-2 and 
upregulation of Bak, Fas, FasL, c-Myc, NpKB and the PKC-6 proteins. EGCG was also 
found to enhance the growth and differentiation of mouse bone marrow cells. It is hoped 
that the above findings can provide better insights into the beneficial health-promoting 
effects of green tea and leads to better understanding of the molecular basis and action 
mechanisms of the epicatechin isomers. This may ultimately lead to the development of 
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